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Prostaglandin (PG) F output from the guinea pig uterus increases after
Day 11 of the oestrous cycle and oestradiol (whose output from the ovary increases
after Day 10) acting on a progesterone-primed uterus is probably the physiological
stimulus for this increase in uterine PGF„ release. The availability of free
Act
arachidonic acid in the endometrium is the rate-limiting step in PGF synthesis.
The aim of the present studies was to determine the source of arachidonic acid
for endometrial PGF synthesis. Initially, the endometrium ^as maintained in
tissue culture in the presence of tritiated arachidonic acid ( H-AA) and the
radioactivs* contents of the various lipids was subsequently measured. The
uptake of H-AA into phosphatidylcholine (PC) and phosphatidylethanolamine (PE),
was significantly higher on Day 15 (day of high PGF^ synthesis) than on Day 7
(day of low PGF„ synthesis) . Arachidonic acid couid be ir.coroorated into these
Act
phospholipids by an increase in the mass amounts of phospholipids. However
results indicated that there was no significant difference in the amount of
phospholipids present on Day 7 and Day 15. Arachidonic acid could be incorporated
into the phospholipids either by an increase in de novo synthesis or by the
addition to lysophospholipid. The rates-of PC synthesis and phosphatidylinositol
synthesis did not differ on Days 7 and 15, indicating that the measured uptake
of arachidonic acid into phospholipid is not due to increased de novo synthesis
but rather to increased addition to lysophospholipid. Oestradiol may be the
stimulus for this latter process.
A procedure for determining the major pool (s) of release of arachidonic acid
in the guinea pig endometrium was carried out, utilising the same tissue culture
technique. The release of radioactivity from endometrial tissue lipids prelabelled
with H-AA |or 24hr, was measured over a 24hr time period. There was no significant
release of H-AA from any^endometrial lipid class on Day 15; but on Day 7 there was
a significant release of H-AA from diglyceride and monoglyceride. In order to
stimulate a greater release of arachidonic acid (which is more easily monitored)
calcium ionophore A23187 was used since A23187 stimulates PGF„ release from the
2ot .
guinea pig uterus. This stimulus however did not cause any significant decrease
in H-AA content of any lipid class. In the tissue culture system used, oestradiol
stimulates and progesterone inhibits PGF^ output from the guinea pig endometrium.
Therefore, the effects of these steroids on arachidonic acid release from the various
lipids have been measured also. After labelling the lipids with H-AA, Day 7 and
Day 15 endometrial tissue was incubated for a further 48hr in fresh medium containing
no steroids, lOng/ml oestradiol or lOOOng/ml progesterone. The radioactive content
of ^he various lipids were measured. There was no significant changes in the release
■of H-AA from any lipid class (in the absence of steroids) on Day 7 or Day 15 except
that on Day 15 a significant decrease in H-AA content of PC and PE was observed
after 48hr. The presence of steroids had no further significant effect.
The overall data for the uptake and release studies suggest that PE and PC
may be the source of arachidonic acid for increased synthesis of PGF in the guinea
pig endometrium after Day 10 of the cycle.
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An ubiquitous family of compounds known under the general
term of prostanoids has been identified over the last 50
years. Its scientific origins can be traced back to 1930
when New York gynaecologist Raphael Kurzrok and
pharmacologist Charles Lieb reported that an unknown
substance in human semen caused uterine contractions in some
women and relaxation in others. Experiments i_n vitro with
semen added to strips of human uterus resulted in similar
observations and also revealed the interesting observation
that a single tissue sample would contract or relax when
treated with different semen samples.
A short time later Goldblatt (1935) in England and Von Euler
(1935,1937) at the Karolinska Institute in Sweden extended
this work. They discovered .that the unidentified
substance(s) in human seminal fluid not only stimulated the
contraction of a variety of smooth muscles but also affected
the blood pressure of animals when injected intravenously.
In his paper published in 1935, Von Euler suggested the name
prostaglandin for the unknown factor because he had found
trace amounts of it in prostate gland tissue. Four years
later he concluded that prostaglandin was a lipid soluble
fatty acid probably containing a double bond and a hydroxyl
group (Von Euler, 1939)
Inadequate analytical techniques and the intervention of
World War II slowed prostaglandin research for nearly 15
years. However with the encouragement of Von Euler, Bergstrom
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resumed efforts at the Karolinska Institute after the war in
order to purify the unknown factors from seminal fluid, using
techniques such as paper chromatography, gas-liquid
chromatography and countercurrent distribution. Bergstrom
and Sjoval (1957) were then able to isolate one prostaglandin
'factor' (PGF) in crystalline form. By 1960 they were able
to demonstrate the structures of prostaglandins F and E using
techniques such as X-ray crystallography (Bergstrom and
Sjoval, 1 960 a, b). This firmly established that
prostaglandin was not a single compound but a group of
chemically related compounds known under the general term of
prostanoids. The use of mass spectrometry (Bergstrom,
Ryhage, Samuelsson and Sjoval, 1963) confirmed the identities
of both prostaglandins F^K and E^.
Other groups of the prostanoid family include those of the A,
B, C and D series. A mixture of prostaglandins A and B (PGA
and PGB) and their 19-hydroxylated derivatives were initially
measured in human seminal fluid (Bygdeman, Svanborg and
Samuelsson, 1969). Since these earlier studies were
performed on semen stored under haphazard conditions,
controversy developed as to whether PGA and its isomer,
PGB,were formed naturally by the seminal vesicles or by
dehydration of PGE during the extraction techniques prior to
analysis.
Later studies were performed on freshly collected semen or on
semen samples immediately frozen after collection at -10°C.
Also, prior to extraction, the unstable p-ketol systems in
the PGE compounds were protected by oximation thus ensuring
minimal degradation to the A or B series. Data from such
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studies indicated that the PGA and PGB and their T9-
hydroxylated derivatives were not detectable indicating that
the PGA and PGB compounds monitored in the earlier studies
had been formed by the decomposition of the PGE and 19-
hydroxylated PGE compounds in semen (Taylor and Kelly, 1974)
There is no evidence as yet that PGA can be synthesised in
the body from PGE. However PGA can be converted
enzymatica 11y to PGC. PGC is degraded to PGB by
isomerisation in the body (Jones, Cammock and Horton 1972).
Prostaglandins of the D series are isomers of the PGE
compounds (Granstrom, Lands, and Samuelsson, 1968). Formerly
PGD was regarded as an inactive byproduct of prostaglandin
biosynthesis. This view has changed after the identification
of several biological effects, including its ability to
inhibit platelet aggregation (Smith, Silver, Ingerman and
Kocsis, 1974).
Intermediates in PGE, PGF and PGD biosynthesis, namely PGG2
and PGH2 were isolated by Nugteren and Hazelhof (1973) and by
Hamberg and Samuelsson (1973). Both groups used crude enzyme
preparations from sheep vesicular glands in their bio-
syntheses. These intermediates have since been shown to be
precursors to two other groups of compounds - the
thromboxanes (TXs) (Hamberg, Svensson and Samuelsson, 1973)
and prostacyclin (PGI) (Gryglewski, Bunting, Moncada, Flower
and Vane, 1976).
Chemistry
The prostaglandins (PGs) are unsaturated hydroxy acids with a
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five membered ring in a twenty carbon atom skeleton. Their
structure is based on a monocarboxylic acid given the general
name prostanoic acid, which is not known to be a naturally
occurring substance. A large number of variants of the
original substance have now been identified and they may be
classified into nine types (PGA to PGI inclusive). They
differ only in the position of double bonds and/or varying
functional groups occurring usually within the cyclopentane
ring, (see Fig.1.). The number of double bonds in the side
chains are designated by a subscript numeral e.g. PGE2 which
has two double bonds in its side chains. PGs of the "1"
series invariably have only one double bond in the trans A1^~
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position. Members of the "2" series have another double
bond in the cis^""^ position whilst members of the "3" series
17 1 ft
have a further double bond in the trans A position. In
the F series of PGs, an additional subscript refers to
whether the C-9 hydroxyl group is above (k) or below (p) the
plane of the cyclopentane ring i.e. denotes its isomeric
form.
The degree of unsaturation of PG.y is determined by the fatty
acid precursor. For the "1" series this is cis-8,11,T4-
eicosatrienoic acid (dihomo-tf-linoleic acid, DHLA); for the
"2" series this is arachidonic acid(cis-5,8, 11,14-
eicosatetraenoic acid, AA) and for the "3" series this is
cis-5,8,11,l4,17-eicosapentaenoic acid.
Since the "2" series are the major P G * found in most
biological systems (the major exception being primate seminal
fluid where PGs of the "1" and "2" series are found in equal
quantities, see Kelly, 1978) it will be necessary to



























Figure 1. Nomenclature of prostaglandins A to H inclusive.
Prostacyclin (PGI^) is depicted in Fig. 2.
R, - C-.y 0£ ^ ; C5 Hl0
Biosynthesis
PGs are not stored within the cell so biosynthesis of them
must precede their release. Biosynthesis of the n2" series
PGs is dependent upon the availability of the precursor,
namely arachidonic acid. Once released the arachidonic acid
is converted to prostaglandins and thromboxanes by
prostaglandin synthetase, a term commonly used to describe a
microsomal complex of enzymes. The first step is catalysed
by cyclooxygenase which converts arachidonic acid to the
cyclic endoperoxide, 15-hydroperoxide compound, namely PGG^
(by the dioxygenase component of the enzyme). The cyclic
endoperoxide is rapidly converted to its 15-hydroxy analogue,
PGH2 (by the peroxidase component of the enzyme). PGH2 is
the key intermediate in the biosynthesis of the
prostaglandins and thromboxanes (Fig. 2). The precise
nature of the products formed depends upon the tissue under
study". For instance in platelets thromboxane (TXA2) is
the major product (Hamberg et al., 1975) whereas in aortic
tissue prostacyclin (PGI2) is formed primarily (Gryglewski et
al., 1976).
Prostaglandin cyclooxygenase is common to all tissues, so all
"tissues in the body have the capacity for synthesising PGs.
Studies on the oxygenation process of this enzyme
demonstrated an unusual kinetic pattern (Smith and Lands,
1972). Utilisation of arachidonic acid accelerated until a
maximum velocity was reached and then it dropped to zero
velocity gradually. Addition of fresh enzyme to the reaction
mixture caused further biosynthesis of PGs. The deceleration
and cessation of biosynthesis indicated an inactivation of
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the enzyme i.e. the enzyme was "self-limiting" or "suicidal"
in behaviour. Further investigations revealed that the
prosthetic group, ha&W, contained within the enzymes was
destroyed at a much slower rate than the enzyme (Hem'ler and
Lands, 1980). Therefore the inactivation of the enzyme was
due to some direct action on the enzyme rather than
destruction of hJC") per se. In addition glutathione
peroxidase was shown to inhibit cyclooxygenase activity
(Smith and Lands, 1972). This finding, together with the
observation that the induction period required for the
oxygenation of arachidonic acid was reduced by the
incorporation of hydroperoxy acids in the medium, implied
that PGG2 (a hydroxyperoxy acid) acted as a cofactor in its
own biosynthesis (see Lands, 1981).
The major class of inhibitors of cyclooxygenase i.e. the non¬
steroidal, anti-inflammatory drugs such as aspirin and
indomethacin, cause reversible inhibition of the
cyclooxygenase enzyme by competing with the substrate
(arachidonic acid) for the catalytic site (Vane, 1971).
Aspirin also inhibits the cyclooxygenase by transferring an
acetyl group to a serine residue at the active site; the
action was shown to be irreversible (Roth and Majerus, 1975).
Indomethacin also has a time dependent irreversible action,
which is dependent upon the presence of a free carboxyl
moiety and of a halogen atom in the indomethacin

















Figure 2 Major routes of biosynthesis of prostaglandins
(PGs) and thromboxanes (TX) of the 2-series. 12-L-hydroxy-
5,8,10-heptadeoatrienoic acid "(HHT) and malondialdehyde (MDA)
may also be formed from arachidonic acid.
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Both cyclic endoperoxide intermediates resulting from
cyclooxygenase activity are stable for several months in dry
acetone at -20°C but they decompose rapidly upon addition of
hydroxylic solvents. The half life of PGH2 and PGG2 in
aqueous medium at 37°C is about 5 min (Hamberg, Svensson,
Wakabayashi and Samuelsson, 1974).
Action of an isomerase enzyme on PGH2 results in PGE2 while a
reduction step, possibly non enzymatic, on PGH2 yields PGF2K«
The enzyme thromboxane A2 synthase converts PGH2 to TXA2,
malondialdehyde (MDA) and 12-L-hydroxy-5,8,1O-heptadeca-
trienoic acid (HHT) (Hammarstrom and Falardeau, 1977). In
the presence of water TXA2 is rapidly converted to the
relatively inactive but stable thromboxane B2 (TXB2) (Hamberg
et al., 1975). Another enzyme, prostaglandin I2 synthase,
converts PGH2 to the labile but biologically active PGI2.
This prostanoid is unstable in aqueous solution and rapidly
yields the biologically inactive but stable 6-keto-
prostaglandin F 1(X (6-keto-F 1k). PGD2, an isomer of PGE2
(Granstrom et al., 1968) is also formed enzymatically from
PGH2 (Fig. 2)
The synthesis and release of prostaglandins from many intact
tissues has been examined and one organ which has received
much attention is the uterus. The main reason for this is
that in many non-primate mammalian species, the uterus
controls the life-span of the corpus luteum.
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Uterine Luteolytic Hormone (luteolysin)
In 1923> Loeb carried out investigations into the importance
of the uterus in controlling the length of the oestrous
cycle. He demonstrated that hysterectomy in the guinea pig
prevented regression of the corpus luteum resulting in a
prolonged oestrous cycle of 60 to 120 days. Loeb suggested
that "it is possible that the uterus, in particular its
mucosa, produced an internal secretion which exerted a
specific, abbreviating effect on the life of the corpus
luteum " (Loeb, 1927). It was hypothesised therefore that,
in the guinea pig, there existed a uterine luteolytic hormone
with the ability to cause the corpus luteum to regress.
The total removal of the uterus with subsequent prolonged
luteal function has also been demonstrated in the cow
(Wiltbank and Casida, 1956 ; Anderson, Neal and Melampy,
1962), the mare (Hughes, Stabenfeldt and Evans, 1977), the
sheep (Wiltbank and Casida, 1956), the pig (Spies, Zimmerman,
Self and Casida, 1958), the pseudopregnant rat
(Bradbury, 1937), the rabbit (Asdell and Hammond, 1933) and
the hamster (Caldwell, Mazer and Wright, 1967).
Treatment resulting in the destruction of the endometrium in
the pig often caused luteal maintenance (Anderson, Butcher
and Melampy, 1961) suggesting that the luteolytic hormone was
probably secreted by the endometrial cells of the uterus.
In certain species such as the Macacus rhesus monkey (Burford
and Diddle, 1936) and most notably the human (Jones and
Telinde, 1961; Beavis, Brown and Smith, 1969) the removal of
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the uterus had no effect on cyclic ovarian function. It is
probable that in these primate species the uterus exerts no
control over the life span of the corpus luteum.
Between 1929 and 1969 attempts to isolate the luteolytic
principle from the uterus of those species which apparently
produced it were unsuccessful. However several important
characteristics of the uterine - luteal relationship were
established. One of the most striking features was that in
many species the uterine horn exerted an influence over its
adjacent ovary only. Thus in the hemi-hysterectomised
animal, the corpora lutea were maintained in the ovary
adjacent to the hem i-hysterectomy and normal luteal
regression occurred in the ovary ipsilateral to the retained
horn. The local effect of the luteolysin was demonstrated
in the ewe'(Inskeep and Butcher, 1966), guinea pig (Bland and
Donovan, 1966), pseudopregnant rat (Barley, Butcher and
Inskeep, 1966) and hamster (Orsini, 1968). An exception was
found in the cycling pig where normal bilateral regression
continued to occur after hemi-hysterectomy. However, when
only one quarter of one horn was left intact corpora lutea on
the other side did not now regress (Anderson et al., 1961).
The local nature of the uterine luteolytic hormone seemed to
indicate that the pituitary was not involved in the uterine -
luteal relationship (Bland and Donovan, 1966).
In 1 969, PGF2oc was found to mimic i_n vivo the effect of the
luteolytic hormone in the guinea pig (Blatchley and Donovan,
1969), the rat (Pharriss and Wyngarden,1 969) and the rabbit
(Gutknecht, Cornette and Pharriss, 1969). ^^^'2oc
(1mg/kg/day) was infused into the uterine lumen of
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pseudopregnant rats for two days (Days 5 and 6) and the
progesterone content of the ovaries of these animals was
compared to that of animals receiving only saline. It was
observed that the progesterone levels were decreased compared
to the saline controls (Pharriss and Wyngarden, 1969).
Therefore administration of PGF2K a time when the corpora
lutea had become established and functional resulted in
morphological regression of the corpus luteum and a decrease
in ovarian progesterone levels.
Subsequently, PGF'2K was shown to be luteolytic in other non-
primate, mammalian species including the sheep (McCracken,
Glew and Scaramuzzi, 1970), the cow (Liehr, Marion and Olsen,
1972; Lauderdale, 1972), the pig (Glee-s°n, 1974) and the mare
(Noden, Oxendir and Hafs, 197*0
Evidence That PG^oc Ts the Luteolytic Hormone
To determine whether PGF-2K was indeed the uterine luteolytic
hormone, it was necessary to demonstrate that luteal
regression occurredafter PGF2K had been released from the
uterus in the normal and experimental situation'. The levels
of PGF2k in the uterine venous blood were shown to increase
towards the end of the oestrous cycle just prior to luteal
regression in the sheep (Bland, Horton and Poyser, 1971J
McCracken, Carlson, Glew, Goding, Baird, Green and
Samuelsson, 1972), the guinea pig (Blatchley, Donovan, Horton
and Poyser, 1972), the pig (Gleeson and Thorburn, 1973;
Gleeson, Thorburn and Cox, 1974) and the cow (Nancarrow,
Buckmaster, Chamley, Cox, Cumming, Cummins, Drinari, Findlay,
Goding, Restall, Schneider and Thorburn, 1973)- The levels
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of PGF2k in the uterine venous blood of these four species
increased from about Day 11 although this timing was not
invariable. Significant increases were usually evident by
Day 13 and luteal regression in these species was usually
complete by Days 16 to 18. Elevated PGF2oc levels were
maintained throughout this period.
Bland and Donovan (1966) demonstrated that the insertion of
foreign bodies such as glass beads into the uterine lumen of
guinea pigs on Days 2 to 4 of the cycle caused luteal
regression to occur between Days 9 to 11. In such guinea
pigs, an increase in utero-ovarian PGF2k occurred by P>ay 8
and reached a peak by Day 12 when utero-ovarian plasma
progesterone levels were greatly reduced (Blatchley, Donovan
and Poyser, 1976). The pattern of PGF2oc secretion was
similar to and of the same order of magnitude as that found
during the normal oestrous cycle of the guinea pig (Earthy,
Bishop and Flack, 1975). Consequently, premature regression
induced by intra-uterine beads is associated with early
release of PGF2o{ from the uterus. The production of PGF2k by
the uterus in response to stimuli such as beads and intra¬
uterine devices was demonstrated also in the sheep (Spilman
and Duby, 1972) rat and hamster (Saksena, Lau and Castracane,
1974) .
If PGF20C was dndeed the uterine luteolytic hormone, it was
necessary to determine whether the inhibition of uterine
prostaglandin synthesis prevented normal luteal regression
and elongated the oestrous cycle. Inhibition of PGF2k
synthesis was brought about by indomethacin, a potent
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inhibitor of the cyclooxygenase enzyme (Vane, 1971). A
slow-release preparation of indomethacin placed in the
uterine lumen increased oestrous cycle length in guinea pigs
(Horton and Poyser, 1973; Marley, 1973). Oral or parenteral
administration of indomethacin to guinea pigs was not really
as effective as local administration of the drug (Marley,
1972; Horton and Poyser, 1973). A subsequent study (Poyser
and Horton, 1975) showed that intra-uterine administration of
indomethacin maintained high plasma progesterone
concentrations for much longer than normal indicating that
regression of the corpora lutea had been prevented.
Therefore, it was probable that the increase in cycle length
induced by indomethacin treatment was due to inhibition of
uterine prostaglandin synthesis. Indomethacin treatment was
also able to prolong the corpora luteal life span in other
species including the rabbit (O'Grady, Caldwell, Auletta and
Speroff, 1972) and the rat (Chatterjee, 1973).
Active immunisation against PGF2K resulted in elongation of
the oestrous cycle in several species; it is probable that
the antibodies effectively neutralised PGF£K when released
from the uterus into the vascular system. In the guinea pig
(Horton and Poyser, 1974) animals with high anti-PGF2K titres
had their oestrous cycles prolonged to a greater extent than
those animals with lower antibody titres. Immunisation
against PGF2K also prevented luteal regression in the sheep
(Scaramuzzi, Baird, Wheeler and Land, 1973)-
To summarise, the accumulated data has demonstrated that:
i) pgf2<x Present in the uterine vein at the time of
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luteolysis in greater amounts than during the earlier stages
of the cycle, the increase preceding luteolysis in the guinea
pig, sheep, cow and pig
ii) the insertion of foreign bodies such as glass beads into
the uterine lumen causes an increase in PGF2K output from the
uterus, which is followed by premature luteal regression in
the guinea pig, sheep, rat and hamster
iii) indomethacin treatment prolongs luteal function in the
guinea pig, rabbit and rat
(iv) immunisation against PGF2K> ei^her active or passive,
prolongs the luteal life span in the guinea pig and sheep.
Overall the findings have provided much evidence in favour of
PGF2k being the uterine luteolxjtic hormone.
Transfer of PGF^k ^rom the Uterus to the Ovary
The means by which PGF2K travels from the uterus to instigate
an effect on the corpora lutea of the ovary probably involves
the vascular system'. Ligation of the vascular tissue in the
region of the uterus and ovaries in guinea pigs caused
maintenance of the corpora lutea but ligation and removal of
the oviduct had no effect on luteal regression (Bland and
Donovan, 196"9; Oxenreider and Day, 1967). In the sheep,
bilateral ligation of the middle uterine arteries and veins
caused luteal maintenance but ligation of the arteries alone
were without effect (Kiracoffe, Menzies, Gier and Spies,
1966; Kiracoffe, Spies and Gier, 1973). These observations
indicated that an intact uterine vein is necessary for luteal
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regression to occur. Further investigations by McCracken et
al. (1972) were carried out in the sheep; tritiated PGF20C
(3h-PGF2K) was infused into the uterine vein at a point
proximal to its confluence with the utero-ovarian vein. A
small but significant increase in radioactivity was monitored
in the ovarian arterial blood after 20 min. During the next
60 min this increase continued to rise and peak levels
occurred approximately 20 to 30 min after termination of the
infusion. The data indicated that there was a local
vascular transfer of PGF2K between the utero-ovarian vein and
ovarian artery enabling PGF2k to Pass Prom one uterine horn
to its adjacent ovary. The efficiency of transfer was
estimated to be about 2%. Horton and Poyser (1972) stated
that since the ability of most tissues with the exception of
the lungs, liver and kidney, to metabolise prostaglandins is
very low then "most of the PGF^ reaching the ovary via the
ovarian artery will eventually have to leave the ovary via
the utero-ovarian vein and will mix with the fresh PGF2K
coming from the uterus. If the transfer process were 100%
and metabolism were nil, PGF2<x would Pass through the ovary
ad infinitum. Also the amount passing through would
increase steadily. In order to prevent a situation like
this from arising a fairly low efficiency for transfer would
seem necessary". Any PGF2K not retained by the ovarian
artery/utero-ovarian vein countercurrent mechanism will pass
into the systemic circulation and be inactivated in the lungs
"(Ferreira and Vane, 1967)". This countercurrent mechanism
has been demonstrated in two species namely the sheep
(McCracken et al., 1972) and the cow '(Hixon and Hansel,
1974). In species such as the rabbit where the uterine
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vasculature is anatomically more independent from the ovarian
vasculature, a countercurrent mechanism cannot explain the
transfer of PGF2K from the uterus to the ovary (Hunter and
Casida, 1967). It has been reported that the vasculature of
the guinea pig, rat, hamster and pig is such as to allow a
counter current mechanism of PGF2K to exist (Del Campo and
G inther, 1972 and 1973). However Egund and Carter (197*0
reported that no special arrangement for countercurrent
exchange could be demonstrated in the guinea pig. To date
the counter current mechanism has not been demonstrated in
any of these species, or in fact how PGF2K does reach the
ovary from the uterus in a local manner.
Mechanism Of Action Of PGF2K In Inducing Luteolysis
It was originally suggested that the potent venoconstrictor
properties of PGF2K (DuCharme, Weeks and Montgomery, 1968) on
the utero-ovarian vein may result in a reduced ovarian blood
flow with luteolysis ensuing as a consequence of anoxia
(Pharriss, Cornette and Gutknecht, 1970). This hypothesis
was not proven in practise since, in the sheep, PGF2K infused
directly into the ovary resulted in no reduction of total
ovarian blood flow but there was a rapid decline in
progesterone output (McCracken et al., 1970; Baird, 197*0.
However, PGF2K was shown to selectively reduce blood flow to
the corpus luteum in the sheep (Thorburn and Hales, 1972)
without affecting total ovarian blood flow at the time of
luteal regression in the oestrous cycle. These observations
suggested that reduced luteal blood flow may be the cause of
luteal regression. Subsequent investigations by Einer-
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Jensen and McCracken (1977) demonstrated that the decrease in
progesterone output from the corpus luteum preceded the
reduction in luteal blood flow". Therefore the luteolytic
action of PGF20C probably resulted as a direct consequence of
the hormone's effect on metabolic functions within the corpus
luteum and not due to changes in blood flow. The reduced
luteal blood flow occurring later was probably the result of
luteolysis which caused the small luteal capillaries to
become blocked with cell debris (O'Shea", Nightingale and
Chamley, 1977). This blockage possibly accelerated luteal
regression.
PGF2k receptors in the corpus luteum in relation to the
luteolytic activity of PGF2oc have been studied also.
Specific PGF2k receptors were found to be present in the
luteal cell membrane in the sheep (Powell, Hammerstrom and
Samuelsson, 197*0, the rat (Wright, Luborskymoore and
Behrman, 1979), the mare (Kimball and Wyngarden, 1977) and
the cow (Rao, Carman and Gorman, 1978), and also in the human
even though PGF2K is not luteolytic _in vivo in this species
(Powell, Hammerstrom, Samuelsson and Sjoberg, 1974). The
apparent Kd varied between 5 and 100nM among the species and
in the human there was also a lower affinity receptor of
apparent Kd 500nM^ The low affinity receptor in the human
may explain why PGF2K has very little effect in women _in vivo
(see, Poyser 1981). In non-primates, changes in the number
and/or affinity of PGF2K receptors during the oestrous cycle
may account for the resistance of the corpus luteum to the
luteolytic activity of PGF2K during the early part of the
cycle. Also changes in other parameter s such as the
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ability (efficacy) of the PGF2K/receptor complex to induce
luteolysis may increase as the cycle progresses; such changes
may be hormonally inducedl The luteolytic action of PGF2oc
can be divided into two categories - the decrease in
progesterone output from the ovary (functional luteolysis)
and the regression of the corpus luteum (structural
luteolysis).
Attention by investigators has been focussed largely on the
functional luteolytic processes. Progesterone production by
the luteal cell is known to be stimulated by the luteinizing
hormone (LH). LH binds to specific receptors in the plasma
membrane of the granulosa cell and stimulates the production
of cyclic-adenosine monophosphate (c-AMP) by activation of
the enzyme, adenylate cyclase. The c-AMP then interacts
with protein receptors to activate a protein kinase (Garren,
Gill, Masui and Walton, 1971). It has been suggested that
the c-AMP binds to the regulatory unit of a protein receptor
to cause dissociation of this receptor moiety from the
catalytic unit thereby activating the protein kinase. Should
the levels of c-AMP decrease then the regulatory unit
recombines with the catalytic unit to suppress protein kinase
activity (Henderson and McNatty, 1975). The protein kinase
phosphorylates and thereby activates enzymes like cholesterol
esterase. This enzyme is responsible for conversion of the
cholesterol esters stored in the lipid droplets into free
cholesterol which is then converted to progesterone.
It has been proposed that one of the earliest actions of
PGF2k on the corpus luteum, occurring within 15 min, is to
prevent the LH-induced increase in c-AMP levels (Lahair,
Freud and Lindner, 1976). Subsequently the reduction in
c-AMP production causes cholesterol esterase to be
dephosphorylated to its inactive form thereby inhibiting the
availability of cholesterol for conversion to progesterone
(Henderson and McNatty, 1975). A decline in cholesterol
. . . ., . .. . „, treatment has
esterase activity in the rat ovary after FGFaac
been monitored (Behrman, MacDonald and Greep, 1971), though a
greater effect was observed on the activity of cholesterol
ester synthetase. Nevertheless overall cholesterol turnover
was probably reduced leading to inhibition of progesterone
synthesis.
PGE2 - stimulated progesterone production by the ovary was
not inhibited by FGF2oc iS vitro nor i_n vivo (McNutty,
Henderson and Sawers, 1975; Henderson, Scaramuzzi and Baird,
1977). PGF2cc therefore specifically antagonises the action
of LH, probably by preventing the LH - induced conversion of
adenosine ^'-triphosphate (ATP) into c-AMP (Wakeling and
Green, 1981). It has been proposed that PGf2k> after binding
to its receptor on the luteal cell, either directly or
indirectly uncouples the receptor unit for LH from the
catalytic unit on the adenyl cyclase enzyme, thus preventing
LH from causing a rise in c-AMP levels in the luteal cell
(Henderson and McNatty, 1975). Administration of c-AMP to
rat luteal cells cultured i_n vitro was able to overcome the
inhibition in progesterone secretion produced by FGF2oc
(Thomas, Dorflinger and Behrman, 1978).
The ability of FGF2oc uncouple the LH receptor unit from
the adenyl cyclase catalytic unit was expressed only in the
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intact luteal cell and may be due to PGF2K increasing calcium
influx or causing a release of intracellular bound calcium
which in turn prevents activation of adenyl cyclase
(Dorflinger and Behrman as reported in Behrman, 1979).
PGF2K also significantly reduced gonadotrophin accumulation
in the functional rat corpora lutea and a maximum effect was
observed within 2hr; a 63% reduction in gonadotrophin uptake
was observed as early as 30 min after PGF^k treatment.
Plasma progesterone levels were decreased by 47$ after 30 min
and by 83$ after 2hr. The decrease of gonadotrophin uptake
was not due to loss of LH receptors or to a decrease in the
affinity of the receptor for LH. However after 8hr of PGF^^
treatment there was a 30$ reduction in the number of LH
receptors with 72$ loss occurring after 24hr of treatment.
It has been proposed that the luteolytic effect of PGF20J is
due initially to a rapid loss in the ability of the corpus
luteum to respond to and to accumulate LH, although LH
receptors of high affinity are still present, than to an
actual loss of LH receptors thus making luteolysis
irreversible (Behrman, Grinwick, Hichens and MacDonald,
1978).
A detailed analysis of the luteolytic action of PGF^^ in
species other than the rat is lacking. In hysterectomised
guinea pigs, PGF'2K treatment caused plasma progesterone and
pregnenolone levels to decrease (Dwyer and Church, 1979a).
As in the rat, the cholesterol esterase activity in the
guinea pig ovary' was reduced by PGF2k treatment (Dwyer and
Church, 1979b). Although cholesterol ester synthetase
activity was unaffected, ovarian steroid output was sti II
reduced. The events described so far relate only to
biochemical changes occurring during functional lute'olysis.
Since PGF-2K increases the rate of release of enzymes from
lysosomes in luteinized rat ovaries (Weiner and Kaley, 1975),
it has been suggested that these enzymes are responsible for
the structural changes during luteolysis (McClellan, Abel and
Niswender, 1977).
The Physiological Stimulus For Uterine PGF2<x ^e^-ease
Once the role of P G F 2 ^ as ^ h e uterine luteolysin was
established, it was necessary to determine the physiological
stimulus for PGF20£ output from the uterusl The cyclical
pattern of release suggested that some form of hormonal
control was responsible. As exogenous oestradiol induced
premature luteolysis (Blatchley et al., 1972), it was
proposed that perhaps endogenous oestradiol released from the
developing follicles in the ovaries was the physiological
stimulus for PGF2K release from the uterus and the normal
occurrence of luteal regression (Blatchley, Donovan, Horton
and Poyser, 1972).
A small rise in the plasma oestradiol levels after about Day
10 of the cycle just prior to the first release of PGFg^ from
the uterus has been demonstrated in the sheep (Barcikowski,
Carlson, Wilson and McCracken, 197'4; Cox, Thorburn, Currie
and Restall, 1974), the guinea pig (Joshi, Watson and
Labhsetwar, 1973), the pseudopregnant rat (Welschen, Osman,
Dullaart, de Greef, Uilenbrook and de Jong, 1975) and the pig
'(Henricks, Guthrie and Handlin, 1972). In the cow, PGF2of
release from the uterus has been associated with increased
oestradiol output from the ovary during luteolysis (Shemesh,
Ayalon and Lindner, 1972; Nancarrow et al., 1973). The
overall data suggest that the release of oestradiol from the
ovary and the subsequent increased PGF20C output from the
uterus is related.
In ovariectomised animals oestradiol had little or no effect
in stimulating PGFg^. release from the uterus. However if
the ovariectomised animal was pre-treated with progesterone,
oestradiol was then able to cause a much greater release of
FGF2C{ from the uterus as demonstrated in the guinea pig
(Blatchley and Poyser, 1974) and the sheep (Caldwell,
Tillson, Brock and Speroff, 1972). It was postulated,
therefore, that oestradiol acting on the progesterone-primed
uterus is the physiological stimulus for P"GF20{ synthesis by,
and release from, the uterus.
In the sheep the importance of progesterone priming of the
uterus for PGF2oc release from the uterus was reflected in the
observation that the small peaks of oestradiol occurring
randomly in the oestrous cycle (a small peak consistently
occur s at Days 3 to 4 of the cycle) are unable to stimulate
PGF2QJ release from the uterus (Cox et al., 1 974 ).
Progesterone priming for 7 to 9 days is probably necessary
before oestradiol can induce release Prom the sheep
uterus. However, other species such as the cow exhibit a
small rise in plasma oestradiol levels on Days 4 to 5 of the
cycle together with an increase in the level of PGF2<X in
utero-ovarian venous plasma and a transient decline in plasma
progesterone levels (Nancarrow et al., 1973). The overall
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observations indicated that the uteri of different species
exhibits different responses to oestradiol, since prolonged
progesterone priming of the uterus is not always required.
It is not yet clear why this occurs.
It has also been demonstrated that the joint administration
of ovarian hormones to the sheep can cause progesterone under
certain experimental conditions to antagonise the PGF2CC -
releasing action of oestradiol on the uterus (Scaramuzzi,
Baird, Boyle, Land and Wheeler, 1977). In cultured human
and guinea pig endometrial tissue i_n vitro, progesterone
reduced the basal PGFo„ . .2cc output and, in the human, inhibited
also its stimulation by oestradiol (Abel and Baird, 1980;
Leaver and Seawright, 1982). The observations reported have
indicated that, although progesterone priming of the uterus
is necessary to obtain PGFg^ output from the uterus, too much
progesterone acting for too long,results in inhibition and
progesterone withdrawal is required to obtain the maximum
release of PGF2K from the uterus.
If oestradiol acting on the progesterone primed uterus is the
necessary stimulus for complete luteolysis then immunisation
against oestradiol should result in luteal maintenance.
Passive immunisation of sheep against oestradiol was able to
prevent oestrus and ovulation but not luteal regression
(Fairclough, Smith and Peterson, 1976). This observation
suggested that oestradiol is not the only requirement for
normal luteolysis. Passive immunisation of sheep against
progesterone was also unable to prevent luteolysis
(Fairclough, Smith, Peterson and McGowan, 1976). These two
observations indicated that the ovarian steroids oestradiol
and progesterone may not be the only stimuli for uterine
FGF2oc output.
In 1906, Dale reported that intravenously injected extracts
of the pituitary gland caused the uterus of the preganat cat
to undergo powerful contractions (Dale, 1906). The active
substance in these extracts, named oxytocin by Dale, has been
implicated in the control of uterine FGF^^ synthesis and
release by the uterus'. Infusions of oxytocin into the
uterine arterial supply of the sheep evoked a substantial
increase in FGF20C release from the uterus following
administration after Day 14 of the cycle (Roberts,
Barcikowski, Wilson, Skarnes and McCracken, 1975)'. Oxytocin
treatment also stimulated PGF^^ release from the uterus of
the cow (Newcomb, Booth and Rowson, 1977), the rat (Campos,
Liggins and Seamark, 1980) and the rabbit (Small, Gavagan and
Roberts, 1978). Since immunization of sheep against oxytocin
delayed corpus luteal regression (Sheldrick, Mitchell and
Flint, 1980), it has been proposed that oxytocin forms part
of the physiological stimulus which increases PGF2K release
from the sheep uterus at the end of the oestrous cycle
(McCracken, Schramm, Barcikowski and Wilson, 1981). Oxytocin
has a negligible effect on uterine PGF20C release in an
anoestrous sheep unless the sheep has been primed with
oestradiol (Sharma and Fitzpatrick, 1974). Since the
relative concentrations of oxytocin receptors in the
endometrium of the ovine uterus increased toward the end of
the cycle (Wilson, Roberts and McCracken, 1974), it may be
that oestradiol stimulates the production of the oxytocin
receptors (McCracken, 1980). The interaction of oxytocin
with its receptors may then evoke PGF2X synthesis and release
by the uterus. In vitro studies using the guinea pig uterus
demonstrated that oxytocin was unable to stimulate uterine
pgp output in this species (Poyser and Brydon, 1983). In
a*
addition oxytocin injected into guinea pigs during any part
of the cycle failed to initiate premature corpus luteal
regression (Donovan, 19 6 1). The evidence suggests that
oxytocin does not form part of the physiological stimulus in
the guinea pig necessary for increased PGF20C release the
end of the oestrous cycle! Therefore the requirement for
oxytocin as part of the physiological stimulus for increased
PGF2K synthesis and release by the uterus varies from species
to species.
Mechanism of Action of the Ovarian Hormones In Stimulating
Uterine PGF2<x Output
The action of oestradiol in stimulating uterine PGF2K
production may be linked with fresh protein synthesis based
on the known intracellular actions of oestradiol.
Oestradiol enters a cell via a specific protein-mediated
carrier process (Milgrom, Atger and Baulieu, 1977) and then
becomes bound to a cytosol protein receptor (Gorski, Taft,
Shyamala, Smith and Nolides, 1 9 6 8 ). The resulting
oestradiol-cytosol receptor complex is then able to attach
itself to a nuclear acceptor structure. The steroid acts on
the DNA within the nucleus to stimulate RNA synthesis. Small
amounts of a "specific induced" protein are detectable 1hr
after oestrogen administration. This protein stimulates the
production of general RNA which is detectable 2hr after
administration. There is a subsequent increase in general
protein levels and an accumulation of phospholipids (Mueller,
Gorski and Aizawa, 1961). The intrauterine injection of
actinomycin D in the guinea pig significantly prolonged
luteal function and oestrous cycle length (Poyser, 1979).
These results suggest that in the guinea pig the oestradiol
acts on the progesterone-primed uterus to stimulate protein
synthesis, by increasing DNA-dependent RNA synthesis and
thereby increasing the concentration of enzymes involved in
PG synthesis. Actinomycin D has been shown to prevent the
increase in uterine PG synthetase levels normally observed at
the end of the cycle (Poyser, 1979).
Oestrogen treatment of the ovariectomised rat was able to
influence the ratio of PG products formed (Ham, Cirillo,
Zanetti and Kuehl, 1975). Prior to hormone treatment,
ovariectomy induced a tenfold increase in uterine tissue
levels of PGE and a threefold increase in PGF levels. After
oestrogen treatment there was a decrease in PGE levels and a
parallel elevation in PGF levels.
In the normal cycling guinea pig, PGF'2a: was the major PG
synthesized by homogenates of the uterus together with lesser
quantities of PGE2> 6-keto-PGF*- and TXB2 i.e. there is a
relatively specific stimulation of PGF£K synthesising
capacity toward the end of the cycle. Oestradiol had a
similar effect on ovariectomised guinea pigs (Poyser, 1983a).
Outputs of PGF^qj, PGE2 and 6-keto-PGF-|K from the superfused
uterus of ovariectomised guinea pigs were all low
(approximately 0.1 to 0.2 ng/min/uterine horn). PGF2of was
released in greatest quantities followed by PGE2 and then by
6-keto-PGF(Poyser, 1983b). Progesterone treatment had no
effect on PG output. Oestradiol treatment increased
output sevenfold, but increased PGE2 and 6-keto-PGF^ outputs
1.7-fold and 2.9-fold, respectively. Oestradiol treatment
reversed the PGE2 to 6-keto-PGFratio; progesterone priming
before oestradiol treatment potentiated the stimulatory
effect of oestradiol on PGF20C release by up to twofold but
had no such action on PGE2 and 6-keto-PGF .j release. The
overall observations indicated that oestradiol has a dual
action, namely increasing the uterine synthetic capacity of
PGs and exerting a directional influence on the products
formed.
It was subsequently noted that the output of PGF2K from the
guinea pig uterus varied 10- to 20-fold during the oestrous
cycle (Blatchley et al., 1972; Earthy et al., 1975) yet there
were only 2- to 3-fold fluctuations in the activity of the
prostaglandin synthetase enzyme (Poyser, 1972; Wlodawer,
Kindahl and Hamberg, 1976). Such results suggested that
although oestradiol increased the synthetic capacity of the
uterus for PGs (Poyser, 1983a), it also had an effect on
other factors influencing uterine PG synthesis, some of which
may control substrate availability. In the guinea pig, free
arachidonic acid represented only 0.1% of the total
arachidonic acid content of the uterus (Leaver and Poyser,
1981). Further analysis of uterine tissue indicated that
the amount of esterified arachidonic acid available in the
lipid membranes was about 1 mg/gm uterine tissue. The
accumulated evidence suggested that oestradiol influenced the
availability of arachidonic acid from these lipid "stores",
and the subsequent release of arachidonic acid was the rate-
limiting step in prostaglandin biosynthesis. The role of
progesterone in uterine PGF-2K synthesis was also considered.
A period of progesterone pretreatment before oestrogen
administration to the uterus resulted in maximal levels of
PGF-2k in the utero-ovarian venous plasma of the guinea pig
(Blatchley and Poyser, 197*0, the sheep (Caldwell et al.,
1972) and the mouse (Saksena and Lau, 1973). All the
species studied were ovariectomized.
Since oestradiol is not totally responsible for the increase
in PGF"2k output from the uterus, it is possible that
progesterone aids oestradiol in its regulation of the
mobilization and turnover of the prostaglandin precursor,
arachidonic acid. Like oestradiol, progesterone is bound to
a uterine cytosol receptor protein as demonstrated in many
species including the guinea pig (Corval, Falk, Freifald and
Barden, 1972), mouse and rat (Feil, Glasser, Toft and
O'Malley, 1972). Progesterone has been shown to accumulate
in the nucleus (Sar and Stumpf, 197*0. Progesterone has
been shown to specifically alter the chick oviduct gene
expression to effect unique RNA transcriptions (O'Malley,
McGuire, Kahler and Korlman, 1969). Such observations imply
that progesterone probably has an effect on the synthesis
and/or activation of the enzymes responsible for the
mobilization and turnover of arachidonic acid. Consequently,
Horton and Poyser (1976) stated that "both progesterone and
oestrogen are necessary for the "switching on" of PGF^^.
synthesis in which phospholipase A2, cholesterol esterase or
triglyceride lipase are mobilised from their intracellular
compartment(s). These in turn produce the free arachidonic
acid. This is then converted to PGF20C ^ prostaglandin
synthetase enzymes". The release of arachidonic acid is
considered, therefore, to be the rate-limiting step in PG
synthesis by the uterus (as in other tissues).
Consequently, when considering how oestradiol acting on a
progesterone-primed uterus stimulates PGF2a release from
the uterus for luteolysis, one must consider the factors
controlling arachidonic acid turnover.
Nutritional Factors
Arachidonic acid is classified as an essential fatty acid
i.e. it is required for reproduction and growth by biological
systems (Burr and Burr, 1930). It is usually found in the
meat and fish constituents of the diet and also in esoteric
plant food such as seaweed. It may also be derived from
linoleic acid via chain elongation and
desaturation steps (see Gurr and James, 1971). Linoleic
acid is an 18 carbon molecule containing two double bonds,
one bond being six carbon atoms from the methyl terminus of
the molecule i.e. 18:2 (n-6). Ox i do/fcton of linoleic acid
(18:2 (n-6)) results in linolenic acid (18:3 (n-6)).
Subsequent elongation and desaturation of linolenic acid
results in arachidonic acid (20:4 (n-6)). The synthetase
enzymes consist of tightly bound complexes of enzymes
responsible for fatty acid synthesis. The lack of
arachidonic acid in the body can seriously imbalance the
physiological state of a subject. For example, Dyerberg and
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Bang (1979) demonstrated the influence of diet at a
physiological level comparing Greenland Eskimos (upholding a
traditional cuisine) with a similar number of age- and sex-
matched Danish controls. They showed that there was a
significantly higher proportion of cis-5,8,11,14,17-
eicosapentaenoic acid, which originates in Eskimo food, in
the platelet lipids of the Eskimo group. Bleeding times
were increased in all cases indicating that the aggregating
properties of the platelets were affected by the presence of
cis-5,8,11,14 , 1 7-eicosapentaenoic acid in the platelet
lipids. Since the increased bleeding time discourages the
formation of large blood clots it has been suggested that the
difference in diets is indirectly responsible for the reduced
r
incidence of thrombotic disorders in Greenland Eskimos
(Dyerberg and Bang, 1979). Laboratory experiments have also
supported the importance of a suitable dietary intake to
maintain animals in a healthy, physiological condition.
Willis, Comai, Kuhn and Paulsrud (1974) fed rats with
dihomo-5-linoleate, the substrate for prostaglandins of the
"1" series. Since the type of PGs produced by any one cell
depends on the type of fatty acid present in the lipid
stores, more PGE-, , . , .. , , . ,' 1 was produced by the platelets. The
parallel decrease in production of TXA2 also served to
inhibit platelet aggregation. Therefore the lack of
arachidonic acid in the diet can seriously affect
biosynthesis of prostaglandins of the 2-series.
After digestion and intravascular lipolysis of chylomicrons
or following release from adipose tissue, arachidonic acid
passes readily into the blood. Previously it was assumed
that after ionization at physiological pH, the fatty acid
binds immediately to albumin. However, Spector (1968)












The importance of the equilibrium of these free fatty acid
forms is reflected in the fact that the existence of the
anion appears to be essential for binding i.e. the bonds to
albumin are not covalent. Thus, albumin has the ability to
bind most of the available free fatty acid, thereby reducing
the effective or unbound concentrations to levels that are
not injurious to man.
It is important to note that long chain fatty acids present
in blood plasma are also esterified into glycerides,
phosphatides and cholesterol esters. These lipid esters are
transported in combination with specific proteins, the
complex being known as lipoprotein. They may act to replete
the free fatty acid to albumin concentration, if the
also exists in equilibrium with the i onised
shown below:
Kd













equilibrium is disturbed (Nestel, Bezman and Havel,
Arachidonic Acid Transfer Into the Cell
1962).
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Circumstantial evidence suggests that free fatty acid in
unbound form crosses the cell membrane, since its rate of
efflux from the plasma into the cell far exceeds that of the
albumin (Havel and Frederickson, 1956; Gordon, 1960). The
driving "force" that moves free fatty acids in the direction
of the utilizing cell is a concentration gradient maintained
because the cell can rapidly metabolize the fatty acids
presented to it. Uptake of free fatty acids cannot be
dependent on metabolically produced energy, for preincubation
of EAirlick Ascites tumour cells with 2,4-dinitrophenol which
uncouples oxidative phosphorylation, or with cyanide which
inhibits oxidative phosphorylation does not decrease the
1 A
incorporation of palmitate-1- C into the cell free fatty
acid pool (Spector, Steinberg and Tanaka, 1965). The rate
of incorporation indicated a linear, passive mode of uptake,
such as diffusion. Once within the cell, arachidonic acid
is then available for prostaglandin biosynthesis. However
free fatty acid levels in the uterine cells are low; in the
guinea pig there is only about 1pg free arachidonic acid
available per gm uterine tissue (Leaver and Poyser, 1981).
Spector (1968), using prelabelled Ebriick Ascites tumour
cells, demonstrated that exogenous free fatty acid which was
quickly incorporated into the cell free fatty acid pool was
made available for oxidation, for release from the cell or
for ester ification into membrane lipid pools. The last
alternative may be considered as a form of "storage
container" since as much as 1mg arachidonic acid per gram
tissue is esterified in the guinea pig uterus (Leaver and
Poyser, 1981).
The lipids can be classified into two types, neutral lipids
and phospholipids, either one or both classes could act as
the source of arachidonic acid for prostaglandin
biosynthesis.
Neutral Lipids
The neutral lipids are mainly composed of esters of glycerol
and long chain fatty acids; the three hydroxyl groups of
glycerol offer many combinations for fatty acid ester
formation. The presence of one, two or three acyl groups
attached to the glycerol backbone results in monoacylglycerol
(monoglyceride), diacylglycerol (diglyceride) and triacyl-
glycerol (triglyceride) respectively. The structural
formulas are shown in Fig. 3. According to convention, the
three carbon atoms of glycerol are identified as of,j3 andoc<|
or 1, 2 and 3. Arachidonic acid may be esterified at any of
these three carbon atom positions. The neutral lipids also
include the cholesterol esters. They are formed by the
addition of a fatty acid like arachidonic acid to the
hydroxyl group at the carbon-3 position of cholesterol. The
structures of cholesterol ester and of the parent compound
cholesterol are depicted in Fig. 3.
It is important to consider the synthesis of the neutral
lipids at this point in relation to the esterification of
arachidonic acid.
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The biosynthesis of diglycerides and triglycerides involves
an inital phosphorylation of glycerol by ATP to form L-oc-
glycerophosphate (Bublitz and Kennedy, 1954). Before the
incorporation of a fatty acid such as arachidonic acid can
proceed, it is necessary to convert the fatty acid to its
coenzyme A derivative. The reaction is catalyzed by an
enzyme called thiokinase (acid: CoA ligase JaHp] or acyl-CoA
synthetase). There are several thiokinases, each specific for
a group of fatty acids with a certain range of chain lengths.
A detailed study of the factors needed for phosphatidate
synthesis by a "residue fraction" (principally microsomal)
from guinea pig liver led Kornberg and Pricer (1953) to
conclude that straight chain fatty acids with 16, 17 or 18
carbon atoms were far more effective than shorter or longer
chain acids for esterification of glycerophosphate. The
fatty acid reacts with ATP releasing pyrophosphate (PPi) and
an intermediate called fatty-acyl AMP.
R. COOH + ATP -—^ R. CO-AMP + PPi
where R = fatty acid chain
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Figure 3. Structures of neutral lipids including
cholesterol (a) and its ester (b), where R, R-j and R2 are the
fatty acid carbon chains.
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The intermediate then reacts with coenzyme A (CoASH) to
liberate AMP.
R CO-AMP + CoA.SH TR.CO.S-CoA + AMP
Subsequent esterification of L-ec-glycerophosphate, using the
enzyme glycerol-3 phosphate acyl transferase with two
coenzyme A derivatives of long chain fatty acids results in
phosphatidic acid and two coenzyme A molecules (CoASH)
(Kornberg and Pricer, 1953). Although phosphatidic acids
are rapidly synthesized by enzyme systems _in vitro the
concentration of phosphatidic acid in mammalian tissues is
very low. However their presence has been detected (Hokin
and Hokin, 1958). The failure of phosphatidic acids to
accumulate in tissues is due to the cleavage of the phosphate
group (Pi) from phosphatidic acid by the enzyme phosphatidate
phosphohydrolase to leave the 1, 2 diglyceride (Smith, Weiss
and Kennedy, 1957). The addition of a final coenyme A
derivative of a long chain fatty acid to the 1, 2 diglyceride
results in the synthesis of triglyceride and coenzyme A
(Weiss and Kennedy, 1956). See Fig. 4. This last reaction
is also catalysed by an acyltransferase.
An alternative route of formation of triglycerides involves
the monoglyceride, formed by the hydrolysis of triglyceride
(from the diet) to diglyceride to monoglyceride by action of
the enzyme lipase which is present in the intestinal lumen
(Borgstrom, 1954). The route is known as the monoglyceride
pathway and involves the acylation of monoglyceride by the
CoA derivative of a fatty acid using the enzyme monoglyceride
acyltransferase. A second CoA derivative of a fatty acid is
then added to the resultant diglyceride to form a






where 1 - monoglyceride acyltransferase
2 = diglyceride acyltransferase
The enzymes involved in triglyceride synthesis form a multi-
enzyme complex called the triglyceride synthetase.
Esterification of cholesterol by a fatty acid such as
arachidonic acid is brought about by three main types of
enzyme. The first type of enzyme catalyses the reversible
reaction:
cholesterol + non-esterified fatty acid -—^ cholesterol ester
The enzyme , sterol ester hydrolase, sometimes called
cholesterol esterase does not require ATP or coenzyme A, and
is present in the pancreas and the intestinal mucosa (see
Goodman, 1965).
The second enzyme, acyl-CoA:cholesterol-0-acyl transferase is
found in liver and adrenal gland. Unlike sterol ester
hydrolase, this enzyme requires ATP and coenzyme A to
catalyze:
Acyl-CoA + cholesterol ^ cholesterol ester
(Mukherjee, Kunitake and Alfin-Slater, 1958)
The third enzyme, 1,2-diaey1g1ycery1phosphory1 -
choline:cholesterol-0-acyl transferase is present in the
plasma (Glomset, 1962). It has the ability to transfer
fatty acids from phosphatidyl choline to cholesterol.
The reactions stated above indicate that there are many
routes by which arachidonic acid is incorporated into the
neutral lipids. The contribution of arachidonic acid from
the neutral lipid stores for prostaglandin synthesis by and
release from various tissues has been difficult to assess.
Lipases are responsible for hydrolysing the ester bonds of
triglycerides and esterases act on cholesterol ester to
release arachidonic acid (see Gurr and James, 1971). In
tissues where the mass of neutral lipids matches or exceeds
that of phospholipids, such as adrenal cortex or adipose
tissue, it is possible that there is a significant
contribution of arachidonic acid contained within neutral
lipids to the free arachidonate pool (Christ and Nugteren,
1970; Vahouny, Chamberbhan, Hodges and Treadwell, 1978). On
the other hand, in rabbit polymorphonuclear leucocytes, it is
not possible to determine to what extent the neutral lipids
contributed to arachidonate release because even a small
(unquantifiab1e) phospholipid breakdown resulting in
arachidonate release would have exceeded the arachidonate
loss from neutral lipids (Kaplan-Harris and Elsbach, 1980).
It is therefore necessary to consider the pathways by which
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Figure 4. Biosynthetic steps leading to the formation of
diglycerides and triglycerides
where 1 = reaction catalysed by glycerokinase
2 =reaction catalysed byglycerol-3phosphate:acyl
transferase
3 = reactioncatalysed by phosphatidate
phosphohydrolase
4 = reaction catalysed by acyltransferase
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Phospholipids
The major phospholipids include phosphatidylcholine (PC),
phosphat idylethanolamine (PE), pho s pha t i dy 1 s er i ne (PS),
phosphatidylinositol (PI) and sphingomyelin (Sph) (see Fig.
5). All the compounds have a 3-carbon "backbone" structure
which is a derivative of glycerol. According to convention
the three carbon atoms are identified as tx,p and <x-|, or 1, 2
and 3. The glyceryl esters of two fatty acid ester
molecules occur at the 1- and 2-carbon positions, and
esterified at the 3-carbon position is a phosphate group.
The phosphate group in turn is joined by an ester linkage to
a nitrogenous base such as choline or ethanolamine, from
which the name of the phospholipid is derived. Unsaturated
fatty acids like arachidonic acid are preferentially
esterified at the 2-carbon position (Lands and Merk 1, 1963)-
In sphingomyelin, a long chain alcohol called sphingosine is
bound by an amide linkage to a long chain fatty acid and by
ester linkage to phosphorylcholine, (see Fig. 5).
Studies of the biosynthesis of phospholipids have usually
involved the administration of isotopically labelled
precursors to define the interrelationships between the
pathways; these are summarised below:
a) Phosphatidylcholine may be synthesised in two ways.
The first pathway involves an initial phosphorylation of
choline (as the free base) by adenosine triphosphate (ATP) to
produce phosphorylcholine and adenosine diphosphate (ADP)
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Figure 5 Structures of phospholipids + sphingomyelin,
where and R2 are the fatty acid carbon chains.
"activated" in a reaction with cytidine-5'-triphosphate
(CTP). The resultant products are cytidine diphosphate-
choline (CDP-choline) and pyrophosphate (PPi) (Kennedy and
Weiss, 1 956 ). The enzyme, phosphorylcholine-cyt idyl
transferase is completely specific for cytidine nucleotides.
The phosphorylcholine moiety of CDP-choline is then
transferred to the vacant primary hydroxyl group of a
diglyceride, a step catalysed by the enzyme
phosphorylcholine-glyceride transferase (Weiss, Smith and
Kennedy, 1958). Phosphatidylcholine is then formed together
with the byproduct cytidine monophosphate (CMP). The
diglyceride involved in this reaction is synthesized as
described previously for triglyceride synthesis.
The second pathway for phosphatidylcholine is catalyzed by
two methyltransferases and involves the stepwise methylation
of phosphatidylethanolamine with 3 moles of S-adenosyl-
methionine as the methyl donor (Bremer and Greenberg, 1961).
See Fig. 6.
b) The enzymic synthesis of phosphatidylethanolamine is
essentially analagous to the formation of phosphatidyl¬
choline, except that phosphorylethanolamine and cytidine
diphosphate ethanolamine are the intermediates involved
(Kennedy and Weiss, 1956). The syntheses of cytidine
diphosphate ethanolamine (CDP-ethanolamine) and phosphatidyl¬
ethanolamine in these reactions are catalysed by enzymes
different from those involved in the analagous synthesis of
CDP-choline and phosphatidylcholine.
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a) HOH2C.CH2N<CH3)3 + ATP ==i (p)OH2C.CH2N(CH3)a + AOP
choline phosphorylcholine
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Figure 6 Summary of pathways involved in the synthesis of
phosphatidyl choline. Pathway a) outlines de novo synthesis
of phosphatidylcholine from choline and diglyceride. Pathway
b) outlines the synthesis of phosphatidylcholine from the
stepwise methylation of phosphatidylethanolamine with
S-adenosylmethionine
where :
1 = reaction catalysed by phosphokinase
2=reactioncatalysedbyphosphorylcholine-cytidyl transferase
3 = reaction catalysed by phosphorylcholine-glyceride transferase
4 - reaction catalysed by two methyltransferases
Decarboxylation of phosphatidylserine is also a means by
which phosphatidylethanolamine is synthesized. To date, the
importance of this pathway has not been assessed, see Fig. 7.
c) Unlike phosphatidylcholine and phosphatidylethanolamine,
phosphatidylinositol synthesis involves the activation of the
diglyceride rather than the nitrogenous base. The initial
step in the reaction involves phosphatidic acid and cytidine
triphosphate (CTP) to form cytidine diphosphate-diglyceride
(CDP-diglyceride) and pyrophosphate (PPi). The phosphatidic
acid involved in this reaction is synthesized as previously
described for triglyceride synthesis. The enzyme which
catalyses this reaction is CTP-phosphatidate cytidyl-
transferase. Addition of inositol to the CDP-diglyceride
completes the synthesis of this phosphoinositide (Possmayer
and Strickland, 1967). The enzyme responsible for catalysing
this reaction is CMP-phosphatidate:inositol phosphatidate
transferase.
Therefore,
phosphatidic acid + CTP x CDP - diglyceride + PPi
CDP - diglyceride + inositol v - CMP + phosphatidylinositol
d) Like phosphatidy1inosito1, the synthesis of
phosphatidylserine involves the activation of the diglyceride
rather than the nitrogenous base. The initial step is
catalysed by CTP-phosphatidate cytidy1transferase and
involves the reaction of phosphatidic acid and cytidine
triphosphate (CTP) to form cytidine diphosphate-diglyceride
(CDP-diglyceride) and pyrophosphate (PPi). The phosphatidic












^ CHO.CO.(CH2)„.CH3 + CMP
CHO.CO.(CH3)„.CH3 + CDP-ethanolamine ^=± | ^OH
CHaOH CHaO.P^O
O.CHa-CHaNHa
diglyceride phosphatidyl ethanolamine •
b)
CHaO.CO.(CHa)„.CH3 CHaO.CO.(CHa),. CH3
CHO.CO.(CHa)„.CH3 a CHO.CO. (CH5)„.CH3
j yOH ► COa + | /0H
CHaO.P=0 CHaO. P=0
OCHa.CHNHj.COOH \>CH3. CHjNH2
phosphatidyl serine phosphatidyl ethanolamine
Figure 7 Summary of biosynthetic pathways involved in the
synthesis of phosphatidylethanolamine. Pathway (a) outlines
the de: novo synthesis of phosphat idylethanolamine from
ethanolamine and diglyceride. Pathway (b) outlines the
synthesis of phosphatidylethanolamine from phosphatidylserine.
where :
1 =reaction catalysed by phosphatidylkinase
2 =reaction catalysed by phosphoryl-ethanolamine transferase
3 = reaction catalysed by phosphoryl ethanolamine-glyceride
transferase
a =reaction catalysed by decarboxylase
chjoh , ch,oh
I 1 i
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Figure 8 The de novo
where :
1 =reaction catalysed by
2 =reaction catalysed by
transferase
3 =reaction catalysed by
transferase








Addition of serine to CDP-diglyceride results in the
synthesis of phosphatidylserine. The enzyme responsible for
the reaction is CMP-phosphatidate:serine phosphatidate
transferase. See Fig. 8.
e) Sphingomyelin biosynthesis involves the nitrogenous base
choline. Choline reacts with oytidine triphosphate (CTP) as
described previously in phosphatidylcholine synthesis to form
cytidine diphosphate-choline (CDP-choline). Sphingosine
then combines with CDP-choline to form sphingosylphosphoryl-
choline and cytidine monophosphate (CMP). Sphingomyelin is
subsequently formed by the acylation of sphingosylphosphoryl-
choline by acyl-S.CoA. Coenzyme (CoASH) is also formed as a
byproduct.
Sphingosine + CDP-choline—»sphingosylphosphorylcholine +
CMP
Sphingosylphosphorylcholine + acyl-S.CoA > Sphingomyelin +
CoASH
An alternative pathway for the synthesis of sphingomyelin
involves the reaction catalysed by phosphoryl choline-
ceramide transferase between N-acyl sphingosine (ceramide)
and CDP-choline. Cytidine monophosphate (CMP) is formed as
well as sphingomyelin (Sribney and Kennedy, 1957).
N-acyl-sphingosine + CDP-choline—^sphingomyelin +CMP
The relative importance of these two pathways _in vivo has not
been established.
Fatty acids such as arachidonic acid are incorporated into
diglycerides. Since diglycerides are also essential
intermediates for the synthesis of phosphatidylcholine,
phosphatidy1ethano1 am i ne, phosphatidylserine and
phosphatidylinositol, it is obvious that arachidonic acid may
be incorporated into these phospholipids at this stage.
Arachidonic acid may also be linked to sphingomyelin (see
Fig. 5) via sphingosine by an amide linkage. However the
pathways described here are not the only routes by which
fatty acids, such as arachidonic acid, are incorporated into
the phospholipids. An alternative means of incorporation can
occur after de novo synthesis of phospholipid has been
completed. This route involves the formation of a lyso-
phospholipid by removing one fatty acid moiety of a
phospholipid. This reaction can be catalysed by a
phospho1ipase. Before the arachidonic acid can be
incorporated into the lysophospholipid, it must be converted
to the coenzyme A derivative, as previously described in the
synthesis of triglycerides. The enzyme acyl Co.Arlyso-
phosphatide acyltransferase (Lands and Merk 1, 1963)
catalyses the addition of arachidonyl CoA to the lysophospho¬
lipid. In addition Ferber and Trotter (1981), using
homogenates of murine thymocytes, have shown that a CoA-
dependent transfer of fatty acyl chains between phospholipids
can also provide a means of achieving turnover of phospho¬
lipid acyl chains.
Investigation into acyl CoA:1-acyl-sn-glycero-3-phospho-
choline acyltransferase extracted from rat liver microsomes
demonstrated the enzyme's maximal activity with arachidonyl
CoA at pH 8 (Hasegawa-Sakai and Ohno, 1 9 8 0 ) i.e.
esterification by this pathway is increasingly favoured with
more unsaturated fatty acids.
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Figure 9 Deacylation and Reacylation of Phospholipids
FFA + acyl CoA > FA-acyl CoA
1
FA - acyl CoA + lysophospholipid —phospholipid
rr2_
where FFA = free fatty aoid
FA = fatty acid
1 = acyltransferase
2 = phospholipase
The reaction in Fig. 9 may be of importance for the
incorporation of arachidonic acid into phospholipids.
Mobilization of Arachidonic Acid From Phospholipids
It seems reasonable to consider the phospholipases (the
phospholipid degrading enzymes) as the enzymes responsible
for the release of arachidonic acid from phospholipids.
Initial evidence for the involvement of these enzymes came
from the perfusion of guinea pig lungs or frog intestine with
phospholipase A. These perfusions led to a rapid release of
large quantities of prostaglandins in both tissues (Vogt,
Meyer, Kunze, Luft and Babilli, 1969; Bartels, Kunze, Vogt
and Wille, 1970). Since prostaglandins could also be
generated by the infusion of arachidonic acid through frog
intestine (Bartels et al., 1970) or lungs (Palmer, Piper and
Vane, 1973), it was possible to connect phospholipase A




a) Phospholipase A is readily available from certain snake
venoms. Enzyme activity was investigated by de Haas, Daemen
and Van Deenan (1962) who prepared "mixed acid" phosphatidyl¬
cholines and ethanolamines so that the 1- and ' 2-position
fatty acids were specified exactly. Hydrolysis of these
lipids with phospholipase A demonstrated the cleavage action
at the 2 position of 3-phosphoglycerides yielding a 1-
monoacyl analogue. Further studies with synthetic analogues
of the substrate were able to pinpoint the precise structural
and stereochemical features necessary for the enzyme to
hydrolyse a fatty ester bond (Van Deenan and Haas, 1963).
The enzyme seems to require the presence of three points of
attachment: the hydroxyl function of the phosphoryl moiety
(calcium ions may act as a "linking bridge" between the
enzyme and substrate at this point), the carbon-2 fatty acid
ester linkage and the oxygen alkyl function connected to the
carbon-1 atom.
Conclusive pharmacological evidence was provided by Flower
and Blackwell (1976) who labelled phosphatidylcholine of
guinea pig spleen slices with [l-^c] arachidonic acid
chiefly in the carbon-2 position. Cellular damage caused by
homogenisation, mechanical stimulation or anaphylactic shock
resulted in an increase in free substrate levels and an
increase in the biosynthesis of prostaglandins. Mepacrine,
an antimalarial drug inhibited the release of arachidonic
acid by blocking phospholipase action at the carbon-2
position. This hydrolytic enzyme is now denoted as
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Figure 10 Simplified diagram showing the points of attack
of the various phospholipase enzymes
where A^ = phospholipase
A2 = phospholipase A2
C = phospholipase C
D = phospholipase D
the phosphol ipase family, sueh as phosphol ipase A -j
phospholipase D and phospholipase C. The four types of
phospholipases and their points of attack are illustrated in
Fig. 10.
Phospholipase A2 hydrolyses the carbon-2 fatty acid from the
glycerol backbone leaving a 1-acyl lysophosphatide (as
described above). 5ince unsaturated fatty acids (including
arachidonic acid) are found predominantly in the'2-position
of phospholipids, it is clear that phospholipase A2 is
important for the release of arachidonic acid from phospho¬
lipids. It acts with equal facility upon phosphatidylcholine
with oleic or arachidonic acid, i.e. there is no marked
preference to either acid. The enzyme shows no marked
preference for phosphatidylethanolamine over phosphatidyl¬
choline (Rittenhouse-Simmons and Deykin, 1981). Conditions
for optimal phospholipase A£ activity vary from tissue to
tissue e.g. using human platelet homogenates and membranes,
the enzyme's maximum hydrolysis leading to release of
arachidonic acid occurs at pH 9.5 and is dependent upon 10mM
calcium ions (Derksen and Cohen, 1975; Jesse and Cohen,
1976). However in guinea pig endometrium, phospholipase A2
activity is maximal at a pH of 8; the membrane-bound enzyme
requires 5mM calcium ions whilst the soluble enzyme requires
2mM calcium ions (Downing and Poyser, 1983).
b) Phospholipase A^ hydrolyses the fatty acids at the
carbon-1 position giving a~2-acyl lysophosphatide. These
lysophosphatides are generally cytotoxic causing haemolysis
in red blood cell suspension and membrane damage to other
cells or organelles. They are usually quickly disposed of
in the cell either by lysophospholipases or by reacylation to
phosphatides (Lands and Merk 1, 1963).
Since phospholipase only releases fatty acids from the
carbon-1 position, its activity is not important for the
release of arachidonic acid, which is usually found
esterified at the carbon-2 position of a phospholipid.
c) Phospholipase D acts by removing the base to leave
phosphatidic acid. Since it has only been detected in
plants it is of little consequence for arachidonic acid
release and PG synthesis in animals (see Flower, 1981).
d) Phospholipase C (sometimes known as phosphatidyl
inositol phosphodiesterase) acts by cleaving the phosphate
group from phosphatidylinositol leaving the diglyceride
molecule intact (Rittenhouse-Simmons, 1979). It is present
in the supernatant fraction of platelets that have been
sonicated and sedimented at 100,000g for 60 min. Optimal
activity is observed near pH 7 in the presence of 5mM calcium
ions (Rittenhouse-Simmons, 1979). Half maximal enzyme
activity can be observed in the platelet cytosol in the
presence of calcium concentrations as low as 5 to 10pM,
(Mauco, Chap and Douste-Blazy, 1979). This is about one to
two orders of magnitude more sensitive than platelet
phospholipase Ag whose half maximal enzyme activity in the
presence of calcium is 0.25 to 0.3mM (Jesse and Franson,
1979).
Evidence for the specific activity of phospholipase C on
phosphatidylinositol has been mainly described in
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thrombin - or collagen-stimulated platelets. Degradation of
phosphatidylinositol results in the generation of 1, 2
diacylglycerol as well as small quantities of myo-inositol
1:2 cyclic phosphate and myo-inositol 1-phosphate
(Rittenhouse-Simmons, 1978; 1979).
The amount of diglyceride occurring 15 sec after thrombin
addition may be as much as 30 times greater than basal
levels. However, this elevation is transitory and within 2
min diglyceride is at the low levels that characterize the
resting state. It is clear that the diglyceride is
metabolized further.
Two hypotheses exist at present to explain the next stage of
diglyceride metabolism. The first, put forward by Call and
Rubert (1973) and Lapetina and Cuatrecasas (1979) indicates
the presence of a diglyceride kinase enzyme which is able to
phosphorylate diglycerides. The resultant phosphatidic acid
yielded is thought to constitute the "primary response" to
stimulation and appears to precede the liberation of
arachidonic acid from the various phospholipids. The
mechanism by which this latter phase is brought about is not
clear, but it is believed that phosphatidate and its
metabolite lysophosphatidate have the properties of a calcium
ionophore (Lapetina, 1982). An increase in the
concentration of free, intracellular calcium could then
activate phospholipase and result in arachidonic acid
liberation from phosphatidylcholine, phosphatidylethanolamine
and phosphatidylinositol (Lapetina, Billah and Cuatrecasas,
1981). Phosphatidic acid may be removed by combining with
cytidine triphosphate to form cytidine diphosphate
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Phosphatide acid fR,-PR2
Figure 11 Phosphatidylinositol (PI) Cycle
The turnover of phosphatidylinositol is represented
diagramatically, thus
the circled P = phosphate group
the circled I = inositol
R.j + ^2 = fatty acid chains
1 = reaction catalysed by CMP-phosphatidate:inositol
phosphatidate transferase
2= reaction catalysed by phosphatidylinositol
phosphodiesterase (phospholipase C)
3 = reaction catalysed by diglyceride kinase
4 = reaction catalysed by CTP-phosphatidate
cytidyltransferase
5 = reaction catalysed by diglyceride lipase and
monoglyceride lipase
diglyceride and pyrophosphate. The "activated" cytidine
diphosphate diglyceride is then once again available for
phosphatidylinositol synthesis. The continuous turnover of
phosphatidylinositol (the PI cycle) is hypothesized as being
the key factor for arachidonate release in platelets
(Lapetina, 1982). (See Fig. 11.) Another view which is
under investigation suggests that a phospholipase exists
which is capable of hydrolyzing fatty acids specifically from
phosphatidic acid (Billah, Lapetina and Cuatrecasas, 1981).
The second theory, proposed by Bell, Kennerly, Stanford and
Majerus (1979), involves a diglyceride-specific lipase which
degrades diglyceride to monoacylglycerol and stearic acid.
The enzyme is membrane bound and shows enhanced activity at
neutral pH in the presence of calcium ions and sulphydryl-
reducing agents. Release of arachidonic acid from " 2-
arachidonyl monoglyceride requires the action of mono-
glyceride lipase (Chau and Tai, 1981). It has been suggested
that diglyceride lipase activity is very low in platelets.
However it has been demonstrated in human platelets that
indomethacin (25 to 50jig/ml) blocked the activity of
diglyceride lipase at concentrations that do not affect
diglyceride kinase or phospholipase C (Rittenhouse-Simmons,
1980). Increased amounts of diglyceride were formed
suggesting that diglyceride lipase activity was important in
platelets for the release of arachidonic acid.
Such evidence implicates both pathways in diglyceride
metabolism within the platelet. The pathways are summarised
in Fig. 12. The two pathways described for the release of
arachidonic acid from plateLet membrane phospholipids as a
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Figure 12 Diagram To Summarise Suggested Pathways For
Phosphatidylinositol Metabolism and Arachidonic




























PA specific phospholipase A£
consequence of activation were recently monitored by Imai,
Yano, Kameyama and Nozawa (1982). Their results revealed
that although phosphatidylinositol provided some arachidonic
acid by phospholipase C activation, the pathway involving
phospholipase A2 was of more importance for providing
arachidonic acid for prostanoid synthesis by, and release,
from thrombin activated human platelets.
Lysophospholipase
Lysophospho1ipase (lysophospholipid acyl hydrolase) is
another fatty acid releasing enzyme. The enzyme removes the
fatty acid at the carbon-1 position from a 1-monoacyl-
lysophosphat i d e to form glycerol-3-phosphate. Since
arachidonic acid is not usually found esterified at the
carbon-1 position, the activity of the enzyme is not
important for the release of arachidonic acid.
Sulpholysis
The liberation of arachidonic acid from the probable main
sources (phosphatidylethanolamine, phosphatidylcholine or
phosphatidylinositol) may not take place by direct hydrolytic
action of phospholipase Ag, but by a CoA-mediated transfer of
fatty acid from a donor phospholipid to another phospholipid,
followed by hydrolysis of the acceptor lipid; this is known
as sulpholysis. The pathway is catalysed by acyl-
CoA:lysophosphatide acyltransferase. The same enzyme is
involved in the acylation of a lysophospholipid (Lands and
Merk 1, 1 963 ). .In vitro the enzyme exhibits some
specificity for arachidonate (Irvine and Dawson, 1979;
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Trotter and Ferber, 1981).
Thus, PL + CoA-SH -—^ Lyso PL + acyl-CoA
phospholipid Coenzyme A
A If A T D T V T5 T COA-SHAcyl-CoA + Lyso PL-| -—^ PLf
lyso phospholipid 1
Thus, the availability of arachidonic acid for prostaglandin
synthesis may be indirectly brought about by influencing the
fatty acid pattern of the phospholipids. It is possible
that more arachidonic acid is esterified into one particular
phospholipid which is more likely to undergo hydrolysis than
any other phospholipid source.
It is clear that the mechanisms controlling arachidonic acid
turnover in tissues are complex but nevertheless it is
important to study these processes in relation to PG
synthesis particularly in tissues where PG synthesis is
necessary for normal physiological functions.
Experimental Aims
The overall evidence from the literature indicates that PGF2K
is the uterine luteolytic hormone in many non-primate,
mammalian species including the guinea pig. The release of
arachidonic acid from some bound source is necessary for
PGF2K synthesis as it is the rate-limiting step in PG
synthesis by tissues including the guinea pig uterus (Leaver
and Seawright, 1982). The work presented in this thesis has
investigated some of the mechanisms involved in controlling
arachidonic acid uptake into, and release from, the various
lipid classes in the guinea pig uterus in relation
endometrial PGF2oc production and luteolysis.
SECTION 1. MATERIALS AND GENERAL METHODS
The work presented in this thesis has involved a radio-
labelling technique to monitor the uptake of the
prostaglandin precursor, arachidonic acid, as it passes into
the endometrial cell and becomes incorporated by¬
es t e r i f i ca t i on into the lipid components of the cell.
Subsequently, the basal release and the effects of the
steroid hormones, oestradiol and progesterone, and the
calcium ionophore A23187 on the release of the unsaturated
fatty acid from the various lipids have been measured. Some
of the pathways involved in the incorporation of arachidonic
acid into the phospholipid components of the cell have also
been examined. Methods of analysis have involved the
isolation and purification of neutral lipids and phospho¬
lipids using silicic acid column chromatography and thin
layer chromatography, and the detection and measurement of
radioactivity by liquid scintillation counting. The
experimental work has been divided into several sections but,
as many of the analytical procedures are common to each
section, the details of such procedures are described in this
section.
a) List of Materials
Solvents
Absolute ethanol J. Boroughs Ltd., London
Acetic acid, glacial (analar grade)
B.D.H. Chemicals Ltd., Poole
Acetone Mackay and Lynn, Edinburgh
Chloroform (analar grade) B.D.H. Chemicals Ltd., Poole
Diethyl ether (analar grade) B.D.H.Chemicals Ltd., Poole
Methanol (analar grade) Fisons Scientific Apparatus,
Loughborough
Methyl acetate (analar grade) b.d.h. Chemicals Ltd., Poole
Petroleum spirit (analar grade) b.d.h. Chemicals Ltd., Poole
(b. pt 40° - 60° C)
Propan-1-ol (analar grade) b.d.h. Chemicals Ltd., Poole
Toluene (analar grade) Fisons Scientific Apparatus,
Loughborough
Radioactive Compounds
[5,6,8,9,1 1, 12,14,15 — -^H^] arachidonic acid
(Sp. act. 120-131 Ci/mmol)
Amersham International Ltd., Cardiff
6-keto £5, 8 ,9 ,11, 12 ,14 ,15(n) - 3hJ prostaglandin F^
(Sp. act. 150 Ci/mmol)
Amersham International Ltd., Cardiff
(Hethyl - 3h] choline chloride
(Sp. act. 77 Ci / mmol)
1 Amersham International Ltd., Cardiff
S-adenosyl-L-jTmethyl-3h] methionine
(Sp. act. 60-68 Ci / mmol)
Amersham International Ltd., Cardiff
£9,10(n) - 3hJ oleic acid
(Sp. act. 8.2 Ci / mmol)
Amersham International Ltd., Cardiff
L-K-phosphatidyl [methyl - C 3 choline,dipalmitoyl
(Sp. act. 80 mCi / mmol)
Amersham International Ltd., Cardiff
5,6,8,11,12,14,15(n) - prostaglandin E2
(Sp. act. 160 Ci / mmol)
Amersham International Ltd., Cardiff
5,6,8,9,11,12,14,15(n) - prostaglandin F2k
(Sp. act. 180 Ci / mmol)
Amersham International Ltd., Cardiff
Other Chemicals and Materials
Ammonium molybdate B.D.H. Chemicals Ltd., Poole
Amphotericin B Flow Labratories, Irvine
Arachidonic acid (99% pure) Sigma Chemical Co., London
Bovine serum albumin Sigma Chemical Co., London
(fatty acid free)
Cholesterol oleate Sigma Chemical Co., London
Diglyceride standard
(33-33% dipalmitin, 33-33% diolein
33-33% distearin) Sigma Chemical Co., London
2,5 - diphenyloxazole B.D.H. Chemicals Ltd., Poole
Glutamine Flow Laboratories, Irvine
Iodine Sigma Chemical Co., London
Kanamycin Flow Laboratories, Irvine
Medium 199 (plus Earles salts) Flow Laboratories, Irvine
Mercury B.D.H. Chemicals Ltd., Poole
Monoglyceride standard (33-33%
monopalmitin, 33-33% monostearin,
33-33% monolein) Sigma Chemical Co., London
17-J3 Oestradiol Sigma Chemical Co., London
Oleic Acid Sigma Chemical Co., London
























{25% tristearin, 25% trilinolein
25% triolein , 25% tripalmitin )
Sigma Chemical Co., London
Sigma Chemical Co., London
Sigma Chemical Co., London
Sigma Chemical Co., London
Sigma Chemical Co., London
Sigma Chemical Co., London
Sigma Chemical Co., London
Sigma Chemical Co., London
BDH Chemicals, Poole
Sigma Chemical Co., London
Sigma Chemical Co., London
um Ionophore A23187
Sigma Chemical Co., London
Calbiochem-Behring Corp.,
Zinsser disposable plastic
scintillation vials Mackay and Lynn, Edinburgh
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Thin-layer chromatography
plates ( silica gel,
0.25mm thick) Merck A.G., Darmstadt
Unisil silicic acid (100 to
200 mesh) Clarkson Chemical Co., Inc.
Williamsport
Vented petri dishes
5cm diameter Sterilin Ltd., Teddington
b) Preparation of Chemicals and Solutions
i) Sodium Salts of Tritiated Arachidonic Acid
And Tritiated Oleic Acid
Sufficient of the radioactive fatty acid for each
investigation was dissolved in ethanol (5ml) which contained
phenolphthalein as indicator. Ethanolic sodium hydroxide
(0.1M) was slowly added until the solution just changed
colour from clear to purple. The solution was then
evaporated to dryness at 35°C on a rotary evaporator and was
dissolved in an appropriate volume of culture medium.
Preparation of the sodium salts in this manner ensured that
the fatty acids readily and completely dissolved in the
aqueous media for uptake into the tissue.
ii) Scintillation Fluid
Scintillation fluid was made up as required using the
following chemicals: 10.5g 2,5-diphenyloxazole (PPO)
2.5 1 toluene
iii) Supplemented Culture Medium 199
The Medium 199 used in tissue culture has as a basis a
synthetic mixture of inorganic salts known as a physiological
or balanced salt solution (see Table 1.1). The functions of
this salt solution in the medium are:
1. to maintain the pH
"2. to maintain the osmotic pressure
3. to provide a source of energy
The buffer utilised in the tissue culture medium is sodium
bicarbonate (2200mg present in every litre of medium).
Sodium bicarbonate is also a nutritional requirement.
Medium 199 does not contain glutamine, an essential factor
for stromal viability and good epithelial preservation, which
is only stable below 0°C (see Kaufman, Adamec, Walton,
Carney, Melin, Genta, Mass, Dorman, Rodgers, Photopulos,
Powell and Grisham, 1980). The tissue culture medium is
stored at 5°C and glutamine is then added when required.
Since the medium may also be susceptible to bacterial growth,
the culture medium was supplemented with antibiotics (Abel
and Baird, 1980; Leaver and Seawright, 1982). Supplemented
tissue culture medium was made up under sterile conditions in
the following manner:
To Medium 199 (500ml) was added glutamine (200mM; '4ml)
kanamycin (5000 pg/ml; 3ml) and amphotericin B (250 pg/ml;
'3ml). After mixing well, the supplemented culture medium
was dispersed into 20ml storage bottles and stored at -20°C
until required.
Medium 199
199 with 199 with
Earle's Earle's
Salts Salts
Ingredient mg/litre Ingredient mg/litre
L-Aianine 25 00 CaClj 2HjO 264 9
L-Arginine HCI 70 00 Fe(NO,l) 9H,0 0 10
l-Asparnc acid 30 00 KCI 400 0
L-Cysleine HCI 00987 KH,PO.
L-Cystine. disodium salt 23 66 MgSO. 7HjO 2000
L-Glutamic acid 66 82 NaCI 6800
l-Glutamine 100.0 NaHCOj 2200
Glutathione 005 NaH,P04 2H,0 158 3
Glycine 50 00 Na2HP04
L-Histidine HCI H20 21 88 Adenine sulphate 10 00
L-Hydroxyproline 10 00 5-AMP 0 20
L-lsoleucine 20.00 ATP. disodium salt 10 00
L-Leucine 60 00 Cholesterol 0 20
I-Lysine HCI 7000 2-Deoxyribose 0 50
L-Methionine 15 00 Glucose 1000
L-Phenylalanine 25 00 Guanine HCI 0.30
L-Proline 40 00 Hypoxanthine 0 30
L-Serine 25.00 Ribose 0 50
L-Threonine 3000 Sodium acetate 36 71
L-Tryptophan 10.00 Sodium phenol red 17.00
L-Tyrosine 40.00 Thymine 0.30
L-Valine 25.00 Tween 80 5 00
L-Ascorbic acid 0.05 Uracil 0 30
Biotin 0 01 Xanthine 0 30
Calciferol 0.10

















Vitamin A acetate .0 1 147
Table 1.1
The individual ingredients of the tissue culture Medium
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c) Animals Used
Virgin guinea pigs weighing between 500 and 1000 g were
examined daily and a vaginal smear was taken when the vaginal
membrane was open. The first day of the oestrous cycle was
taken as the day before the post-ovulatory influx of
leucocytes when cornification was maximal (Nicol and Snell,
1954). All animals had exhibited at least two normal cycles
immediately before being used.
Each guinea pig was killed by stunning and incising the neck
either on Day 7 or Day 15 of the cycle, days of low and high
PGF^^ output from the uterus respectively (Blatchley et al.,
1972). The uterus was rapidly removed and placed in culture
medium in preparation for culture by a method based on that
of Baker and Neal (1969)
Histological Studies
Since a number of parameters are involved in tissue
culture, it has been necessary to determine the quality of
tissue maintenance before and after experimental conditions
by morphologic evaluation using light microscopy. Slides
were prepared by courtesy of Dr. W. Blyth and Mrs Susan
Bartlett of the Botany Department, Edinburgh University.
Endometrial tissue was obtained from a guinea pig on Day 15
of the oestrous cycle. Uncultured tissue and specimens of
tissue incubated for 72 hours (under conditions to be
described later) were fixed in formalin for 24 hours. The
tissue was then dehydrated through graded concentrations of
ethanol (from 70 to 100%) over a period of two days ( see
Table 1.2.) After being embedded in wax, the tissues were
i
blocked, sectioned and stained with hematoxylin and eosin
(Boutsellis, De Neef, Ullery and George, 1963).
Table 1.2




























- Warm vacuum 2hr
Tissues now blocked and ready for sectioning
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Figure 1,1
Photograph A is taken from a slide preparation of uncultured
Day 15 endometrial tissue
Photograph B is taken from a slide preparation of Day 15
endometrial tissue cultured for 72 hr.
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Histologic appearance of uncultured tissue was compared
with that obtained from endometrial tissue cultured for 72
hours. Tissue was considered viable if the nuclear and cell
membranes appeared intact and the nucleus stained well with
a
the basic dye, hematoxylin. Loose cellular stroma
surrounding glands composed of cuboidal to columnar
epithelium were also observed, confirming that the tissue
culture system was functioning adequately (see Fig. 1.1).
Also there were no obvious differences between tissue before
and after culture; therefore the tissue culture procedure is
adequate for normal maintenance and survival of endometrium.
d) Tissue Culture Technique
i) Preparation of tissue
When the endometrium was required for tissue culture, it was
necessary to dissect it from the myometrium by cutting away
1mm by 2mm portions of endometrium under sterile conditions.
This technique produced greater than 85% separation of
uterine tissues (Leaver and Poyser, 1981). The myometrium
was discarded and approximately 20mg endometrial tissue was
placed onto sterile lens paper which lay across a sterile,
stainless steel grid or cradle in a vented petri dish (Fig.
1.2) The dish contained 4ml supplemented Medium 199
together with other agents, according to the nature of the
experiment. This arrangement enabled the tissue to remain
above the culture medium but still allowed the medium to be
readily available to the endometrial tissue by capillary
action through the lens paper. The number of dishes
prepared again depended on the nature of the experiment.
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Figure 1.2
The above diagram illustrates the arrangements for tissue
culture. The endometrial tissue was placed onto the lens
tissue which lay across a stainless steel grid or cradle in a
vented petri dish containing culture medium. Four petri
dishes supported by a wire frame could be placed in the
modified "Kilner jar" for incubation.
ii) Conditions Required for Tissue Culture
Groups of 4 petri dishes were placed in racks and then
into modified Kilner jars to be incubated at 37°C in the
presence of a 1:1 mixture of air/carbon dioxide (95%i5%) and
oxygen / carbon dioxide (95% :5%) at a pressure of 10 lb/in
for periods of time as required. The presence of a small
amount of carbon dioxide in the atmosphere is necessary to
set up a CO2/HCOJ" buffer situation. If this procedure is
not carried out, the pH increases rapidly at the normal
temperature of incubation. The resultant red to purple
colour change in the medium then indicates that the pH has
risen and cell growth may be inhibited.
iii) Use of Bovine Serum Albumin
In the literature, experiments investigating the
stimulated release of arachidonic acid from prelabelled
lipids have been unsuccessful. For example cultured rabbit
14
alveolar macrophages were prelabelled with C-arachidoni'c
acid (Hsueh, Desai, Gonzalez-Crussi, Lamb and Chu, 1981).
Stimulation of the macrophages with various phagocytic and
non-phagocytic stimuli resulted in prostaglandin release.
However, only a small amount of arachidonic acid could be
detected in the medium. It was suggested that free
arachidonic acid which passed out of the cell was
immediately taken back up again and reincorporated into the
phospholipids. To avoid this problem, fatty acid free bovine
serum albumin, a protein with a molecular weight of about
70,000, was used to "trap" the released fatty acid; a more
accurate assessment of the effects of the stimuli was then
observed.
Since an immediate re-uptake and reincorporation of radio¬
active arachidonic acid could have occurred in the release
experiments to be described in Section 4, it was decided that
the addition of 0.1% bovine serum albumin to the culture
medium would be advantageous in this respect.
e) Silicic Acid Column Chromatography
The separation of phospholipid and neutral lipids into
individual molecular species is a complex multistep
procedure. The initial step has to allow quantitative
isolation in amounts large enough for further analysis. It
was therefore necessary to utilise silicic acid column
chromatography to produce group separation of the neutral
lipids from the phospholipids.
i) Preparation
Preparation involved the use of glass columns (1cm x 10cm).
About 0.5 cm of fine white sand was placed initially into
each column so that none of the smaller particles of the
Unisil silica gel would damage the scinter. After filling
the columns with 20ml diethyl ether, any air bubbles in the
sand were removed by shaking. About 3 to 3-5g silica gel in
diethyl ether was transferred to each column by using a
Pasteur pipette. Excess ether was then removed via the tap
outlet. Before use, each column was washed with 100ml
diethyl ether.
iii)Elution of Neutral Lipids, Phospholipids and Prostaglandins
Methodology
Three silicic acid columns, labelled A, B and C, were set up
76
and each was washed with 100ml diethyl ether. 1pCi Tritiated
arachidonic acid (used to represent the movement of neutral
1 4
lipids ) was applied to column A. O.lpCi C-Phosphatidyl-
choline (used to represent the movement of phospholipids )
was applied to column B. O.lpCi of each of the following
prostaglandins, [3H]PGF-2fic, [3H]PGE2cc and [3H]6-keto PGF1k
were applied to column C. The columns then underwent
stepwise elution using the following solvent mixtures.
TABLE 1.3
Solvent mixtures used to elute silicic acid columns











The results in Table 1.4 indicated that the initial 100ml of
solvent was enough to elute 99% of the tritiated arachidonic
acid from column A. All tritiated prostaglandins were removed
by the solvent mixture of 20# methanol:80# diethyl ether from




Radioactivity eluted by varying solvent mixtures.
% MeOHin DPmC3h] DPM[1^cJ DPi£3hJ
Diethyl prostaglandin phosphatidyl- arachidonic
Ether choline acid
0 1995 2839 1394637
0.5 7232 137 76972
1 5120 0 2313
2 29508 0 1120
4 4374604 0 325
10 19815 0 0
20 692 0 0
50 6566 578 0
100 316 55787 0
Therefore, for silicic acid column chromatography it was
decided to use
1) 100ml diethyl ether to elute neutral lipids
2) 20ml methanol in 80ml diethyl ether to elute
prostaglandins
3) 100ml methanol to elute phospholipids
iii) Recovery from Columns
Before samples for analysis( derived from endometrial tissue
by methods to be described later) underwent silicic acid
column chromatography, each sample was placed in a known
volume (5ml) of chloroform and methanol (2:1) and a 100yul
aliquot portion was taken for liquid scintillation counting.
Each sample was then applied to the top of a silicic acid
column and eluted with, in succession, 100ml diethyl ether
(which elutes neutral lipids including free arachidonic
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acid), 20ml methanol in 80ml diethyl ether (which elutes
cyclooxygenase and probably lipoxygenase products), and 100ml
methanol (which elutes phospholipids).
After each fraction was collected from the column, the
solvent was removed by a rotary evaporator at 35°c and the
sample was resuspended in 5ml chloroform and methanol (2:1).
Again, 100jil portions of each fraction obtained from the
column were taken for liquid scintillation counting.
The radioactivity present in the sample before and after
column chromatography may then be compared. The results
showed that, in all experiments to be described later, 80$ or
more of the radioactivity was recovered. All subsequent
results are corrected for recovery.
f) Thin-layer Chromatography (tic)
It was decided that tic would be the best means for the
further separation of neutral lipids and phospholipids. The
thin layer of powdered absorbent can cause the solvent to
flow rapidly giving an exceptionally fast separation. Also
the fineness of the powder cuts down the interstitial volume
t
bejween the granules and this minimises diffusion and gives
rise to very sharp spots. Adsorption chromatography in the
tic form is extremely useful for another reason ; adsorption
and desorption take place well in non-polar media and lipids
are therefore better separated in such systems.
i) Preparation
Precoated glass tic plates (silica gel thickness 0.25mm, 5cm
by 20cm) were used rather than "home - made" plates, as they
gave very reproducible separations. The baseline was drawn
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2cm from the bottom of each plate, to indicate the starting
point of the sample. A line was then scored 3cm from the top
of each plate to indicate the point which the solvent has to
reach.
ii) Application of a Sample
e
After drying down in a rotary evaporator at 35 c, the sample
was resuspended in 200^1 chloroform and methanol (2:1) and
"streaked" onto the tic plate by using a micro-syringe. Each
sample was applied to individual tic plates and care had to
be taken that no material was near the edge of the plate. If
this had been allowed to occur, then the sample at the edge
of the plate would have developed faster than the sample
applied to the middle of the plate, and a curved profile of
separation of the different lipids would result.
Standards of phospholipids and neutral lipids were spotted
onto separate tic plates and developed at the same time as
the samples. Solvent tanks, which were lined with white
absorbent paper and which contained approximately 100ml of an
appropriate solvent mixture, were used to develop ten 5cm by
20cm plates simultaneously.
iii) Choice of Solvents
Neutral lipids were separated into individual lipid classes
by tic using a solvent system consisting of petroleum spirit
o fi
(b.pt. 40 _ 60 C), diethyl ether and acetic acid (75:25:1 by
volume). Standards (2 5ju g of each) for triglyceride,
diglyceride, monoglyceride, cholesterol ester and arachidonic
acid were also developed. Plates were usually fully
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Figure 1.3
The pattern of neutral lipid distribution after development
in a solvent system of petroleum spirit (b. pt. 40 - 60 C),
diethyl ether and acetic acid (75:25:1 by
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The pattern of phospholipid distribution after development in
a solvent system consisting of methyl acetate, propan-1-
ol, chloroform, methanol and 0.251 aqueous solution of
potassium chloride (25:25:25:10:9 by volume).
The calculated value of
phosphatidylethanolamine is 0.52 - 0.56
phosphatidylserine is 0.47 - 0.50
phosphatidylinositol is 0.46 - 0.48
phosphatidylcholine is 0.16 - 0.20
sphingomyelin is 0.09 - 0.12
Phospholipids were separated by tic using a solvent system
consisting of methyl acetate, propan-1-ol, chloroform,
methanol and 0.25% aqueous solution of potassium chloride
(25 :25 :25 : 10:9 by volume). Standards (25^ug of each ) of
phosphatidylcholine, phosphatidylethanolamine, phosphatidyl-
inositol, phosphatidylserine and sphingomyelin were developed
with the samples. After development for about 2hr, the
plates were left to air dry for 20min (Fig. 1.4.).
iv) Detection of Lipids on the Plates
Iodine vapour was used for the detection of the standard
lipids, as this is the simplest technique. When developed
and dried, the plates on which the standards had been
spotted, were placed into a tic tank containing a few iodine
crystals. Neutral lipids were visualized after 5 min and
phospholipids were detected after about 1hr exposure to
iodine. The brown hue evaporated spontaneously after a few
minutes.
The plates on which the neutral lipid samples had been
streaked were then marked with 15 lanes 1 cm wide. Each
lane was scraped into a separate scintillation vial,
containing 1ml diethyl ether to aid elution of neutral lipids
from the silica gel.
The plates on which the phospholipid samples had been
streaked were then marked (from the baseline) with 16 lanes
0.5 cm wide followed by 7 lanes 1 cm wide i.e. wider lanes
were marked nearer the solvent front. Each lane was scraped
into a separate scintillation vial, containing 0.5ml methanol
to aid elution of phospholipids from the silica gel.
Scintillation fluid (10ml) was added to each scintillation
vial, and the lids were labelled and screwed down tightly.
Each vial was shaken severely. The Rf value of each
standard lipid was calculated using the formula
distance lipid moved (mm)
distance solvent front travelled (mm)
The resultant Rf values for the standard lipids were then
compared with the R^ values of the sample lipids to determine
the precise nature of the sample lipids.
v) Recovery of Compounds from the Plates
A comparison of results before and after tic of neutral
lipids indicated that between 50% and 90% of compounds were
removed from the plates. In the case of phospholipids, the
recovery of radioactivity from the tic plates ranged from 60%
to 90%. All subsequent results have been corrected for
recovery.
g) Liquid Scintillation Counting
After addition of 10ml scintillation fluid to each vial,
samples were counted for 4 min using a Phillips PW4540 liquid
scintillation analyser. This gave a value of counts per
minute (cpm) for each sample.
The greatest disadvantage of liquid scintillation counting is
quenching, which occurs when the maximum photon yield for a
given radioactive source is interfered with at any point.
Quenching can be due to any one of three reasons. Optical
quenching occurs if dirty scintillation vials are used.
Dirty vials interfere with light being emitted by the sample
before it reaches the photomultiplier. Colour quenching
occurs if the sample is coloured and results in some of the
light being absorbed before it leaves the sample bottle.
These types of quenching can easily be corrected for by using
clean vials and by adding a drop of hydrogen peroxide,
respectively. However, no problems in counting were
encountered in these ways.
The most difficult form of quenching to correct for is
chemical quenching which occurs if anything in the sample
interferes with the transfer of energy from the solvent to
the photomultiplier. Unless it is certain that all samples
are chemically identical except for radioactive content, it
is not sufficiently accurate to compare the counts (cpm)
obtained by liquid scintillation counting. Instead, by
using an appropriate means of standarization, the counting
efficiency of every sample can be determined and the cpm
recorded must subsequently be converted to disintegrations
per minute (DPM). Efficiency is defined as the ratio of the
observed cpm to true DPM.
To determine the efficiency of counting, the scintillation
counter machine constants were first determined by
constructing a quench curve where a calibrated tritium
standard (^H hexadecane) was used to provide a known number
of DPM, and its cpm were determined at different levels of
quenching. Chloroform was used as the quenching agent, and

















The quench curve is plotted by measuring the efficiency
of counting, cpm/DPM (y axis) against the ratio (x axis).
Sample channel ratio was used. The quench curve is
p
described by the equation y = kg + k^x + kpx where kg, k^
and kp are constants. It was necessary to check and if
necessary recalculate the machine constants every year, just
after the liquid scintillation counter was serviced. Typical
quench curves and the values of kg, k -|, and kp are given in
Fig. 1.5.
These constants are used to determine the efficiency of
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Figure 1.5
Plotting percentage counting efficiency versus sample
channels ratio resulted in two typical quench curves. The
machine constants derived from the two curves were used to
convert cpm to DPM.
h) Statistical Tests
Appropriate data was analysed by Student's t-test or Duncan's
multiple range test. Where the variances of the groups were
unequal ( as analysed by the variance ratio 'F" test ), then
data was analysed by a modified t-test ( see Steel and
Torrie, 1980).
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SECTION 2. INCORPORATION OF UNSATURATED FATTY ACIDS IN GUINEA
PIG ENDOMETRIUM
Introduction
Free araohidonic acid is known to be present in low amounts
within tissues (Kunze and Vogt, 1971) including the guinea
pig uterus (Leaver and Poyser, 1981). Prolonged synthesis
of prostaglandins In" vivo would tend to quickly deplete the
available substrate (free arachidonic acid) and would then
have to draw upon the reservoir of arachidonic acid bound in
ester form to the neutral lipids and phospholipids (Van
Dorp, Beerthuis, Nugteren and Vonkeman, 1964; Lands and
Samuelsson, 1968). The arachidonic acid and other fatty
acids released from one or more of these reservoirs must be
replenished by utilizing uptake processes. The fatty acids
may be recycled or fresh supplies derived from dietary
sources or from precursor free fatty acids (as summarised in
the General Introduction). It is important therefore to
monitor the incorporation of fatty acids into these lipid
reservoirs. The experiments reported in this section were
designed to answer the following points
a) Which lipids incorporated arachidonic acid ?
b) The extent to which arachidonic acid was incorporated
into each lipid.
c) To determine whether there was any difference in
incorporation of arachidonic acid into lipids at different
stages of the oestrous cycle.
d) To determine whether a similar pattern of incorporation
was observed using other unsaturated fatty acids.
e) To determine whether there was any difference in
incorporation of other unsaturated fatty acids into lipids
throughout the oestrous cycle.
The experiments employed tritiated arachidonic acid (^H-AA)
to monitor incorporation of this fatty acid into the various
lipids. Measurements were made on Day 7 and Day 15 of the
oestrous cycle as these are respectively days of low and high
PGF^^ synthesis by, and release from, the guinea pig uterus
(Blatchley et al.,1972; Poyser,1972; Earthy et al., 1975;
Wlodawer et al.,1976). The uptake of other unsaturated
fatty acids was monitored by using tritiated oleic acid (^H-
OA), a molecule composed of 18 carbon atoms and one double
bond.
Methods
Experiment 1. Arachidonic Acid Incorporation
Ten guinea pigs were killed by stunning and incising the
neck: five were on Day 7 and five were on Day 15 of the
oestrous cycle. In each case the uterus was rapidly removed
n
and was placed in culture medium, where the ejdometrium was
subsequently dissected from the myometrium by cutting away
1mm by 2mm portions of endometrium. The myometrium was
discarded. Approximately 20mg endometrial tissue was placed
onto sterile lens paper which lay across a sterile, stainless
steel grid in a vented petri dish. The dish contained 4ml
supplemented Medium 199 and 10pCi ^H-AA (as the sodium salt).
Six petri dishes containing endometrial tissue were prepared
from the uterus of each guinea pig. The tissue was then
cultured for 3, 9 or 24 hr by a method based on that of Baker
and Neal (1969) previously described in Section 1(d). Two
samples were cultured for each time period. Following
incubation, the tissue from each dish was washed in fresh
medium, blotted dry, weighed and homogenised in 15ml chloro¬
form and methanol (2:1). Each homogenate was subjected to
silicic acid column chromatography to separate the neutral
lipids and arachidonic acid products from the phospholipids
as described in Section 1 (e). The individual components of
the neutral lipids were resolved by thin-layer chromatography
as described in Section 1(f). Lanes were marked on each tic
plate as described in Section 1(f) and subsequently each lane
was measured for radioactivity by liquid scintillation
counting as described in Section 1 (g). The excess solvent
in the second fraction from the silicic acid columns was
removed under vacuum using a rotary evaporator at 35°C. The
radioactivity in the arachidonate products was measured by
liquid scintillation counting.
Experiment 2. Oleic Acid Incorporation
Twelve guinea pigs were killed by stunning and incising the
neck, six being on Day 7 and six being on Day 15 of the
oestrous cycle. Experiment 1 was repeated but using 10jaCi
^H-OA (as the sodium salt) instead of ^H-AA in each petri
dish. Duplicate samples of endometrium from each guinea pig
were cultured for 3> 9 or 24 hr as described in Section 1(d).
Following incubation, the tissue from each dish was washed in
fresh medium, blotted dry, weighed and homogenised in 15ml
chloroform and methanol (2:1). The resultant homogenate was
then subjected to silicic acid column chromatography as
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previously described in Section 1(e). One of the duplicate
samples from four guinea pigs and both duplicate samples from
two guinea pigs on each day were further analysed by tic as
previously described in Section 1(f). Lanes were marked as
described in Section 1(f) and subsequently each lane was
measured for radioactivity by liquid scintillation counting
as described in Section Kg).
Statistical Analysis
All data was analysed by the Student's unpaired "t" test.
Results
Experiment 1. Arachidonic Acid Incorporation
The total amount of ^H-AA taken up into both Day 7 and Day 15
guinea pig endometrial tissue increased with time and there
was 2 to 3 times more radioactivity incorporated after 24 hr
than after 3 hr (Fig. 2.1). Day 15 tissue incorporated
significantly more ^H-AA than Day 7 tissue (P^0.05) at 3 hr
only (represented as 'total' in Fig. 2.1). At 24 hr there
was no significant difference in incorporation of total ^H-AA
between Day 7 and Day 15 tissue. Data obtained after
silicic acid column chromatography analysis indicated that
both the neutral lipid and phospholipid fractions
incorporated ^H-AA over the 24 hr time period (Fig.2.1). In
Day 7 tissue there was no significant difference in
incorporation of ^H-AA between the neutral lipid and
phospholipid fractions. A similar finding was also observed
in Day 15 tissue. Although no significant differences were
found, it was interesting to note that more ^H-AA was















Figure 2.1 Mean (+ s.e.m., n=10) total uptake of 3H ^
into Day 7 and Day 15 guinea pig endometrium during a 24 hr
culture period, and its distribution among phospholipids
(PL), neutral lipids (NL) and free %-AA (standard errors for
AA are too small to include).
t (P < 0.05), tT (P <. 0.01) Significantly higher than







3 hr on both Days 7 and 15. By 24 hr however there was no
q
difference in the incorporation of JH-AA between the two
q
lipid fractions on Day 7, and more JH-AA was incorporated
into phospholipids than into neutral lipids on Day 15.
A further comparison of the data indicated that the uptake of
^H-AA into phospholipids was significantly greater on Day 15
than on Day 7 at 9 hr (P^O.05) and 24 hr (P< 0.01)
respectively. There were no significant differences in the
uptake of ^H-AA into neutral lipids between Day 15 and Day 7
tissue at any of the times studied, although incorporation at
24hr tended to be higher on Day 15 than on Day 7. There
were relatively low levels of free ^H-AA in endometrial
tissue at 3, 9 and 24 hr on both Day 7 and Day 15. Very
little radioactivity (between 1.3 to 3«9 x 10^ DPM) was found
in the second fraction eluted from the silicic acid columns
indicating that very little ^H-AA was converted to cyclo-
oxygenase and possibly lipoxygenase products (for clarity
results were omitted from the graphs).
Data obtained after further separation by thin-layer
chromatography indicated that the incorporation of ^H-AA into
the different neutral lipid classes was in the order of
monoglyceride > diglyceride > triglyceride > cholesterol
ester at 3 hr and triglyceride > monoglyceride = diglyceride
> cholesterol ester at 24 hr, on both Day 7 and Day 15
(Fig.2.2). There was a significantly higher incorporation
(P 0.05) of ^H-AA into monoglycerides and diglycerides at 3
hr and 9 hr on Day 15 than on Day 7. At 24 hr, more ^H-AA
seemed to be incorporated into triglycerides, monoglycerides
and diglycerides on Day 15 than on Day 7, but none of the
differences between the two days were of statistical
significance.
Incorporation of ^H-AA into phospholipids was in the
order of phosphatidylcholine > phosphatidylethanolamine>
phosphatidylserine+phosphatidylinositol > sphingomyelin at 3,
9 and 24 hr on both Day 7 and Day 15 (Fig.2.2 ). There was
significantly greater incorporation ( P<0.05 ) of ^H-AA
into phosphatidylcholine, phosphatidylethanolamine and
phosphatidylserine+phosphatidylinositol at 24 hr on Day 15
than on Day 7.
Experiment 2. Oleic Acid Incorporation
The total amount of ^H-OA taken up into Day 7 and Day 15
guinea pig endometrial tissue increased with time and there
was twice as much radioactivity incorporated after 24 hr than
after 3 hr (Fig. 2.3). Day 15 tissue incorporated
significantly less (P^c0.05) ^H-OA than Day 7 tissue at 3 hr
and 24 hr.
Data obtained after silicic acid column chromatography
analysis indicated that both the neutral lipid and phospho¬
lipid fraction incorporated ^H-OA over the time period
observed (Fig. 2.3). More ^H-OA was incorporated into
neutral lipids than into phospholipids in both Day 7 and Day
15 tissue. Incorporation of ^H-OA into neutral lipids at 3
hr and into phospholipids at 24 hr was significantly lower
(P<0.05) on Day 15 than on Day 7 (Fig. 2.3). There was a
relatively high level of free ^H-OA in both Day 7 and Day 15
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Figure 2.2 Mean (+ s.e.m., n=10) uptake of ^H-AA into
triglyceride (TG), monoglyceride (MG), diglyceride (DG),
cholesterol ester (cho), phosphatidylcholine (PC),
phosphatidy1ethanolam i ne (PE), phosphatidy1serine +
phosphatidylinositol (PS + PI) and sphingomyelin (Sph) in Day
7 and Day 15 guinea pig endometrium during a 24 hr culture




(P <0.05) than corresponding Day 7
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radioactivity (between 0.1 to 1.6 xlO-5 DPM) was found in the
second fraction eluted from the silicic acid columns
indicating that, as expected, very little ^H-OA was converted
to cyclooxygenase and lipoxygenase products (for clarity
results were omitted from the graphs).
Data obtained after further separation by thin-layer
chromatography indicated that neutral lipids and phospho¬
lipids incorporated ^H-OA over the time period observed (Fig.
2.4). Of the ^H-OA incorporated into neutral lipids,
generally more ^H-OA was incorporated into triglycerides and
diglycerides than into monoglycerides at 3> 9 and 24hr on
both days. There was a significantly greater (P<0.05)
incorporation of ^H-OA into monoglycer ides on Day 7 than on
Day 15 at 24hr only. Incorporation of ^H-OA into
cholesterol ester was low at all time periods studied
although uptake on Day 7 was generally higher than on Day 15
(significantly different (P<£0.05) at 24hr).
Incorporation of ^H-OA into phospholipids was in the order of
phosphatidylcholine > phosphatidy1ethano1 amine >
phosphatidylserine + phosphatidylinositol at 3> 9 and 24 hr
on both Day 7 and Day 15 (Fig.2.4). However, at 24 hr it was
noted that there was a significantly greater (P <0.0 5 )
incorporation of ^H-OA into phosphatidylethanolamine and
phosphat idylser ine + phosphat idylinosi tol on Day 7 than on
Day 15. The incorporation of ^H-OA into phosphatidylcholine
was similar on both days. The incorporation of ^H-OA into
sphingomyelin was so low that it was not feasible to mark the






















Figure 2.3 Mean ( + s.e.m., n=12) total uptake of ^H-OA into
Day 7 and Day 15 guinea pig endometrium during a 24 hr
culture period, and its distribution among phospholipids
(PL), neutral lipids (NL) and free -%-OA.
t (P < 0.05) tfCP < 0.01) Significantly lower than
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Figure 2.4 Mean ( + s.e.m., n = 8) uptake of -^H-OA into
triglyceride (TG), monoglyceride (MG), diglyceride (DG),
cholesterol ester (cho), phosphatidylcholine (PC),
pho spha t idy 1 ethano 1 am ine (PE) and phosphatidylserine +
phosphatidylinositol (PS + PI) in Day 7 and Day 15 guinea pig
endometrium during a 24 hr culture period.
f (P < 0.05) tf(P < 0.01) Significantly lower than
corresponding Day 7 value.
Conclusion
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The data obtained from these experiments were more than
adequate to answer the points raised in the introduction of
the current section. It was demonstrated that all the
neutral lipids and phospholipids examined were capable of
incorporating arachidonic acid to a greater or lesser extent.
Of the neutral lipids, triglycerides had the greatest
capacity to incorporate arachidonic acid; of the
phospholipids, phosphatidylcholine was observed to
incorporate the largest amount of arachidonic acid. A
comparison of the data from Day 7 and Day 15 indicated that
the lipids therein incorporated arachidonic acid to a
different extent, and that all the phospholipids with the
exception of sphingomyelin of Day 15 tissue incorporated
significantly more arachidonic acid than the phospholipids of
Day 7 tissue.
Analysis of the second set of results indicated that, like
arachidonic acid, oleic acid was incorporated into all the
neutral lipids and phospholipids of Day 7 and Day 15 tissue.
However the pattern of incorporation of oleic acid throughout
the oestrous cycle differed markedly from that of arachidonic
acid. The most notable differences were :-
1) there was a greater incorporation of oleic acid into
monoglycerides on Day 7 than on Day 15 at 24 hr only. For
arachidonic acid there was greater incorporation into
monoglycerides on Day 15 than on Day 7 at 3 and 9 hr.
2) there was a lower incorporation of oleic acid into
phosphatidy1ethano1 am i ne and phosphat idy1serine +
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phosphatidylinositol at 24 hr on Day 15 than on Day 7.
Arachidonio acid incorporation into phosphatidylethanolamine,
phosphatidylcholine, phosphatidylinositol + phosphatidyl-
serine was greater on Day 15 than on Day 7.
It was not possible to compare the actual amounts of ^H-AA
"3
and JH-0A incorporated into the different lipid classes
because the quantity of ^H-OA used was much greater than the
quantity of ^H-AA used (10pCi of both tritiated compounds was
used but the specific activity of ^H-AA was 14 times higher
than that of ^H-OA). However, at 24hr, particularly on Day
15, more of the ^H-OA was incorporated into neutral lipids
while more of the ^H-AA was incorporated into phospholipids.
In vivo, there is a 10- to 15-fold higher incorporation of
endogenous oleic acid than of endogenous arachidonic acid
into triglycerides while the incorporation of both
unsaturated fatty acids into phospholipids is similar (Leaver
and Poyser, 1981). These two sets of observations indicate
that there are differences in the incorporation and relative
distribution of arachidonic acid and oleic acid among the
different lipid classes in guinea pig endometrium. To
conclude, the overall data indicated that there was a
specific, increased incorporation of arachidonic acid into
the phospholipids of Day 15 endometrial tissue, which is a
day of high PGF2K synthesis, compared to Day 7, which is a
day of low PGF2K synthesis.
Discussion
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During the period of culture in the presence of tritiated
unsaturated fatty acids, it was noted that the levels of free
^H-OA in guinea pig endometrium were much higher than the
levels of free ^H-AA presumably due, at least in part, to the
conversion of ^H-AA into cyclooxygenase and possibly
3
.. , . H-OA was not a precursor substratelipoxygenase products.
for the prostaglandin synthetase enzymes and therefore was
not metabolised. However approximately 10$ of the ^H-AA
taken up into endometrial tissue underwent further
metabolism.
The tritiated fatty acids, which had not undergone futher
metabolism or removal from the uterine cells, were
incorporated into the neutral lipids and phospholipids.
Levasseur, Sun, Friedman and Burke (1983) have demonstrated
that 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE)
was incorporated into triglycerides in much greater
quantities than into phospholipids of mouse thyroid glands.
In the present study, it was not known whether the
radioactivity in neutral lipids was solely ^H-AA, or whether
a proportion of the radioactivity consisted also of ^H-12-
HETE which had been synthesized from ^H-AA by lipoxygenase
enzymes in the guinea pig endometrium. Further analysis
into the identity of the radioactivity present in
triglycerides is necessary to establish whether this is the
case or not.
Over 90$ of the total endogenous arachidonic acid present in
the guinea pig uterus is contained in phospholipids
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particularly phosphatidylcholine and phosphatidylethanolamine
(Leaver and Poyser, 1981). Phospholipids may therefore be
the source of precursor for prostaglandin synthesis by the
guinea pig endometrium. The present experiments have shown
that there is a specific and significantly increased
incorporation of arachidonic acid into endometrial phospho¬
lipids, particularly phosphatidylcholine and phosphatidyl¬
ethanolamine, on Day 15 compared to Day 7 (days of high and
low PGF2K synthesis, respectively). Therefore the increased
uptake of arachidonic acid into phospholipids may compensate
for the release of arachidonic acid from phospholipids at the
time of increased PGF2K synthesis.
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SECTION 3 PHOSPHOLIPIDS IN THE GUINEA PIG ENDOMETRIUM
Introduction
The previous section showed that the pattern of incorporation
of arachidonic acid within the phospholipids of the guinea
pig endometrium was of the order: phosphatidylcholine >
phosphatidylethanolamine > phosphatidylserine + phosphatidyl-
inositol > sphingomyelin. There was a significant increase
in incorporation of arachidonic acid into the endometrial
phospholipids (with the exception of sphingomyelin) of Day 15
tissue compared to Day 7 tissue. The rise in oestradiol
output from the ovary towards the end of the oestrous cycle
(Joshi et al.,1973) may be responsible especially as Aizawa
and Mueller (1961) have demonstrated an increase in uterine
phospholipid synthesis _in vivo and _in vitro after oestrogen
administration to ovariectomised rats. The experiments
presented in the current section were designed to investigate
whether an increase in phospholipid synthesis was responsible
for the increased incorporation of arachidonic acid into
endometrial phospholipids at the time of increased PGF20C
production by the endometrium. Three avenues of
investigation were explored:
a) The phospholipid content of the endometrium from guinea
pigs on Day 7 and Day 15 of the oestrous cycle was measured.
b) The rate of synthesis of phosphatidylcholine in the
endometrium from guinea pigs on Day 7 and Day 15 of the
oestrous cycle was estimated.
c) The rate of synthesis of phosphatidylinositol in the
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endometrium from guinea pigs on Day 7 and Day 15 of the
oestrous cycle was monitored also.
a) Quantitative Estimation of Phospholipid Content In
Endometrium of Guinea Pigs on Day 1_ and Day 15 of the
Oestrous Cycle
Introduction
The quantitative estimation of the phospholipid content of
tissues used to involve histochemical methods , based on the
binding of potassium dichromate to the phospholipid; however
the drawback lay in the fact that the individual
phospholipids could not be differentiated one from the other
(see Thompson, 1966). Biochemical methods became available
and were found to be more concise as they were based on the
quantitation of changes in the lipid phosphorus.
Phospholipids to be analysed were usually extracted into
chloroform by the procedure of Bligh and Dyer (1959) and
separated into their major classes by thin-layer
chromatography. The quantity of each phospholipid was then
measured by estimating their phosphorus content. The most
popular technique for analysis of the phosphorus in each
lipid class involved incubation of the sample with sulphuric
acid together with a molybdenum reagent at 160°C for about
3hr (Bartlett, 1959). This step converted the "organic
phosphorus" into "inorganic phosphorus" which subsequently
bound to molybdenum to form phosphomolybdThe latter
was reduced to a blue-coloured complex, the quantity of which
was measured by monitoring ultraviolet absorbance at a
Wavelength of 830 nm. Although the method was
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insensitive to small variations in the concentration of the
reagents and the blue complex was stable at room temperature
for about 24hr, it involved the dangerous procedure of
boiling with acid as well as being a time consuming step.
As a result the following method devised by Raheja, Kair,
Singh and Bhatia (1973) was utilised in the present study to
gain an accurate, reproducible quantitation of the mass
amounts of phospholipids in the endometrium as well as
monitoring any changes in the phospholipid content between
the endometrium of Day 7 and Day 15 guinea pigs.
Method
Preparation of Chromogenic Solution
Ammonium molybdate (8g) was dissolved in 60ml water to give
solution A. Mercury (5ml) and 10N hydrochloric acid (20ml)
were shaken with 40ml solution A for 30 min. The mixture was
filtered and the supernatant fluid collected was designated
solution B. Solution B was added to the remainder of
solution A, and 10N sulphuric acid (100ml) was then added to
give solution C. Methanol (22.5ml), chloroform (2.5ml) and
water (10ml) were added to 12.5ml solution C to give the
chromogenic solution, which was stable for at least three
months when stored at 5°C.
Preparation of Phospholipid Samples
Ten guinea pigs, five on Day 7 and five on Day 15 of the
oestrous cycle, were killed by stunning and incising the
neck. In each case the uterus was rapidly removed and the
endometrium was separated from the myometrium by cutting away
1mm by 2mm pieces of endometrium. The myometrium was
discarded. The endometrial tissue from each uterus was
weighed and then homogenised in 15ml chloroform and methanol
(2:1). Neutral lipids, arachidonate products and
phospholipids were separated by silicic acid column
chromatography as described in Section 1(e). The neutral
lipids and arachidonate products were discarded.
The phospholipids were separated into their individual
classes by thin-layer chromatography as described in Section
1(f). Comparison of the R^ values of the standards with the
Rf values of the samples identified the phospholipid in each
zone of the plate. These areas were scraped into Corning
test tubes, to each of which viss added 20ml chloroform and
methanol (2:1). The tubes were stoppered, shaken vigorously
by hand and then underwent centrifugation at 100g for 15 min
to precipitate the silica gel. The solvent containing the
phospholipid was removed by Pasteur pipette and the
extraction procedure was repeated three times so that all the
phospholipid was removed from the silica gel. The solvent
collected was pooled for each phospholipid and was reduced in
volume under vacuum until near dryness on a rotary evaporator
at 35°C. The phospholipid samples were stored at -20°C under
a layer of nitrogen gas to await further analysis.
C'olorimetric Method
Each phospholipid sample in 1ml chloroform was added to a
15mm by 25mm Corning test tube and the solvent was
evaporated. Chloroform (0.4ml) and chromogenic solution
(0.1ml) were added to each sample test tube. A control test
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tube containing no phospholipid, chloroform (0.4ml) and
chromogenic solution (0.1ml) was also prepared. All tubes
were placed in a boiling water bath from 1 to 1.5 min with
marbles as loose-fitting stoppers. The tubes were then
removed and allowed to cool to room temperature. After a
further 5 min, chloroform (5ml) was added to each tube. The
tubes were shaken gently by hand, and were then allowed to
stand for 30 min to enable the lower chloroform layer to
separate from the upper aqueous layer. By carefully
manipulating each test tube, it was possible to remove the
chloroform layer by use of a Pasteur pipette. The
absorbance of the chloroform layer from each sample was read
at 710nm against the control containing no phospholipid. A
Unicam SP 800B ultraviolet spectrophotometer was used.
Calibration Graphs
Known quantities of standard phospholipids were also treated
in the same way as the sample phospholipids. The resultant
absorbances were plotted against the corresponding
phospholipid concentrations to form a calibration graph.
The observed absorbances of the sample phospholipids were
then read off the calibration graph to give the quantitative
amounts of phospholipid present in each sample (Fig. 3.1).
Mode of Action
The chromogenic solution reacted directly with the
phospholipid phosphorus and a Prussian blue complex was
formed which was stable for over 3hr. That the intact
phospholipid reacted with the chromogenic solution was
supported by the solubility of the coloured complex in
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Figure 3.1 Graphical representation of the absorbances
observed from known quantities of phosphatidylethanolamine
(PE), phosphatidylserine and phosphatidylinositol (PS + PIO,
sphingomyelin (Sph) and phosphatidylcholine (PC)
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chloroform, because digestion of the lipid sample would
result in the conversion of organic phosphorus to inorganic
phosphorus making the complex water soluble.
Statistical Analysis
All data were subjected to a variance ratio "F" test. If
the variances were not unequal, the set of data was subjected
to the Student's unpaired "t" test; if the variances were
unequal, the modified "t" test was utilised.
Results
The data indicated that both Day 7 and Day 15 endometrium
contained detectable quantities of phospholipids. In Day 7
endometrium phosphatidylcholine was the major phospholipid
class present in the tissue i.e. this phospholipid made the
most significant (P<0.001) contribution to the total
phospholipid content compared to phosphatidylethanolamine,
sphingomyelin and phosphatidylserine + phosphatidylinositol
(Fig. 3.2). In Day 15 endometrium phosphatidylcholine also
made the most significant (P<0.05) contribution to the total
phospholipid content of the tissue compared to any other
phospholipid (Fig. 3«2). Further calculation indicated
that about 62% of the total phospholipid content of both
tissues was phosphatidylcholine.
A comparison of the quantitative amounts of the individual
phospholipids between Day 7 and Day 15 endometrial tissue was
carried out using either a Student's "t" test or a modified
"t" test if the variances of the sets of data were unequal.
The statistical analyses revealed no significant differences
in the content of any phospholipid between the two tissues.






Sph PS+PI PE PC
Figure 3»2 Histogram showing the mean quantitive amounts
(+ s.e.m., n = 5) of sphingomyelin (Sph), phosphatidylserine
and phosphatidylinositol (PS + PI}, phosphatidylethanolamine
(PE) and phosphatidylcholine (PC) in the endometrium of
guinea pigs on Day 7 (blank boxes) and Day 15 (hatched boxes)
of the oestrous cycle
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Conclusion
Analysis of the phospholipid content in the endometrium of
guinea pigs on Day 7 and Day 15 of the oestrous cycle
indicated that:
a) phosphatidylcholine made the most significant
contribution to the total phospholipid content of the tissue.
b) there was no significant change in the quantity of any
phospholipid class.
The results presented in this section suggested that the
increased arachidonic acid incorporation observed in the
phospholipids of Day 15 endometrium (reported previously ih
Section 2) was probably not due to a change in phospholipid
content of the uterine tissue.
b) Investigations Into Phosphatidylcholine Biosynthesis
In Guinea Pig Endometrium
Introduction
The experiments in Section 3(a) demonstrated that the
phospholipid content of endometrial tissue was not
significantly different between Day 7 and Day 15 of the
oestrous cycle. Although the mass content did not vary
throughout the cycle it was possible that the turnover of the
phospholipids varied i.e. the continual replacement of
molecules by synthesis and breakdown has to be considered.
The experiments described in the current section were
designed to monitor the biosynthesis of phosphatidylcholine,
the major lipid class in both Day 7 and Day 15 endometrial
tissue.
112
Two separate pathways for phosphatidylcholine synthesis are
known and have been described in detail in the General
Introduction. Briefly, to reiterate, the first pathway is de
novo synthesis of the phospholipid, whereby two fatty acids
are esterified to the glycerol structure to form diglyceride,
with the addition of a phosphorylated nitrogenous base
completing the synthesis (Kennedy and Weiss, 1956). The
second pathway requires three successive methylations of the
ethanolamine moiety in phosphatidylethanolamine by S-adenosyl
methionine (Bremer and Greenberg, 1961; Hirata, Concoran,
Venkatsubramanian, Schiffmann and Axelrod, 1979). This
transmethylation pathway of phosphatidylcholine biosynthesis
has been identified in many cell types including rabbit
leucocytes (Hirata et al., 1979), rat liver (Bremer and
Greenberg, 1961; Kaytal and Lombardi, 1976), bovine adrenal
medulla (Hirata, Viveros, Diliberto and Axelrod, 1978) and
rabbit platelets (Kannagi, Koizumi, Hata-Tanoue and Masuda,
1980). The existence of the transmethylation pathway has not
yet been investigated in the endometrium of any species.
It was important to determine therefore:
"1) the relative rates of phosphatidylcholine synthesis by
the de; novo pathway between Day 7 and Day 15 endometrial
tissue,
2) the relative activities of the transmethylation pathway
of phosphatidylcholine synthesis between Day 7 and Day 15
endometrial tissue.
The findings from these experiments should indicate which
pathway plays the major role in synthesis of
phosphatidylcholine in guinea pig endometrium and should also
determine whether there are any differences in activities of
the two pathways between Day 7 and Day 15 of the oestrous
cycle which may account for the increased uptake of
arachidonic acid into phospholipids on the latter day.
Methods
Experiment A
Estimation of De Novo Phosphatidylcholine Synthesis
Ten, guinea pigs, five on Day 7 and five on Day 15 of the
oestrous cycle, were killed by stunning and incising the
neck. In each case the uterus was rapidly removed and
placed in supplemented Medium 199. The endometrium was
dissected from the myometrium by cutting away 1mm by 2mm
pieces of endometrium. The myometrium was discarded. The
pieces of endometrial tissue were equally distributed among
six petri dishes each containing 10jaCi tritiated choline
chloride (^H-choline chloride) in 4ml supplemented Medium
199, as described in Section 1(d). The petri dishes were
then incubated at 37°C for 1, 3 and 6hr periods by a
procedure previously described in Section 1(d). Two samples
were cultured for each time period. Following incubation,
the tissue from each dish was washed in fresh medium, blotted
dry, weighed and stored in 5ml chloroform and methanol (2:1)
at -20°C for further analysis.
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Experiment B
Estimation of the Transmethy1ation Synthetic Pathway
Ten guinea pigs, five on Day 7 and five on Day 15 of the
oestrous cycle, were killed by stunning and incising the
neck'. In each case, the uterus was rapidly removed and
placed in supplemented Medium 199. The endometrium was
dissected from the myometrium by cutting away 1mm by 2mm
pieces of endometrium. The myometrium was discarded. The
pieces of endometrial tissue were equally divided among six
petri dishes, each containing 10pCi tritiated S-adenosyl
methionine (^H-SAM) in 4ml supplemented Medium 199, as
described in Section 1(d). The dishes were incubated at 37°C
for 1, 3 and 6hr periods by a procedure previously described
in Section 1(d). Two samples were cultured for each time
period'. Following incubation, each tissue sample was washed
in fresh medium, blotted dry, weighed and stored in 5ml
chloroform and methanol ('2:1) at -20°C for further analysis.
In both experiments A and B, each sample was homogenised in
15ml chloroform and methanol (2:1) and the phospholipids,
neutral lipids and arachidonate products present were
separated by silicic acid column chromatography as described
in Section 1(e). The excess solvent in all the samples was
removed by a rotary evaporator at 35°C. The pear-shaped
flasks containing the neutral lipids and arachidonate product
samples were rinsed with 10ml scintillation fluid and any
radioactivity present in the samples were subsequently











Figure 3»3 The standard phospholipids exhibited the above
distribution pattern afer development in a solvent system of
chloroform, methanol and water (100:"40:"6) and visualization
by iodine vapour.









The phospholipid samples were further separated by thin-layer
chromatography (tic). Each sample was "streaked" onto a
precoated glass tic plate (silica gel thickness 0.25mm, 5cm
by 20cm) as described in Section 1(f). Standards (25jig of
each) of phosphatidylethanolamine, phosphatidyl-N-monomethyl
ethanolamine, phosphatidyl-N,N-dimethyl ethanolamine and
phosphatidylcholine were spotted onto a separate tic plate.
All plates were developed in a solvent system consisting of
chloroform, methanol and water (100:40:6) for 3hr (Fig. 3.3).
They were then removed and left to dry in air at room
temperature for 20 min. On each tic plate containing sample
phospholipids, lanes were marked at 0.5cm intervals from the
baseline to 7cm from the solvent front; lanes were then
marked at 1cm intervals to the solvent front. Subsequently,
each lane was measured for radioactivity by liquid
scintillation counting as described in Section 1(g). The
phospholipid standards were visualised by iodine vapour and
the Rf values were calculated (Fig. 3-3).
Statistical Analysis
All data underwent analysis by the variance ratio 'F' test.
If the variances were not unequal then data were analysed
subsequently by the Student's unpaired 't* test; if the
variances were unequal then data were analysed subsequently
be a modified 't' test.
Results
Very little radioactivity was measured in the first two
fractions eluted from the silicic acid columns indicating
that neither the ^H-choline nor the ^H-SAM were incorporated
into the neutral lipids or converted into cyclooxygenase
products (as would be expected).
The radioactivity from the ^H-choline incorporated into the
phosphatidylcholine class of Day 7 and Day 15 endometrial
tissue was monitored as DPM and converted into picomoles
phosphatidylcholine synthesized per gram endometrial tissue
using the following equation:
C
DPM per mg tissue x 10
(2.2x1012 DPM) x specific activity of radiolabel
where 2.2 x 1012 DPM = 1Ci, and the units of specific
activity were Ci/mmol.
The radioactivity monitored in the investigations into the
transmethylation pathway indicated that ^H-SAM was
incorporated into three products: the addition of one
molecule of ^H-SAM to phosphatidylethanolamine formed
phosphatidylmonomethylethanolamine, the addition of a further
molecule of JH-SAM to phosphatidylmonomethylethanolamine
formed phosphatidyldimethylethanolamine, and the addition of
a final molecule of ^H-SAM to phosphatidy1dimethy1-
ethanolamine resulted in phosphatidylcholine. All
radioactivity was monitored as DPM and converted into
picomoles phosphatidylethanolamine methylated per gram
endometrial tissue using the equation mentioned previously.
For phosphatidylcholine (formed by the addition of three ^H-
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Figure 3»^ Graph demonstrating the mean amount (+s.e.m.,
n= 10) of phosphatidylcholine formed from -%-choline taken up
into Day 7 and Day 15 endometrial tissue over a period of
6hr.
ethanolamine (formed by the addition of two ^H-SAM to
phosphatidylethanolamine) it was necessary to divide the
number of DPM by three and two respectively.
Pe no VO Synthesis els demonstrated bjy the csholi-ne
patWaj was active in both Day 7 and Day 15
endometrial tissue, 3.
Statistical analysis using the Student's unpaired 't' test
demonstrated that there was no significant difference in the
amounts of phosphatidylcholine formed at any time period
between Day 7 and Day 15 endometrial tissue i.e. both tissues
possessed an equivalent capacity to produce
phosphatidylcholine via the de novo synthesis pathway.
The data obtained from experiment B indicated that
phosphatidylethanolamine was methylated by transmethylation
on both Day 7 and Day 15 endometrial tissue (Fig. 3>5). The
ratio of the resultant products, phosphatidylmonomethyl-
ethanolamine, phosphatidyIdimethy1ethanolamine and
phosphatidylcholine from Day 7 endometrial tissue did not
vary over the 6hr time period. At 1hr the ratio of the mean
amounts of these products formed was 71 s"10s"19, whilst at 6hr
the ratio was 69fl4f"17.
A similar ratio of methylated products was exhibited by Day
15 endometrial tissue. At 1hr the ratio was 69^12:'19 whilst
at 6hr the ratio was 7 5f10f15. In both tissues the
methylation of phosphatidylethanolamine to phosphatidyl-
monomethylethanolamine appeared to be quite active but the
conversion of phosphatidylmonomethy1ethanolam i ne to
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Figure 3«5 The graphs demonstrate the mean amounts
T+sTeTm., n=10) of phosphatidylmonomethylethanolamine (PMME),
phosphatidyldimethylethanolamine ( PDME ) and phosphatidyl¬
choline (PC) formed from -%-SAM taken up over a period of
6 hr.
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In Day 7 endometrial tissue, using a Student's unpaired *t'
test it was demonstrated that the quantitative amounts of
phosphatidylcholine formed by transmethy1at i onof
phosphatidylethanolamine increased significantly (P<0.0005)
during the 1hr to 3hr uptake period with a mean rate of 0.87
pmol/g tissue/hr. Between the 3hr and 6 hr uptake periods,
the mean amount of phosphatidylcholine formed was 0.133
pmol/g tissue/hr.
In Day 15 endometrial tissue, again using a Student's
unpaired 't' test it was demonstrated that the quantitative
amounts of phosphatidylcholine formed by transmethylation of
phosphatidylethanolamine increased significantly (P<0.025)
during the 1hr to 3hr uptake period with a mean rate of 0.528
pmol/g tissue/hr. Between the 3hr and 6hr uptake period,
there was a significant (P^0.01) production of phosphatidyl¬
choline at a mean rate of 0.584 pmol/g tissue/hr.
Using a modified 't' test it was demonstrated that there was
no significant difference in the amounts of
phosphatidylcholine formed between Day 7 and Day 15
endometrial tissue at any time period i.e. both tissues
possessed an equivalent capacity to synthesize phosphatidyl¬
choline via the transmethylation of phosphatidylethanolamine.
Subsequently, a comparison of the amounts of
phosphatidylcholine formed by the choline pathway with the
amounts of phosphatidylcholine formed by transmethylation of
phosphatidylethanolamine was carried out. Analysis by the
modified 't' test demonstrated that the former pathway
synthesized significantly (P^0.01) greater amounts of
phosphatidylcholine than the latter pathway at all times on
both days.
Conclusion
The results reported here have demonstrated the greater
importance of the choline pathway, reflecting d_e novo
synthesis,for the production of phosphatidylcholine in the
endometrium of guinea pigs on Day 7 and Day 15 of the
oestrous cycle. The transmethylation pathway appears to be a
minor route for phosphatidylcholine synthesis in the guinea
pig uterus. There was also no significant differences in the
activities of either the transmethylation pathway or the
choline pathway between Day 7 and Day 15 endometrial tissues.
Therefore, the increased incorporation of ^H-AA into
phosphatidylcholine on Day 15 as compared to Day 7, observed
in Section 2, appears not to have involved the stimulation of
phosphatidylcholine synthesis by either of the pathways
monitored in these experiments.
c) Studies Into Phosphatidylinositol Synthesis In Guinea
Pig Endometrium
Introduction
Myo-inositol (also called meso-inositol) was isolated from
biological sources over a hundred years ago. It was
required in the medium for survival of most tissue cultures
as well as cultured cell lines (Eagle, Oyama, Levy and
Freeman, 1957). With every one of eighteen cultured human
strains, including liver cells and embryonal fibroblasts,
growth ceased in inositol-deficient media and there was
cytopathogenic evidence of cell injury in cell death and
dissolution. To maintain growth, 10pM exogenous myo¬
inositol had to be added and no other inositol isomer proved
capable of substituting for it.
It was also demonstrated that a concentration gradient for
free inositol existed between cellular and extracellular
fluids (Dawson and Freinkel, 1961). The reason for the high
concentration of inositol in tissue was thought to be due to
a combination of active transport and synthesis within the
tissues. The only known function of inositol is as a
precursor of phosphatidylinositol (see Hawthorne, 1960), a
minor phospholipid of membranes which accounts for less than
10% of the total phospholipids in most cells. The
importance of phosphatidylinositol was highlighted when it
was demonstrated that inositol deficiency caused an
increasing concentration of metabolic products in the
cytoplasm of cells that were constrained by a cell wall
unable to grow (Henry, Atkinson, Kolat and Culbertson, 1977).
Cell surface expansion was terminated after one doubling of
whole cells; membrane properties and functions were probably
affected.
The phosphatidylinositol present in membranes is formed by
de novo synthesis, but also undergoes a constant degradation
and resynthesis by the phosphatidylinositol cycle, mentioned
previously in the General Introduction. An increase in
activity of this cycle has been implicated in providing free
arachidonic acid for prostaglandin synthesis and release in
several cell types such as human platelets (Rittenhouse-
Simmons, Russell and Deykin, 1977), rat peritoneal
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macrophages (Matsubara and Hirohata, 1983) and human
neutrophils (Walsh, Dechatelet, Chilton, Wykle and Waite,
1983). Since phosphatidylinositol synthesis has not been
studied previously in the endometrium of any species, the
following set of experiments were designed to determine the
relative uptake of tritiated inositol (^H-inositol) with time
into Day 7 and Day 15 guinea pig endometrium.
Method
Ten guinea pigs, five on Day 7 and five on Day 15 of the
oestrous cycle, were killed by stunning and incising the
neck. In each case the uterus was rapidly removed and placed
in supplemented Medium 199. The endometrium was separated
from the myometrium by cutting away 1mm by 2mm pieces of
endometrium. The myometrium was discarded. The endometrial
tissue from each uterus were then equally divided amongst ten
petri dishes, each containing 10pCi 3H_inositol in nml
supplemented Medium 199 as described in Section 1(d).
Duplicate samples of tissue were cultured for 0.5hr, 1hr,
3hr, 4hr and 6hr periods respectively, as described in
Section 1(d). After each culture period, the tissue was
washed in fresh medium, blotted dry, weighed and homogenised
in 15ml chloroform and methanol (2:1). Each homogenised
sample underwent silicic acid column chromatography as
described in Section 1(e) to separate the neutral lipids and
arachidonate products from the phospholipids. The excess
solvent in the samples from the column was removed by a
rotary evaporator at 35°C and, after rinsing the appropriate
flasks with 10ml scintillation fluid, the radioactivity in
the neutral lipids and arachidonate product samples was
measured by liquid scintillation counting as described in
Section 1(g).
The phospholipid samples from the column were further
separated by a thin-layer chromatography (tic) procedure
devised by Jolles, Zwiers, Dekker, Wirtz and Gispen (1981).
Precoated glass tic plates (silica gel thickness 0.25mm, 5cm
by 20cm) were impregnated with potassium oxalate by
development in 100ml methanol and water (2:3) containing 1#
potassium oxalate. The plates were then air dried at room
temperature for 15 min and activated at 110°C for a further
15 min. Lipid extracts were applied to these tic plates in
a volume of 15 to 20pl chloroform and methanol (2:1) using a
1 0 0 p 1 syringe. Standards ( 2 5 p g each)
phosphatidylinositol (I"), diphosphoinositide (II") and
triphosphoinositide (IIT) were applied to a separate tic
plate and developed at the same time as the samples (Fig. 3.6
and Fig. 3.7). All tic plates were developed in a
chromatographic chamber containing a solvent system of
chloroform, acetone, methanol, acetic acid and water
(40:15:13^12:8) for 2hr. The plates were then left to dry
in air at room temperature for 30 min. On each 'sample' tic
plate, lanes were marked at 0.5cm intervals from the baseline
to 7cm from the solvent front; lanes were then marked at 1cm
intervals to the solvent front on each tic plate.
Subsequently, the radioactivity in each lane was measured by
liquid scintillation counting as described in Section 1(g).
Standards were visualised by iodine vapour and the values











Figure 3«6 The standard phospholipids exhibited the above
distribution pattern after development in a solvent system of
chloroform, acetone, methanol, acetic acid and water
(40:15:13:12:8). Phospholipids were visualised by iodine
vapour.
The calculated Rf value of
phosphatidylinositol is 0.35 to 0.39
diphosphoinositide is 0.25 to 0.28































JLifiure 3.7 Strucures of phosphatidylinositol (D,
diphosphoinosi tide (II) and triphosphoinositide (III") where R
and R' are fatty acid chains.
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Statistical Analysis
All data were analysed by the variance ratio 'F' test. If
the variances were not unequal then data were analysed
subsequently by the Student's unpaired 't'test. If the
variances were unequal then data were analysed by the
modified *t' test.
Results
Very little radioactivity was measured in the first two
fractions eluted from the silicic acid columns indicating
that the ^H-inositol was not incorporated into either the
neutral lipids or converted into cyclooxygenase products (as
would be expected).
The radioactivity from the ^H-inositol incorporated into the
phosphatidylinositol classes of Day 7 and Day 15 endometrial
tissue was monitored as DPM and converted into picomoles
phospholipid per gram endometrial tissue using the following
equation :
DPM per mg tissue x 10^
(2.2x10^DPM) x specific activity of radiolabel
where 2.2x10^ DPM = 1Ci, and the units of specific activity
were Ci/mmol.
It was demonstrated in rat liver that a small amount of
phosphatidylinositol underwent further metabolism to
diphosphoinositide (Michell and Hawthorne, 1965). Isotope
studies suggested that triphosphoinositide was formed also by
a two-step phosphorylation of phosphatidy1inos i to1
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(Brockerhoff and Ballou, 1962). It was necessary to monitor
the amounts of any polyphosphoinositides formed. Therefore
any radioactivity from ^H-inositol incorporated into the
polyphosphoinositides was converted into picomoles
phospholipid per gram endometrial tissue using the above
equation. As diphosphoinositide and triphosphoinositide
exhibited similar values, the data was combined to form
the "remainder", a measure of the amount of
phosphatidylinositol which underwent further metabolic
conversion.
The resulting data indicated that, in both Day 7 and Day 15
endometrial tissue, the total amount of phosphatidylinositol
synthesized increased with time (Fig. 3.8). Between 0.5hr
and 6hr, the amounts of phosphatidylinositol in Day 7 tissue
increased significantly (P^O.01) with time at an average rate
of 2.036 pmol/g tissue/hr. The "remainder" i.e.
polyphosphoinositides did not increase with time, the values
never exceeding 3 pmol/g tissue at any stage.
Between 0.5hr and 6hr, the amounts of phosphatidylinositol in
Day 15 tissue increased significantly (P^0.01) with time at
an average rate of 1.23 pmol/g tissue/hr. The "remainder"
also increased significantly (P<0.05) with time at an average
rate of 0.078 pmol/g tissue/hr. There was about twelve
times more phosphatidylinositol present after 6hr than after
0.5hr in Day 7 tissue; in Day 15 tissue there was about
fourteen times more phosphatidylinositol present after 6hr
than after 0.5hr. The Student's unpaired 't' test revealed
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Figure 3»8 Graphs indicate the mean quantative amounts
C+ s. e.m., n = 8) of phosphatidylinositol (PIT) formed from
^H-inositol taken up over a 6 hr period into Day 7 and Day 15
endometrial tissue. The remainder is an indication of the
mean quantative amounts of PI which underwent further
metabolism to polyphosphoinositides.
phosphatidylinositol synthesized between Day 7 and Day 15
endometrium at all times.
The combined use of the modified 't' test and the Student's
unpaired 't' test revealed that there was no significant
difference in the amounts of polyphosphoinositides
synthesized between Day 7 and Day 15 endometrial tissue at
all times.
Conclusion
The results reported here have demonstrated that the inositol
was incorporated into phosphatidylinositol by Day 7 and Day
15 endometrial tissue. Route of inositol incorporation may
be by de novo phosphatidylinositol synthesis and/or via the
phosphatidylinositol cycle, i.e. by addition of inositol to
phosphatidic acid formed by breakdown of endogenous
phosphatidylinositol. Since there was no difference in
incorporation of inositol into phosphatidylinositol between
Day 7 and Day 15 endometrial tissue, it can be concluded
that neither de novo phosphatidylinositol synthesis nor the
phosphatidylinositol cycle underwent stimulation. Therefore
the increased incorporation of ^H-AA into the phospholipids
on Day 15 as compared to Day 7, observed in Section 2, had
not involved stimulation of the pathways associated with
phosphatidylinositol synthesis.
Discussion
In Section 2 it was demonstrated that there was a significant
incorporation of arachidonic acid into all the endometrial
phospholipids (with the exception of sphingomyelin) of Day 15
tissue compared to Day 7 tissue. It is possible that the
storage capacity of the phospholipids was increased by an
increase in the amount of phospholipids present in the tissue
membranes. The experiments in Section 3(a) were designed to
quantitatively estimate any differences in the mass amount of
phospholipids between Day 7 and Day 15 endometrial tissue.
The data indicated that none of the phospholipid classes
varied in amount throughout the oestrous cycle. Therefore
the increased incorporation of arachidonic acid into
phospholipids of Day 15 tissue compared to Day 7 tissue
cannot be explained by a change in phospholipid content.
However it is possible that there may have been increased
breakdown and increased synthesis resulting in an apparent
lack of change in content.
The lack of mass change in phosphatidylinositol content of
the endometrium between Day 7 and Day 15 of the cycle may
indicate that arachidonic acid release from phosphatidyl-
inositol by stimulation of phospholipase C and working in
conjunction with diglyceride lipase was probably not
operating or was operating at a very low rate, i.e. there was
no breakdown of the phospholipid to monoglyceride and free
fatty acids (Bell et al., 1979). Phosphatidylinositol-
specific phospholipase C has also been shown to play a minor
role in arachidonic acid liberation from phosphatidylinositol
in human platelets (Imai et al., 1982). However it was
possible that the diglyceride was reincorporated into
phosphatidylinositol via the phosphatidylinositol cycle
(Lapetina, 1982) and arachidonic acid was indirectly released
by phosphatidic acid enroute (see General Introduction). An
apparent lack in phosphatidylinositol content, does not
necessarily mean that there were no changes in the rate of
phosphat idylinos i tol turnover via the phosphatidylinositol
cycle in Day 15 tissue compared to Day 7 tissue.
Consequently it was important to measure the rates of
phospholipid synthesis.
Leaver and Poyser (1981) reported that, of the total
arachidonate bound to phospholipids in the uterus,
phosphatidylethanolamine contained more arachidonate than any
other phospholipid on both Day 7 and Day 15. However data
presented in Section 3(a) indicated that the quantity of
phosphatidylcholine on both Day 7 and Day 15 was
significantly greater (P<0.05) than phosphatidylethanolamine.
It has been suggested that there may be exchange of acyl
"fatty acids from arachidonate-rich phosphatidylethanolamine
to phosphatidylcholine (Trotter and Ferber, 1981) resulting
in enrichment of the latter phospholipid with arachidonic
acid.
Enrichment of phosphatidylcholine with arachidonic acid can
also be brought about by conversion of phosphatidyl¬
ethanolamine to phosphatidylcholine via the transmethylation
pathway (Bremer and Greenberg, 1961). Therefore the
experiments in Section 3(b) were carried out to determine the
importance of this pathway in Day 7 and Day 15 endometrial
tissue by measuring the amounts of phosphatidylcholine formed
from phosphatidylethanolamine. The amounts of phosphatidyl¬
choline formed from the de novo synthesis involving choline
incorporation was also measured. The results indicated that
134
the conversion of phosphatidylethanolamine to phosphatidyl¬
choline played a minor role in the total synthesis of
phosphatidylcholine in the guinea pig endometrium on both Day
7 and Day 15 of the oestrous cycle.
A methyl transferase enzyme is responsible for the trans¬
methylation of phosphatidylethanolamine to phosphatidyl-
monomethylethanolamine. The conversion of phosphatidyl-
monomethylethanolamine to phosphatidyldimethylethanolamine
and then to phosphatidylcholine is catalysed by a second
methyltransferase enzyme. Investigations using rat liver
microsomes (Bremer and Greenberg, 1961) have determined that
incorporation of the first methyl group was the rate-limiting
step in transmethylation. The current investigations
demonstrated that phosphatidylmonomethylethanolamine was
present in greater quantities than phosphatidyldimethyl-
ethanolamine, indicating that the second methyltransferase
enzyme was the rate-limiting step in transmethylation in the
guinea pig endometrium. The discrepancy between the current
investigations and that which was reported in the literature
may be explained by the type of tissue used, species
difference or differences in enzyme distribution.
The experiments in Section 3(b) clearly demonstrated the
importance of the choline pathway (reflecting d_e novo
synthesis) in the formation of phosphatidylcholine, the
pathway being five times as active as the transmethylation
pathway. However there was no significant difference in the
rate of incorporation of choline into phosphatidylcholine
between Day 7 and Day 15 endometrial tissue. It appears
therefore that increased arachidonic acid incorporation
cannot be explained by an increase in de novo synthesis of
phosphatidylcholine in Day 15 tissue.
Increased incorporation of arachidonic acid into
phosphatidylinositol of Day 15 tissue was demonstrated in
Section 2, therefore further experiments were carried out to
determine if an increased rate of synthesis of phosphatidyl-
inositol was responsible. The investigations into
phosphatidylinositol biosynthesis could have been complicated
by the fact that a small amount of phosphatidylinositol
underwent further metabolism to diphosphoinositide and
triphosphoinositide. Reproducible extractions of the
polyphosphoinositides are extremely difficult, good
extraction efficiency is managed with the use of acid
solvents (Michell ft,personal communication). The procedures
in these experiments however did not utilise acid conditions
and it was possible that not all the polyphosphoinositides
formed "were extracted. Nevertheless since diphospho¬
inositide and triphosphoinositide are not usually considered
to occur in appreciable amounts outside the nervous system
(see Hawthorne and Kai, 1970) the formation of these two
compounds was not considered a complication in this study.
The data obtained from the experiments in Section 3(c)
indicated that there was no significant difference in the
amount of inositol inorporated into phosphatidylinositol
between Day 7 and Day 15 endometrial tissue. Thus it appears
that there was no stimulation of de novo phosphatidylinositol
synthesis or of the phosphatidylinositol cycle between Day 7
and Day 15 of the cycle, and that the increased uptake of
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arachidonic acid into phosphatidylinositol between these two
days is not due to increased phosphatidylinositol synthesis.
A comparison of the quantitative amounts of phosphatidyl-
inositol formed with the quantitative amounts of
phosphatidylcholine formed resulted in a phospholipid ratio
of one to eight. It is suggested that the difference in
phospholipid synthesizing capacity of the tissue was a
reflection of the importance of phosphatidylcholine synthesis
in providing arachidonic acid for prostaglandin synthesis,
especially as phosphatidylcholine contains much more
arachidonic acid than phosphatidylinositol (Leaver and
Poyser, 1981).
To summarise, the increased arachidonic acid incorporation
into the phospholipids of Day 15 tissue compared to Day 7
tissue (reported in Section 2) cannot be explained by a
change in phospholipid content or by an increase in the
phospholipid synthesizing capacity of the endometrium. In
)
addition the lack of increased inositol incorporation into
phosphatidylinositol on Day 15 compared to Day 7 also
suggests that the increased output of PG^cx ^rom the uterus
on Day 15 does not involve stimulation of the phosphatidyl-
inositol cycle, in contrast to the stimulation of TXA2
production by thrombin in platelets (Lapetina, 1982).
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SECTION 4 THE CONTROL OF ARACHIDONIC ACID RELEASE FROM
THE GUINEA PIG ENDOMETRIUM
Introduction
Studies carried out by Leaver and Poyser (1981) have
demonstrated that phosphatidylcholine and phosphatidy1-
ethanolamine contain 8055 of the arachidonic acid bound to
phospholipids in the uterus. However there was a
significant (P<f0.05) decrease in the amount of arachidonic
acid esterified to phosphatidylcholine on Day 15 of the
oestrous cycle. These studies suggested that there had been
a greater release of arachidonic acid from phosphatidyl¬
choline on Day 15 than on Day 7 of the oestrous cycle.
Because the ovarian venous plasma levels of oestradiol
increased in the guinea pig after Day 10 of the cycle prior
to release of PGF^^ (Joshi et al., 1973) it was thought that
the release of arachidonic acid may in some way be controlled
by this hormone. Oestradiol (10pg) injected into the tail
vein of ovariectomised rats (Mueller et al., 1961) was able
to increase protein synthesis of the uterus. Activation,
mobilization or possibly cle novo synthesis of the enzymes
involved in the release of arachidonic acid may have
occurred.
The experiments reported in the following section were
designed to measure:
a) the release of ^H-AA from Day 15 endometrial tissue
compared to Day 7 endometrial tissue as these are days of
high and low endometrial PGF2<x synthesis respectively.
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b) the release of ^H-AA in the presence of a general
stimulus of endometrial PGF"2k synthesis, such as calcium
ionophore A23187, from Day 7 and Day 15 endometrial tissue.
c) the release of ^H-AA in the presence of either
oestradiol or progesterone from Day 7 and Day 15 endometrial
tissue. These steroids are known to stimulate and inhibit,
respectively, PGF2K synthesis from the guinea pig endometrium
in vitro (Leaver and Seawright, 1982).
a) Release of Arachidonic ^he Guinea PIg
Endometrium on Day 7 and Day 15 of the Pestrous
Cycle
Introduction
Endogenous oestradiol released from the developing follicles
in the ovaries increases after Day 10 in the guinea pig
(Joshi et al.,1973). It has been proposed that oestradiol
acting on a progesterone-primed uterus is the stimulus for
increased PGF-2^ production in the guinea pig (Blatchley and
Poyser, 1974). The extent to which the endogenous steroid
hormones have an effect on arachidonic acid turnover within
the uterine cells is not fully known. Therefore the
experiments presented in this subsection were designed to
measure the release of ^H-AA from the neutral lipids and
phospholipids of Day 7 and Day 15 endometrial tissue.
Methods
Ten guinea pigs, five on Day 7 and five on Day 15 of the
oestrous cycle, were killed by stunning and incising the
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neck. In each case the uterus was rapidly removed and the
endometrium was dissected from the myometrium by cutting away
1mm by 2mm pieces of endometrium. The myometrium was
discarded.
The endometrial tissue from each guinea pig was placed in a
single petri dish, containing 4ml supplemented Medium 199 and
62.5pCi ^h-AA (as the sodium salt), and was cultured for 24hr
using a modified tissue culture technique, as described in
Section 1(d). This enabled all the different lipid classes
to become "labelled" with ^H-AA. The endometrial tissue was
then equally distributed among six further petri dishes, each
containing 4ml supplemented Medium 199 plus 0.1% bovine serum
albumin, and two glass bottles each containing 5ml chloroform
and methanol (2:1). The last two control samples were
weighed before being placed in the bottles, and were then
stored in the chloroform and methanol (2:1) at -20°C. The
remaining six samples were incubated as described in Section
1(d) for a further 0.5, 3 or 24hr. Two cultured samples
were removed at the end of each time period, weighed and
stored in 5ml chloroform and methanol (2:1) at -20°C to await
further analysis.
Each sample was then homogenised in 15ml chloroform and
methanol (2:1) and subjected to silicic acid column
chromatography as described in Section 1(e). Thin-layer
chromatography as described in Section 1(f) was used to
separate the individual components of the neutral lipid and
phospholipid fractions obtained after silicic acid column
chromatography. The excess solvent in the fraction
containing arachidonate products, from the silicic acid column
was removed by a rotary evaporator at 35°C, and, after
rinsing the flask with 10ml scintillation fluid,
radioactivity was measured by liquid scintillation counting,
as described in Section 1(g). The radioactivity in the
separated components of the neutral lipids and phospholipids
were also monitored by liquid scintillation counting.
Statistical Analysis
All data was analysed by the Student's unpaired *t' test and
Duncan's multiple range test.
Results
About 0.7 x 10^ to 5.3 x 10^ DPM/mg tissue was measured in
the second fraction eluted from the silicic acid columns.
The results were not incorporated in the graphs so that the
other results were more clearly observed. The amounts of ^H-
AA incorporated after 24hr into Day 7 and Day 15 tissue was
used as the control value for the release experiments (Fig.
4.1).
The results from the release experiments indicated that there
was no apparent release of ^H-AA from any lipid class in Day
7 endometrial tissue over the time period studied except for
a significant decrease (P<0.05) in the amount of ^H-AA bound
to diglyceride and monoglyceride at 24hr compared to Ohr
(Fig. 4.1 and Fig. 4.2). On Day 15, there was a general 50
to 80$ decrease in ^H-AA content of all lipid classes over
the release period, particularly at 3hr (Fig. 4.1 and Fig.
4.2). At 24hr, there was an apparent reincorporation of ^H-


























4.1 Mean (+ s.e.m., n=10) total content of
H-arach i don i c acid in Day 7 and Day 15 guinea pig
endometrium, and its distribution among phospholipids (PL),
neutral lipids (NL) and free ^H-arachidonic acid (AA) during
a 24 hr release period following a 24 hr uptake period
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Figure 4.2 Mean (+ s.e.m., n=10) total content of ^H-
arachidonic acid in triglyceride (TG), monoglyceride (MG),
diglyceride (DG), cholesterol ester (cho),
phosphatidylcholine (PC), phosphatidylethanolamine (PE),
phosphatidylserine + phosphatidylinositol (PS + PI) and
sphingomyelin (Sph) in Day 7 and Day 15 guinea pig
endometrium during a 24 hr release period following a 24 hr
uptake period (Standard errors for cho are too small to
include).
t Significantly lower (P < 0.05) than corresponding Day 7
value.
choline and phosphatidylethanolamine (Fig. 4.2). However none
of the values at 0.5, 3 and 24hr were significantly different
from the corresponding value at Ohr due to the wide scatter
of results.
Conclusion
The results show that the endogenous steroids did not have
any apparent significant effect on ^H-AA release from the
neutral lipids and phospholipids of Day 7 and Day 15
endometrial tissue.
b) Release of Arachidonic Acid From the Guinea Pig
Endometrium In the Presence of a Calcium Ionophore
Introduction
The radiolabelling studies carried out in Section 4(a)
utilised ^H-AA which had been made available to the
endometrial tissue in small quantities. In those studies
there was no significant loss of ^H-AA from any of the lipid
stores. It was considered necessary therefore to stimulate
the tissue so that perhaps a larger release of ^H-AA
occurred.
Agents influencing the output of have already been
investigated by modified tissue culture (Leaver and
Seawright, 1982). Of particular interest was the use of
calcium ionophore A23187 as a cell stimulant (see Van den
Bosch, 1980). At a concentration of 5pg/ml the calcium
ionophore A23187 stimulated PGF2oc synthesis from the
endometrium of guinea pigs on both Day 7 and Day 15 of the
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Structural Formula of A23187





Figure 4.3 The figure illustrates the free acid of A23187
together with the schematic representation of the A23187-
metal complex
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oestrous cycle. This compound was first discovered as a
carboxylic acid antibiotic which simultaneously uncouples
oxidative phosphorylation and inhibits ATPase of rat liver
mitochondria incubated in a magnesium-free medium (Reed and
Lardy, 1972). The antibiotic acts as a freely mobile
carrier of calcium and magnesium. Pickett, Jesse and Cohen
(1977) using human platelets were able to demonstrate that
1 1
ethyleneglycol-bis-(J3-aminoethylether)-N",IT,N ,N ,-tetraacetic
acid (EGTA; a chelating agent) in the extracellular medium
did not greatly affect the stimulating action of A23187 on
arachidonate release i.e. A23187 had the ability to mobilise
intracellular calcium stores as well as stimulating the
influx of extracellular calcium. However, further
investigations carried out by Poyser (1983) demonstrated that
the stimulating effect of A23187 on prostaglandin release
from the guinea pig endometrium was abolished by removing
extracellular calcium. The discrepancy observed in the
former report was probably due to the inability of EGTA to
remove the calcium ions completely from the extracellular
medium.
It was now generally accepted that the action of A23 187 is to
greatly increase the ability of divalent ions to cross
biological membranes. Stable complexes (Fig. 4.3)
consisting of two molecules of A23187 per divalent cation are
formed which allow the ions to be soluble in organic solvents
(Pfeiffer and Deber, 1979). The following order of ion
specificity is observed with A23187:
Mn2+ >J> Ca2+ = Mg2+ Sr2+.
The series of experiments reported in this subsection
involved the culture of endometrial tissue in the presence of
A23187 to determine the effects of the calcium ionophore on
the release of arachidonate from the different lipid classes
within Day 7 and Day 15 endometrial tissue
Method
Ten guinea pigs, five on Day 7 and five on Day 15 of the
oestrous cycle, were killed by stunning and incising the
neck. In each case, the uterus was rapidly removed and the
endometrium was dissected from the myometrium by cutting away
1mm by 2mm pieces of endometrium. The myometrium was 1;hen
discarded. The endometrial tissue from each guinea pig was
incubated for 24hr in the presence of 62.5}aCi ^H-AA (as the
sodium salt) in 4ml supplemented Medium 199 as described
previously in Section 1(d). After the neutral lipids and
phospholipids were labelled with ^H-AA, the endometrial
tissue was equally distributed among twelve petri dishes.
Each of six petri dishes contained 4ml supplemented Medium
199, which contained 0.1$ bovine serum albumin and 20jig
A23187 in 20pl ethanol. Each of the remaining six control
petri dishes contained 2Qyl ethanol in 4ml supplemented
Medium 199 containing 0.1$ bovine serum albumin. This
arrangement ensured that only the effects of the calcium
ionophore were observed. Two samples of endometrial tissue
were also stored in two glass bottles, each containing 5ml
chloroform and methanol (2:1) at -20°C for further analysis.
Two control petri dishes and two petri dishes containing
calcium ionophore were removed 0.5hr, 3hr or 6hr after the
start of the second incubation period, blotted dry, weighed
and homogenised in 15ml chloroform and methanol (2:"1). The
neutral lipids, arachidonate products and phospholipids were
separated by silicic acid column chromatography as described
in Section 1(e). The solvent used to elute the arachidonate
products was removed by a rotary evaporator at 35°C and the
radioactivity was measured by rinsing the container with 10ml
scintillation fluid which underwent liquid scintillation
counting as described in Section 1(g). The neutral lipids
and phospholipids were separated into their individual
components by thin-layer chromatography (tic) as described in
Section 1(f). Radioactivity on each tic plate was analysed
by liquid scintillation counting as described in Section
1 (g).
Statistical Analysis
All data were analysed by the variance ratio "F" test to
determine if the variances of any groups were unequal.
Where variances were not unequal, data was analysed by the
Student's unpaired 't* test; where variances were unequal,
data was analysed by a modified 't' test for unequal
variances.
Results
The incorporation of ^H-AA after 24hr into the neutral lipids
and phospholipids of Day 7 and Day 15 endometrial tissue was
used as the control for the release of ^H-AA in the absence
and presence of A23187. The data from Day 7 endometrial
tissue indicated that in the absence of A23187 there was no
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Figure 4.4 The graphs indicate the mean total content
(+ s.e.m., n=10) of ^H-arachidonic acid e^sterified to neutral
lipids (NL), phospholipids (PL), free 3H_araChidoni.c acid
(AA) and arachidonate products (Rem) of Day 7 endometrial
tissue over a release period of 6 hr in the absence ( •)
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Figure 4.5 Grapiis indicate the mean total content ( +
s.e.m., n = 10) of -^H-arachidonic acid esterified to
triglyceride (TG) and diglyceride (DG) of Day 7 endometrial
tissue over a release period of 6 hr in the absence ( —)
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Figure 4.6 Graphs indicate the mean total content (+
s.e.m., n=10) of ^H-arachidonic acid esterified into
phosphatidylcholine (PC), phosphatidylethanolamine (PE),
phosphatidylserine + phosphatidylinositol (PS + PI) of Day 7
endometrial tissue over a release period of 6 hr in the
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Figure 4.7 Graphs indicate the mean total content (+
s.e.m., n=10) of ^H-arachidonic acid esierified to neutral
lipids (NL), phospholipids (PL), free -^H-arachidonic acid
(AA) and arachidonate products (Rem) of Day 15 endometrial
tissue over a period of 6 hr in the absence ( ) and
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Figure 4.8 Graphs indicate the mean total content
(+ s'.e.m., n=10) of ^H-arachidonic acid incorporated into
triglyceride (TG) and diglyceride (DG) of Day 15 endometrial
tissue over a period of 6 hr in the absence (■ ) and
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Figure 4.9 Graphs indicate the mean total content (+
s.e.m., n=10) of ^H-arachidonic acid incorporated into
phosphatidylcholine (PC), phosphatidylethanolamine (PE) and
phosphatidylserine + phosphatidylinositol (PS + PI) of Day 15
endometrial tissue over a release period of 6 hr in the
absence (■ ) and presence (- - - -) of 5^ig/ml A23187.
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time period studied (Fig. 4.4). In the presence of A23187
there was also no significant release of ^H-AA from the
neutral lipid or phospholipid classes. In fact, ^H-AA
content in neutral lipids seemed to increase.
The absence or presence of A23187 did not significantly
affect the levels of free ^H-AA and the relatively lower
levels of arachidonate products at any time.
Separation of the neutral lipids and phospholipids of Day 7
tissue into their individual components indicated that all
the lipids incorporated ^H-AA with the exception of
sphingomyelin, cholesterol ester and monoglyceride. Since
the three lipids classes mentioned had incorporated
negligible amounts of ^H-AA, their results were not included
in Fig. 4.5 and Fig. 4.6.
In the presence of A23187 it was clear that there was no
significant release of ^H-AA from triglyceride, diglyceride,
phosphatidylcholine, phosphatidylethanolamine, phosphatidyl-
serine and phosphatidylinositol at any time period studied.
However the triglyceride class seemed to incorporate more ^H-
AA than any other lipid class at 6hr.
The data from Day 15 endometrial tissue indicated that in the
absence of A23187 there was no significant release of ^H-AA
from either the neutral lipids or the phospholipids (Fig.
4.7). The presence of A23187 seemed to have no significant
effect on the release of ^H-AA from any lipid class. The
absence or presence of A23187 did not significantly affect
the levels of free ^H-AA and the relatively lower levels of
arachidonate products at any time. Further separation of
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the neutral lipids and phospholipids of Day 15 tissue
revealed that none of the individual lipid classes exhibited
a significant decrease in JH-AA content at any time period
studied (Fig. 4.8 and Fig. 4.9). In fact, there seemed to
be an increase in ^H-AA content of triglyceride at 6hr.
The monoglyceride, cholesterol ester and sphingomyelin
classes incorporated negligible amounts of ^H-AA therefore
their data were omitted from Fig. 4.8 and Fig. 4.9.
Conclusion
The overall results indicated that the addition of 5jig/ml
calcium ionophore A23187 to the culture medium did not appear
to have a significant effect on ^H-AA release from any of the
lipid classes of Day 7 and Day 15 endometrial tissue.
c) Release of Arachidonic Acid From the Guinea Pig
Endometrium In The Presence of Oestradiol And
Progesterone
Introduction
It has been established that one of the most consistent
histochemical findings in the rat uterus is that the
quantities of stainable neutral lipids fluctuate during the
oestrous cycle (see Beall, 1972). Further biochemical
analysis of the rat uterus confirmed that the decrease in
neutral lipids paralleled the increase in phospholipids
during oestrus whilst the reverse was true at dioestrus
(Biswas and Mukherjea, 1973). In the guinea pig,
histochemical findings demonstrated that minimal amounts of
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Figure 4.10
Structures of oestradiol-l?£(^)and progesterone (B)
neutral lipids were present in the uterine epithelial cells
at oestrus and maximal amounts were present during dioestrus
(Nicol and Snell, 1955). However further biochemical
analysis of the guinea pig uterus indicated that the decrease
caused by the triglyceride component of the neutral lipids/kt
oestrus was not paralleled by an increase in phospholipid
content (Leaver and Poyser, 1981).
It was demonstrated that the deposition of stainable neutral
lipids in the guinea pig uterus required oestrogen and
progesterone administration in a specific time-related manner
(Nicol and Snell, 1955; Snell and Nicol, 1955). Thus
uterine lipid was produced in spayed guinea pigs with
administration of progesterone but only if sensitizing
amounts of oestrogen were given first. Although the
phospholipid content of the guinea pig uterus did not vary
throughout the oestrous cycle there was a significant
(P<0.05) decrease in the amount of arachidonic acid
esterified to phosphatidylcholine on Day 15 of the oestrous
cycle (Leaver and Poyser, 1981). This study suggested that
release of arachidonic acid from phosphatidylcholine was
higher on Day 15 than on Day 7 of the oestrous cycle. As
oestradiol and progesterone are known to be involved with
lipid metabolism, the steroid hormones may be implicated with
the release of arachidonic acid from phospholipids on Day 15
of the cycle, which is a day of high PGF2cc synthesis.
Leaver and Seawright (1982) using a modified tissue culture
demonstrated that oestradiol stimulated PGF-2K output from the
guinea pig endometrium whilst progesterone inhibited PGF^cx
output.
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The experiments reported in this subsection were carried out
to determine whether oestradiol (A) and progesterone (B) (see
Fig. 4.10) affected the release of ^H-AA from the endometrium
of guinea pigs on Day 7 (day of low PGF^ synthesis) and Day
15 (day of high PGF^^ synthesis) of the oestrous cycle.
Methods
Ten guinea pigs, five on Day 7 and five on Day 15 of the
oestrous cycle, were killed by stunning and incising the
neck. In each case the uterus was removed and the
endometrium was dissected from the myometrium by cutting away
1mm by 2mm pieces of endometrial tissue. The myometrium
was discarded. The endometrial tissue from each guinea pig
was cultured in the presence of 25pCi ^H-AA (as the sodium
salt) for 24hr as described previously in Section 1(d).
After the neutral lipids and phospholipids were labelled with
^H-AA, the endometrial tissue was divided into eight samples:
two samples were washed, placed in two glass bottles each
containing 5ml chloroform and methanol (2:1) and stored
at -20°C for further analysis; two samples were placed in
separate petri dishes each containing 4ml supplemented Medium
199 (plus 0.1% bovine serum albumin) and 40ng oestradiol
which had been added in 20pl ethanol; two samples were placed
in two petri dishes each containing 4ml supplemeted Medium
199 (plus 0.1% bovine serum albumin) and 4jjg progesterone
which had been added also in 20^1 ethanol. The remaining
two samples were used as controls and each was incubated in
4ml supplemented Medium 199 (plus 0.1$ bovine serum albumin)
and 20jdl ethanol. The six samples from each guinea pig were
incubated for 24hr as described in Section 1(d). At the end
of this time period the gas in the Kilner jars was renewed
and the samples were incubated for a further 24hr. At the
end of the 48hr culture period each tissue sample was
removed, washed with fresh medium, blotted dry, weighed and
homogenised in 15ml chloroform and methanol (2:1). Neutral
lipids, arachidonate products and phospholipids were
separated by silicic acid column chromatography, as described
in Section 1(e). The excess solvent in the arachidonate
product fraction was removed by a rotary evaporator at 35°C
and 10ml scintillation fluid was used to remove the
radioactivity from each container. Radioactivity was
measured by liquid scintillation counting as described in
Section 1(g). The neutral lipids and phospholipids were
separated into their individual components by thin-layer
chromatography as described in Section 1(f). Radioactivity
in each lipid component was monitored by liquid scintillation
counting as described in Section 1(g).
Statistical Analysis
All data were analysed by the variance ratio 'F' test to
determine if the variances of any groups were unequal.
Where variances were not unequal data was analysed by the
Student'sunpaired 't' test; where variances were unequal,
data was analysed by a modified 't' test for unequal
variances.
Results
After the initial 24hr uptake period it was observed that
both Day 7 and Day 15 tissue had incorporated ^H-AA as
expected. The values for the amounts of ^H-AA present in
neutral lipids and phospholipids after this 24hr labelling
period were then used as the control values in the release
experiments. The results obtained from these release
experiments were divided into two sections:
i) basal release of ^H-AA from lipids of Day 7 and Day 15
endometrial tissue after a 48hr incubation period.
ii) release of ^H-AA from lipids of Day 7 and Day 15
endometrial tissue after a 48hr incubation period in the
presence of 10ng/ml oestradiol or 1000ng/ml progesterone.
i) Analysis of data by the modified ft' test indicated that
there was a significant (P<0.05) decrease in ^H-AA content
from the total amount of lipid present in Day 7 endometrial
tissue after a 48hr incubation period (Fig. 4.11). Further
analysis revealed that ^H-AA seemed to be released in
significant (P-<0.05) quantities from the neutral lipid
fraction only. There was also a significant (P<0.01)
decrease in ^H-AA content of the arachidonate products after
48hr (Fig. 4.11).
Separation of the neutral lipids of Day 7 tissue into their
individual components revealed that there was an apparent
decrease in ^H-AA content of triglycerides, diglycerides and
monoglycerides over the 48hr time period (Fig. 4.12).
Analysis of these results using the modified * t • test
revealed that there was no significant release of ^H-AA from
any of the neutral lipid classes. Separation of the
phospholipids of Day 7 tissue into their individual
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components confirmed that there was no significant release of
^H-AA from any of the phospholipid classes after 24hr (Fig.
4. 12).
Analysis of data by the unpaired 't' test indicated that
there was no significant decrease in ^H-AA content from the
total amount of lipid present in Day 15 endometrial tissue
after a 48hr incubation period (Fig. 4.13). Further
analysis confirmed that ^H-AA was not released in significant
quantities from the neutral lipids, phospholipids or
arachidonate products fractions.
Separation of the neutral lipids of Day 15 tissue into their
individual components confirmed that there was no significant
release of ^H-AA from any of the neutral lipid classes (Fig.
4.14). However separation of the phospholipids of Day 15
tissue into their individual components revealed that there
was a significant(P<0.05) release of ^H-AA from the
phosphatidylcholine class (Fig. 4.14). Using a modified *tf
test, it was demonstrated that there was also a significant
(P<0.05) decrease in ^H-AA content in the phosphatidyl-
ethanolamine class of Day 15 tissue after 48hr. There was no
significant change in ^H-AA content of phosphatidylserine and












The above histograms indicate the mean total (+ s.e.m., n=10)
of ^H-arachidonic acid in the total lipids (total), neutral
lipids (NL), phospholipids (PL) and arachinonate products
(Rem.) of Day 7 endometrial tissue. Incubations were in the
absence (Co) of steroids, in the presence of 10ng/ml
oestradiol (0) for 48 hr, in the presence of 1000ng/ml
progesterone (P) for 48 hr and in the absence (C-j ) of
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Figure 4.12
The above histograms indicate the mean total content (+)
s.e.m., n=10) of ^H-arachidonic acid in the triglyceride
(TG), diglyceride (DG), monog1yceride (MG),
phosphatidylethanolamine (PE), phosphatidy1serine and
phosphatidylinositol (PS + PI) and phosphatidylcholine (PC)
of Day 7 endometrial tissue. Incubations were in the absence
(Co) of steroids, in the presence of 10ng/ml (0) for 48 hr,
in the presence of 1000ng/ml progesterone (P) for 48 hr and
in the absence (C^) of steroids for 48 hr.
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The above histograms indicate the mean total content (+
s.e.m., n=10) of -'H-arachidonic acid in the total lipids
(total), neutral lipids (NL), phospholipids (PL) and
arachidonate products (Rem.) of Day 15 endometrial tissue.
Incubations were in the absence (Co) of steroids, in the
presence of 10ng/ml oestradiol (0) for 48 hr, in the presence
of 1000ng/ml progesterone (P) for 48 hr and in the absence
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The above histograms indicate
s.e.m., n=10) of ^H-arachidonic
diglyceride (DG), monoglyceride
phosphatidylinositol (PS + PI)
absence of steroids (Co), in
oestradiol (0) for 48 hr, in
progesterone (P) for 48 hr and
(C-|) for 48 hr.
the mean total content (+
acid in triglyceride (TG),
(MG), phosphatidylserine and
Incubations were in the
the presence of 10ng/ml
the presence of 1000ng/ml
in the absence of steroids
ii) To determine whether there was a stimulation or
inhibition of release of ^H-AA from the lipids of Day 7 and
Day 15 endometrial tissue in the presence of steroid hormones
it was necessary to compare the ^H-AA content of lipids after
48hr incubation in the absence of steroids with the ^H-AA
content of lipids after 48hr incubation in the presence of
oestradiol or progesterone.
Using either the Student's unpaired 't' test or the modified
't' test for unequal variances as appropriate it was
determined that there was no significant increase or decrease
in ^H-AA content in any of the lipids following a 48hr
incubation in the presence of 10ng/ml oestradiol or 1000ng/ml
progesterone (Fig. 4.11 and Fig. 4.12). Similar findings
were observed in Day 15 tissue (Fig. 4.13 and Fig. H.'lf-)-
Conclusion
Basal release of ^H-AA occurred from the neutral lipid
fraction only (P<(0.05) after a 48hr incubation period on Day
7. As there was no significant decrease in ^H-AA content in
any of the individual components of the neutral lipid
fraction it is possible that there was a general release of
3h-AA from all the neutral lipid classes over the 48hr time
period.There was no release of ^H-AA from phospholipids on
Day 7. However, basal release of ^H-AA occurred from both
phosphatidylcholine and phosphatidylethanolamine of Day 15
endometrial tissue was shown to be significant (P<0.05) after
the 48hr incubation period. The presence of oestradiol
(10ng/ml) and progesterone (1000ng/ml) were shown to have no
significant effect on the basal release of ^H-AA from either
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the neutral lipids or phospholipids of Day 7 and Day 15
endometrial tissue.
Discussion
In all the release experiments carried out in the current
section, prelabelling of the neutral lipids and phospholipids
of the endometrial tissue with ^H-AA was the prerequisite
step. After the 24hr uptake period it was generally observed
(in Sections 4(b) and 4(c)) that both Day 7 and Day 15 tissue
incorporated similar amounts of ^H-AA, unlike the results
reported in Section 2. The use of less ^H-AA per mg of
tissue as an economy measure was probably the reason why the
significant differences in uptake between Day 7 and Day 15
endometrial tissue were not observed here. However the main
"5
purpose of these experiments was to measure JH -AA release,
and uptake of ^H-AA was considered only as a prelabelling
procedure.
The results from Section 4(a) indicated that the basal
release of ^H-AA from the lipid stores was low over the 24hr
incubation period. An accurate assessment of the amount of
^H-AA released was difficult because factors such as (i) the
large variation in the initial uptake of ^H-AA (ii) dilution
of the incorporated ^H-AA by varying amounts of endogenous
fatty acids (Blackwell, Duncombe, Flower, Parsons and Vane,
1977) and (iii) reacylation of released arachidonic acid into
other lipid classes were probably involved. The only
significant release of ^H-AA occurred from diglycerides and
monoglycerides of Day 7 endometrial tissue. The reason for
this occurrence is not yet clear but since an apparent rise
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of mean total content of ^H-AA in triglyceride coincided with
a decrease in the amount of ^H-AA in diglycerides and
monoglycerides then it is possible that some diglyceride was
converted to triglyceride.
Although there were no other significant changes in ^H-AA
content in the lipid classes on either Day 7 or Day 15, it
was evident that there was an apparent greater release of
arachidonic acid after 3hr of incubation from all lipids of
Day 15 compared to Day 7 endometrial tissue. In order to
try and observe a significant release of ^H-AA from any lipid
of the endometrial tissue, further experiments involving the
use of stimuli were carried out.
The calcium ionophore A23187 was used as a stimulus in the
experiments reported in Section Mb). The data observed
indicated that 5}ig/ml calcium ionophore A23187 was unable to
cause a significant release of ^H-AA from any lipid class of
the endometrium. Consideration of the action of the calcium
ionophore is necessary to explain the results. Calcium
ionophore acting to increase the availability of calcium ions
to all enzymes within the cell exhibits a non-specific
action. So although calcium may have activated
phospholipases to release arachidonic acid from phospholipids
(Flower and Blackwell, 1976), enzymes involved in reacylation
were probably also stimulated. Thus, increases in the
activities of acyl-CoA synthetases and acy1-CoA: lyso-
phosphatide acyltransferases would results in reincorporation
of arachidonic acid into the lipids. The stimulation of
enzymes acting in opposition may have obscur ed any effects
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of A23187 on release of ^H-AA from the lipid reservoirs.
At this juncture it was decided that another stimulus must be
utilised, where monitoring may be facilitated by a greater
release of ^H-AA. The use of the steroid hormones
oestradiol and progesterone was decided upon because both
hormones have been implicated in neutral lipid metabolism
(Nicol and Snell, 1955; Snell and Nicol, 1955), and
oestradiol has a known effect on protein synthesis (Mueller
et al., 1961) and phospholipid synthesis (Aizawa and Mueller,
19 6 1 ; Stooner and Gorski, 1 972) in the rat uterus.
Furthermore, Leaver and Seawright (1982) using cultured
guinea pig endometrium have demonstrated that 10ng/ml 17 J3-
oestradiol had the capacity to increase PGF'2K output 6-fold
in Day 7 endometrial tissue and 2-fold in Day 15 endometrium
(from which basal output is 6-fold higher than on Day 7).
The administration of 50ng/ml progesterone resulted in the
inhibition of output of PGF2K from both Day 7 and Day 15
endometrium. Other investigators (Abel and Baird, 1980:
Tsang and Ooi, 1982) have demonstrated a similar response
using proliferative and secretory human endometrium. The
PGF2k in these experiments must be formed from arachidonic
acid available within the tissues studied. The experiments
reported in Section 4(c) were carried out to determine if the
release of arachidonic acid for PGF2K synthesis from any of
the neutral lipid and phospholipid classes of endometrium
from guinea pigs on Day 7 and Day 15 of the oestrous cycle
was affected by oestradiol or progesterone. Tritiated
arachidonic acid content of the lipids were monitored over a
48hr incubation period and compared to controls incubated for
the same time period in the absence of steroids. There was a
significant (P<0.05) basal release of ^H-AA from
phosphatidylcholine and phosphatidylethanolamine of Day 15
endometrial tissue only. It is possible that the increased
basal release of arachidonic acid from phospholipids on Day
15 of the oestrous cycle may account for the increased PGF^
output observed at this time. Neither oestradiol (10ng/ml)
nor progesterone (1000ng/ml) exhibited a significant effect
on the ^H-AA content of any of the lipids on either day.
Since oestradiol stimulated PGF-2K output and progesterone
inhibited PGF^^ output (Leaver and Seawright, 1982) it was
unlikely that the receptors were already occupied by
endogenous steroids.
Since one mole of arachidonic would result in one mole of
PGF2JJ being formed, each gram wet weight of endometrial
tissue containing 1mg arachidonate (Leaver and Poyser, 1981)
has the capacity in theory to produce 1mg PGF2K. The amounts
of arachidonic acid in the uterus and the amounts of PGF2K
synthesized and released from the endometrium have already
been measured by Leaver and Poyser (1981) and Leaver and
Seawright (1982) respectively. Therefore it was possible to
calculate the percentage of the available arachidonate which
is released and converted to PGF2K in Day 7 and Day 15
endometrial tissue.
Table 4.1 Effects of Oestradiol and Progesterone on
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Arachldonate Release from Day 7 and Day 15
Endometrial Tissue
Approximate $ AA Released and Converted
Into PGF-p^ From 1gm Wet Weight
Endometrial xissue
Experiment A Day 7 Day 15
Control 0.8 2.44
Oestradiol (10ng/ml) 2.9 3.7




The data in Table 4.1 indicates that a release of 0.22 to
3.7$ of the total esterified arachidonic acid in the
endometrium would account for the amounts of PGF2cx
synthesized by the endometrium during the culture period.
Since the variation in the initial labelling of endometrial
lipids among animals and among tissue samples for the same
animal is greater than 3.7$, these tissue culture techniques
have proved inadequate to monitor the action of steroids on
the release of arachidonic acid.
A different and perhaps more accurate ap proach for the
determination of the lipid source(s) of the prostaglandin
precursor is now being considered. The idea stems from
investigators utilising single cell preparations and there is
little problem where release studies are concerned. For
example it can be demonstrated that bradykinin stimulates the
release of arachidonic acid from phosphatidylinositol in
mouse fibrosarcoma cells maintained in culture (Bell et al.,
1980). The bradykinin is immediately available to every
cell and the response is very rapid. For a response to be
monitored it is therefore necessary to use cells of one type
only so that all the cells respond in a similar fashion and
at the same time to a stimulus. Since endometrial tissue is
composed of glandular epithelium and stromal cells, current
research must centre around the isolation and maintenance of
the cell types in monolayer culture. To date the
investigators have demonstrated that prostaglandin
biosynthesis in human endometrium is principally a function
of the stromal cells (Gal, Casey, Johnston and MacDonald,
1982). The next stage will probably involve stimulation of
the cells with steroid hormones after prelabelling with ^H-AA
to determine the lipid source(s) of arachidonic acid.
GENERAL DISCUSSION
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The overall evidence from the literature indicates that PGF2K
released during the latter half of the oestrous cycle is the
uterine luteolytic hormone in the guinea pig. The release
of arachidonic acid from some bound source is necessary for
endometrial PGF^qj synthesis as this is the rate-limiting step
in PG synthesis. However the level of free arachidonic acid
available for PG synthesis is influenced by many other
factors as well as those which govern arachidonate liberation
(reviewed in the General Introduction).
In order to study arachidonic acid metabolism within the
uterine cell, the ability to monitor the movements of a
compound behaving in an identical fashion to the endogenous
arachidonate was needed. The use of tritiated arachidonic
acid (^H-AA) fulfilled this requirement. Such a radioactive
tracer technique monitored the fatty acid pattern of
incorporation within the uterine lipids as well as enabling
the products of the cyclooxygenase and probably lipoxygenase
to be detected. There is only one theoretical disadvantage
to this technique i.e. the uptake and release (or "turnover")
of arachidonic acid varies amongst the lipids (Jesse and
Cohen, 1976) such that during the short labelling period, the
distribution of ^H-AA does not match the distribution of
endogenous arachidonic acid among the various lipids. In
the present study, neutral lipids and phospholipids were
approximately equally labelled with 3H-AA, yet phospholipids
contain over 90$ of the endogenous arachidonic acid present
in the guinea pig uterus (Leaver and Poyser, 1981). Also it
is not possible to detect the loss of fatty acids from non-
labelled sources. However, no serious problems were caused
by this objection since all the major neutral lipids and
phospholipids incorporated ^H-AA (previously described in
Section 2). Also the 'turnover' of some of the
phospholipids were monitored by specific radiolabelling
techniques such as those described in Section 3.
In the guinea pig uterus it has been demonstrated that,
although the mass amounts of neutral lipids and phospholipids
are equal, 93% of the total arachidonic acid in the uterus is
esterified to uterine phospholipids (Leaver and Poyser,
1981). Therefore it is possible that the major contribution
of arachidonic acid for PG synthesis in the guinea pig uterus
comes from the phospholipids. If this is the case then
prolonged synthesis of PGs _in vivo would tend to deplete the
available substrates and draw upon the reservoirs of
arachidonic acid in the lipid stores (Lands and Samuelsson,
1963). A mechanism must exist to replenish fatty acids
within these stores. The results presented in Section 2
established that there was an uptake of free ^H-AA into both
the neutral lipids and phospholipids of Day 7 and Day 15
guinea pig endometrial tissue incubated _in vitro for 24hr in
a modified tissue culture system. Analysis of the fatty
acid pattern within the lipids of both tissues indicated that
triglyceride, phosphatidylcholine and phosphatidyl-
ethanolamine incorporated most ^H-AA. Furthermore there was
significantly (P<0.05) and specifically more ^H-AA
incorporated into the phospholipids of Day 15 tissue than
into the phospholipids of Day 7 tissue. On both days, the
incorporation of ^H-AA was higher into phosphatidylcholine
than into phosphatidylethanolamine, although more endogenous
arachidonic acid is found in phosphatidylethanolamine than in
phosphatidylcholine (Leaver and Poyser, 1981). In spite of
the enhanced rate of incorporation of ^H-AA into the
endometrial phospholipids on Day 15 than on Day 7, the amount
of endogenous arachidonic acid bound as phosphatidylcholine
and phosphatidylethanolamine in guinea pig uterus is lower on
Day 15 tha.n on Day 7 (Leaver and Poyser, 1981). This
suggests that the release of arachidonic acid from
phosphatidylcholine and phosphatidylethanolamine in the
guinea pig endometrium is also higher on Day 15 than on Day 7
(Leaver and Poyser, 1981) and that the increased amount of
arachidonic acid released possibly contributes to the
increase in PGF2K synthesis during the latter half of the
oestrous cycle.
The incorporation of the tritiated fatty acid into the
phospholipids could have occurred in two ways, namely by the
de novo synthesis of fresh phospholipid or by acylation of
lysophospholipids by the enzyme acyl-CoA:lysophosphatide
acyltransferase. The results presented in Section 3(b)
established that phosphatidylcholine, the major phospholipid
component of both Day 7 and Day 15 endometrial tissue (see
Section 3(a)) was synthesized by d_e novo synthesis via the
'choline pathway' as well as by stepwise methylation of
phosphatidylethanolamine. However, of the two pathways, the
choline pathway synthesized significantly more (P<0.05)
phosphatidylcholine i.e. it is the major pathway for
phosphatidylcholine synthesis in the guinea pig endometrium
on both Day 7 and Day 15 of the oestrous cycle. The data
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presented in Section 3(b) also indicated that there was no
significant difference between the amounts of phosphatidyl¬
choline synthesised by the choline pathway of Day 7 and Day
15 tissue. Therefore the increased incorporation of ^H-AA
into Day 15 endometrial phosphatidylcholine cannot be
explained by an increase in de novo synthesis. Since
phosphatidylethanolamine is synthesized de novo in a similar
manner to phosphatidylcholine presumably phosphatidyl¬
ethanolamine synthesis was also not increased between Days 7
and 15 of the cycle. Analysis of the synthesis of
phosphatidylinositol also indicated that there was no
difference in activities of the cie novo synthetic pathway or
the phosphatidylinositol cycle between Day 7 and Day 15
endometrial tissue (see Section 3(c)). Consequently the
increased incorporation of arachidonic acid into phospho¬
lipids on Day 15 is not due to an increase in the
biosynthesis of phospholipids. Therefore the increased
uptake of ^H-AA into the phospholipid of Day 15 tissue must
be due to other mechanisms.
Trotter and Ferber (1981) stated that 'the rapid
incorporation of fatty acids into membrane phospholipids
appears to be due to a turnover of fatty acyl chains rather
than the de novo synthesis of phospholipids'. Furthermore,
arachidonic acid is incorporated into phospholipids almost
exclusively by thismechanism in rat and guinea pig liver
microsomes (Hills and Lands, 1968; Yamashita, Hosaka and
Nuna, 1973). An increased uptake of ^H-AA into phospholipids
by this route could be due to one or more of 4 reasons,
namely s
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i) an increase in acyl-CoAilysophosphatide acyltransferase
activity
ii) changes in the amount of lysophospholipid present
iii) an increase in the amount of arachidonyl-CoA present due
to an increase in acyl-CoA synthetase activity
iv) an increase in coenzyme A availablity.
The acyl-CoA:lysophophatide acyltransferase in rat liver has
been shown to be fairly specific for arachidonyl-CoA, being
eight times more active when arachidonyl-CoA rather than
oleoyl-CoA was used as substrate (Yamashita et al., 1973).
Furthermore, Okuyama, Yamada and Ikezawa (1975) used rat
liver to demonstrate that, although maximum velocities for
oleoyl-CoA and arachidonyl-CoA were approximately the same,
more arachidonic acid was incorporated than oleate at very
low concentrations of the acceptor even when both acyl-CoAs
were present at saturating concentrations. This latter
study suggested that different enzymes or different sites on
a single enzyme existed for the transfer of different acyl-
CoAs to lysophospholipids in rat liver (Okuyama et al., 1975).
An increase in activity or affinity of the enzyme, or of the
sites on one enzyme for arachidonyl-CoA, but not for other
acyl-CoAs, towards the end of the oestrous cycle may explain
the increased uptake of ^H-AA but not of ^H-OA (tritiated
oleic acid) on Day 15 (see Section 2).
Changes in the concentration of lysophospholipid have been
shown to affect the rates of incorporation of different fatty
acids into the lysophospholipid in rat liver microsomes
(Holub, MacNaughton and Piekarski, 1979). Low concentrations
of lysophospholipid were found to favour the incorporation of
arachidonic acid and this factor may contribute towards the
increase in the uptake of ^H-AA but not of ^H-OA on Day 15.
The amounts of arachidonyl-CoA synthesized by acyl-CoA
synthetase must also be considered. Until recently it was
assumed that only one acyl-CoA synthetase was present in
tissues (see Groot, Scholte and Hulsmann, 1976). However
platelets have been found to contain an acyl-CoA synthetase
specific for arachidonic acid and a more general acyl-CoA
which reacts with a wide range of fatty acids including oleic
acid (Wilson, Prescott and Majerus, 1982). The existence of
two such enzymes in the guinea pig endometrium with the
specific stimulation of arachidonyl-CoA synthetase towards
the end of the cycle could then explain the increased uptake
of ^h-AA but not of ^H-OA into endometrial phospholipids
observed on Day 15.
Finally, an increase in the amount of coenzyme A available to
a specific acyl-CoA synthetase may favour the equilibrium
towards more arachidonyl-CoA being synthesized, and therefore
more arachidonyl-CoA being available for lysophospholipid
acylation.
The findings in this thesis indicate therefore that the
control of arachidonic acid turnover for PG synthesis
involves a specific increase in the incorporation of
arachidonic acid into the phospholipids of endometrial
tissue, by the acylation of lysophospholipids at the time of
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increased endometrial PGF2o<: synthesis (i.e. after Day 10 of
the cycle). Obviously this hypothesis needs studying
further; additional experiments which could be carried out
must involve the measurement of the amounts of arachidonic
acid incorporated into exogenous lysophospholipids by
endometrial tissue possibly using a radiolabelling technique.
Any increase in the amounts of arachidonic acid incorporated
into lysophospholipids towards the end of the oestrous cycle
may then confirm the importance of this pathway for the
incorporation of arachidonic acid into phospholipids.
The experiments carried out in Section 4 attempted to
identify the lipid classes from which the arachidonate is
released for PG synthesis by Day 7 and Day 15 endometrial
tissue. However, difficulties occurred because only a small
fraction of the arachidonate present is required for PGF2of
synthesis. In the case of platelets, approximately 10$ of
the total arachidonate is released following stimulation by
thrombin (Rittenhouse-Simmons and Deykin, 1981), though in
most other cells the proportion is less. For example mouse
fibrosarcoma cells released 3% of cellular arachidonate in
response to bradykinin, and human umbilical vein endothelial
cells released about 1$ when they were stimulated to produce
prostacylin (see Majerus, Prescott, Hofmann, Neufeld and
Wilson, 1983). In the present study, to determine which
cellular lipid pool liberated arachidonic acid, it was
necessary to substract two large numbers from each other to
get a small difference. The results from Section 4
indicated that the amounts of ^H-AA present in the different
lipid pools following labelling for 24hr and then incubated
further for various periods of time up to 24hr were too
variable among tissue samples for small differences in
arachidonic content (which reflects arachidonic acid release)
to be monitored, even in the presence of a releasing agent
such as the calcium ionophore A23187 or oestradiol. However,
after a 48hr release period, a significant decrease in -^H-AA
content of phosphatidylcholine and phosphatidylethanolamine
on Day 15 was monitored. It is probable, therefore, that
phosphatidylcholine and phosphatidylethanolamine acted as
substrates for hydrolysis in order to release arachidonic
acid for PGF^qj synthesis. To summarise:
i) 90% of endogenous arachidonic acid is present in
phospholipids particularly phosphatidylcholine and
phosphatidylethanolamine (Leaver and Poyser, 1981)
ii) there is a drop in the endogenous content of arachidonic
acid in phosphatidylcholine and phosphatidylethanolamine on
Day 15 compared to Day 7 (Leaver and Poyser, 1981)
iii) there is specific uptake of arachidonic acid into
phospholipids on Day 15
iv) there is specific release of arachidonic acid from
phosphatidylcholine and phosphatidylethanolamine on Day 15.
The above observations indicate that phospholipids
(especially phosphatidylcholine and phosphatidylethanolamine)
may form the source of arachidonic acid for PGF2oc synthesis
in the guinea pig endometrium.
Any release of arachidonic acid from the phospholipid stores
may involve one or a combination of the following mechanisms
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of acylhydrolase activity:
'1) phosphatidylcholine, pho spha t i dy 1 i nos i t o 1 and
phosphatidylethanolamine as substrates for distinct
phospholipase A2 activities
2) phosphatidylinositol as a substrate for sequential
activities of phospholipase C, a diacylglycerol lipase and a
monoacylglycerol lipase
3) phosphatidic acid, generated by sequential actions of a
phospholipase C on phosphatidylinositol and phosphorylation
of the diacylglycerol, may indirectly stimulate phospholipase
A2 attack of phosphatidylcholine and phosphatidylethanolamine
by acting as a calcium ionophore
4) sulpholysis, a CoA-mediated transfer of arachidonic acid
followed by hydrolysis of another phospholipid by phospho¬
lipase A2 (see General Introduction for more detailed
account)«,
The lack of any mass change in phosphatidylcholine and
phosphatidylethanolamine of uterine phospholipids of Day 7
and Day 15 tissue (see Section 3(a)) suggested that
deacylation of esterified arachidonate and the generation of
lysophospholipid followed by a reacylation process was the
possible mechanism of arachidonic acid release in the
endometrial cell.
The minor role played by phosphatidylinositol and
phosphatidylserine in providing arachidonic acid for PG
synthesis is demonstrated by the fact that ^H-AA was
incorporated in very low quantities into the phosphatidyl-
inositol and phosphatidylserine classes over the time period
of 24hr. Work carried out by Leaver and Poyser (1981)
confirmed that the amount of arachidonic acid bound (pg/g
uterus) to phosphatidylinositol and phosphatidylserine was at
least 2 to 3 times lower in value than the amount of
arachidonic acid bound ("Jig/g uterus) to phosphatidylcholine.
The data from Section 3(b) indicated that there was no
increase in inositol incorporation into phosphatidylinositol
on Day 15 i.e. there was no increase in de novo synthesis of
phosphatidylinositol or the activity of the phosphatidyl-
inositol cycle. Also there was no change in phosphatidyl-
inositol content of the endometrium between Day 7 and Day 15.
Such data indicates that the second and third mechanisms of
acylhydrolase activity are of minor importance in the guinea
pig endometrium.
The activity of phospholipase A 2 and the enzymes in
sulpholysis need to be considered. Phospholipase A2 activity
was detected in both the microsomal fraction and supernatant
fraction of guinea pig endometrial homogenates following
centrifugation at 100,000 x g for 60 min (Downing and Poyser,
1983). Between 85 to 95$ of the phospholipase A£ activity
was dectected in the microsomal fraction. The phospholipase
A2 enzyme in both fractions had a pH optimum of 8. There
was a 1.5 to 1.9 fold stimulation in the initial rate of
phospholipase A2 activity between Day 7 and Day 16 of the
oestrous cycle (Downing and Poyser, 1983). However phospho¬
lipase A2 activities on both days were more than adequate to
provide sufficient arachidonic acid for PG synthesis.
Arachidonic acid release from PG synthesis may be governed by
the activatt'on of phospholipase A2 rather than by the absolute
activity of phospholipase A2«
Sulpholysis involves a CoA-mediated transfer of arachidonic
acid from a donor phospholipid to another phospholipid;
subsequently this is followed by hydrolysis of the acceptor
phospholipid by phospholipase A2- If the activity of the
latter enzyme remains unchanged then increased activity of
the enzymes involved in the initial phase of sulpholysis may
be responsible for providing arachidonic acid for PG
synthesis. The enzymes involved are acyl-CoA synthetase and
acyl-CoAilysophosphatide acyltransferase, the same enzymes
responsible for the increased incorporation of ^H-AA into the
phospholipids of Day 15 endometrial tissue (see Section 2).
Therefore arachidonic acid for PG synthesis may be provided
by stimulating the 'turnover' of arachidonic acid at one
focal point i.e. by stimulation of acyl-CoA synthetase and
acyl-CoA ilysophosphat ide acyltransferase to suitably modify
preformed phospholipid molecules and adapt their fatty acid
composition to the requirements of a particular tissue.
Arachidonic acid may be transferred to a phospholipid which
is more available for hydrolysis by phospholipase A2«
It is necessary to determine which phospholipid source is
hydrolysed by phospholipase A2. In rat liver microsomes it
was demonstrated that phosphatidylinositol readily donated
arachidonic acid to phosphatidylcholine (Irvine and Dawson,
1979). In homogenates of mouse thymocytes it was
demonstrated that phosphatidylcholine acted as the
phospholipid donor and lysophosphatidylethanolamine the
acceptor substrate for the CoA-mediated transfer of
arachidonyl moieties (Trotter and Ferber, 1981). Whether
phosphatidylcholine or phosphatidylethanolamine acts as the
substrate for phospholipase A2 action in the guinea pig
endometrium is not known. There is twice as much
arachidonic acid bound (jig/g uterus) to phosphatidyl-
ethanolamine than to phosphatidylcholine but there is
significantly more phosphatidylcholine present in the
endometrium compared to phosphatidylethanolamine (see Section
3(a)). Either of these phospholipids could act as the source
of arachidonic acid for PG synthesis in the guinea pig
endometrium.
Broekman, Ward and Marcus (1981) measured the absolute mass
of fatty acids liberated in the human platelet in response to
thrombin. They showed that the liberation of fatty acids
occurred in roughly the proportion expected if phosphatidyl¬
ethanolamine were the main substrate, as it is when isolated
platelet membranes are incubated _in vitro (Jesse and Cohen,
1976). However the situation was complicated by the fact
that unknown substantial proportions were found metabolised
to eicosanoids. Conclusive evidence in favour of arachidonic
acid being liberated from a specific phospholipid has yet to
be found.
The importance of the fatty acid composition of specific
lipids has been questioned by Hassam, Willis, Denton, Stevens
and Crawford (1979). They demonstrated that in rabbits fed
an essential fatty acid deficient diet, arachidonic acid in
the membranes did not fall over a period of 4 to 8 weeks but
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PGEp PGE2 and PGF^k were depressed in the brain, liver, lung
and eye. These experiments indicated that there would have
been increased cellular linoleic acid uptake followed by
direct synthesis to PGs via arachidonic acid i.e. a membrane
source of PG precursor was not required. However,
Schwartzman, Liberman and Raz (1981) perfused unlabelled
arachidonic acid into a kidney prelabelled with radioactive
arachidonate and demonstrated a release of radioactive PGs.
This experiment suggested that arachidonic acid is not
converted directly to PGs but becomes esterified into a lipid
component of the cell. Therefore the importance of a direct
metabolic link between PGs and linoleic acid has not been
confirmed.
Evidence from the literature (reviewed in the General
Introduction) has implicated the ovarian steroid hormones,
oestradiol and progesterone, in the control of arachidonic
acid turnover for PG synthesis in the guinea pig endometrium.
The hormones may in some way activate the enzymes acyl-CoA
synthetase, acyl-CoA:lysophosphatide acyltransferase and
phospholipase A2 so that specific release of arachidonic acid
occurs. How this activation occurs is still unknown.
Various hypotheses have been suggested such as regulation by
specific association with non-enzymatic proteins, cyclic
adenosine monophosphate and the availability of calcium ions
(see Van den Bosch, 1980). Since most of the enzymes are
calcium dependent it may be that control occurs via
increasing the free calcium concentration. The calcium
ionophore A23187 stimulates PGF2K release from Day 7 and Day
15 guinea pig uterus (Leaver and Seawright, 1982; Poyser and
Brydon, 1983). It has been proposed, therefore, that
oestradiol acting on the progesterone-primed uterus increases
the free intracellular calcium ion concentration thereby
activating phospholipase A2 to release arachidonic acid for
PGF2cc synthesis (Downing and Poyser, 1983). It is possible
that oestradiol and progesterone have an affect on the
lysosomes in which many of the phospholipases are contained
(Liggins, Forster, Grieves and Schwartz, 1977). Gustavii
(1975) suggested that progesterone stabilises the lysosomes
thereby preventing release of phospholipase A2 in human
decidua. Local withdrawal of progesterone then results in
the release of hydrolytic enzymes. The i_n vitro tissue
culture of human and guinea pig endometrium demonstrated a
similar inhibition of arachidonic acid for PG synthesis by
progesterone (Abel and Baird, 1980; Leaver and Seawright,
1981). This mode of control by the ovarian hormones appears
attractive except for the fact that 85 to 95$ of the phospho¬
lipase A2 in guinea pig endometrium is membrane-bound and is,
therefore, not contained in lysosomes. Also lysosomal
phospholipase A2 tends to have maximum activity at pH '4.5 to
5 and not pH "8 as seen for phospholipase A2 in guinea pig
endometrium.
In conclusion, oestradiol and progesterone may act on the
guinea pig endometrium to cause an increased 'turnover' of
arachidonic acid by stimulating acyl-CoA synthetase and acyl-
CoAilysophosphatide acyltransferase so that one or more
specific phospholipids are enriched with the PG precursor.
The increase in activity of phospholipase A2 (Downing and
Poyser, 1983) and PG synthetase levels in the guinea pig
endometrium (Poyser, 1979) means that, following activation
of phospholipase A2 by calcium, a greater release of
arachidonic acid occurs and a greater proportion of the
released arachidonic acid is converted to PGF2K at stages
later in the cycle.
To conclude, increased arachidonic acid turnover for
increased PGF20C synthesis in the guinea pig endometrium
appears to be controlled at two levels namely (i) increased
specific acylation by arachidonic acid of lysophospholipids
and (ii) increased release of arachidonic acid from phospho¬
lipids, particularly phosphatidylcholine and phosphatidyl-
ethanolamine, by stimulation of an acylhydrolytic enzyme
(e.g. phospholipase A2K The subsequent increase in the
release of arachidonic acid from phospholipids after Day 10
of the cycle may be partly responsible for the increased
synthesis of PGF^qj in the guinea pig endometrium at this
time. The published data (see Poyser, 1981) has clearly
shown that PGF-2K released from the uterus is responsible for
the luteolytic action of the uterus, so the mechanisms
controlling arachidonic acid turnover in the endometrium may
have an important and necessary physiological function.
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ABSTRACT
Endometrium from guinea-pigs on Days 7 and 15 of the oestrous cycle
(days of low and high endometrial prostaglandin Fgc production,
respectively) was maintained in tissue culture for periods up to 24 h
(uptake experiments) or 48 h (release experiments). Tritiated
arachidonic acid (%1-AA) was incorporated into endometrial phospholipids
and neutral lipids in a time-dependent manner. After 24 h of culture,
phosphatidylcholine (PC) and phosphatidylethanolamine (PE) were the
major phospholipids, and triglyceride (TG) was the major neutral lipid
which had incorporated "%-AA. PC, PE and phosphatidylserine/
phosphatidylinositol (PS/PI) incorporated significantly more %-AA on
Day 15 than on Day 7. TG also incorporated more ^H-AA on pay 15 than
on Day 7, but the increase was not statistically significant. Tritiated
oleic acid (^H-OA) was incorporated into endometrial phospholipids and
neutral lipids in a time-dependent manner. No increase in uptake of
H-OA occurred on Day 15 compared to Day 7. There appears to be a
specific stimulation of the mechanisms involved in the uptake of
arachidonic acid into guinea-pig endometrium (particularly into the
phospholipids) at the end of the oestrous cycle.
There was little apparent release of ^H-AA from any endometrial
lipid class, except diglyceride (DG) and monoglyceride (MG), on Day 7.
In contrast, there was an apparent 50 to 80% decrease in the ^H-AA
content of several endometrial lipid classes, particularly PC, PE and TG,
on Day 15. Overall, the uptake and release studies suggest that PC, PE
and possibly TG form the source of free arachidonic acid for PGF2a
synthesis by the guinea-pig endometrium.
"'"Present address: Department of Biological Sciences, Napier College,
Colinton Road, Edinburgh EH10 5DT, Scotland.
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INTRODUCTION
There is much evidence that prostaglandin (PG) F2a secreted by the
uterus is responsible for controlling the length of the oestrous cycle
in guinea-pigs (1). Output of PGFga from the uterus in vivo is 10- to
20-fold higher on Day 15 than on Day 7 of the oestrous cycle (2, 3).
Such a difference in output probably cannot be explained solely by the
2- to 3-fold increase in PG synthetase levels which occurs in the
uterus (4); this suggests that the activity of the cyclo-oxygenase enzyme
is limited by the amount of substrate available. Previous studies (5)
have shown that only low levels (1 ug/g tissue) of free arachidonic acid
are present in the guinea-pig uterus, whilst much larger amounts
(1 mg/g tissue) of arachidonic acid are bound to uterine lipids,
predominantly phospholipids and in particular phosphatidylcholine (PC)
and phosphatidylethanolamine (PE). Consequently, arachidonic acid has to
be released from some bound source in the uterus for conversion into
PGF2a. In this study, the turnover of the PG precursor in guinea-pig
endometrium has been investigated by monitoring tritiated arachidonic
acid (3H-AA) uptake into and release from the various lipid classes.
Measurements were made on Days 7 and 15 of the oestrous cycle as these
are, respectively, days of low and high PGFga synthesis by and release
from the guinea-pig uterus (2, 3, 4). The uptake of tritiated oleic
acid (3H-0A) into guinea-pig endometrial lipids on Days 7 and 15 was
also monitored and was compared to the uptake of ^H-AA.
METHODS
Sources of Materials. Arachidonic acid (99% pure and checked by
thin-layer chromatography), L-a-phosphatidylethanolamine Type III,
L-a-phosphatidyl-L-serine, L-a-phosphatidylinositol Grade III,
L-a-phosphatidylcholine Type VII E, cholesterol oleate, sphingomyelin,
monoglyceride standard (33% monopalmitin, 33% monostearin, 33%
monolein), diglyceride standard (33% dipalmitin, 33% diolein, 33%
distearin), and triglyceride standard (25% tristearin, 25% trilinolein,
25% triolein, 25% trilinolein) were all purchased from Sigma Chemical
Co. Ltd., Poole, England; tritiated arachidonic acid (sp. act. 112
Ci/mmol) and tritiated oleic acid (Sp. act. 8.2 Ci/mmol) were purchased
from Amersham International, Amersham, England; Unisil silicic acid
(100 to 200 mesh) was purchased from Clarkson Chemical Co. Inc.,
Williamsport, USA; thin-layer chromatography plates (0.25 mm silica
gel) were purchased from Merck, Darmstadt, Germany; vented petri-dishes
were purchased from Sterilin, Ltd., Teddington, England; Medium 199
(plus Earles salts), glutamine, kanamycin and amphotericin B were
purchased from Flow Laboratories, Irvine, Scotland.
Preparation of the sodium salts of 3H-AA and ^H-OA. Sufficient of
the radioactive fatty acid for each investigation was dissolved in 5 ml
ethanol, which contained phenolphthalein as indicator. Ethanolic
sodium hydroxide (0.1 M) was slowly added until the solution just
changed colour from clear to purple. The solution was then evaporated
to dryness at 35°C on a rotary evaporator, and was dissolved in an
appropriate volume of culture medium.
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Animal Studies. Thirty-two virgin guinea-pigs, weighing between 550 and
850' g, were examined daily and a vaginal smear taken when the vaginal
membrane was open. The first day of the oestrous cycle was taken as the
day before the post-ovulatory influx of leucocytes when cornification
was maximal. All animals had exhibited at least two normal cycles
immediately before being used. Each guinea-pig was killed by stunning
and incising the neck, either on Day 7 or Day 15 of the cycle. The
uterus was rapidly removed and was placed in culture medium. Under
sterile conditions at room temperature, the endometrium was dissected
from the myometrium by cutting away 1 mm by 2 mm portions of endometrium.
The tissue was then allocated to one of the following experiments and was
cultured by a method based on that of Baker and Neal (6). Histological
examination has shown that guinea-pig endometrium remains viable
during tissue culture (7).
Experiment 1 - Uptake Studies
a) Arachidonic acid (AA). Approximately 20 mg endometrial tissue
was placed onto sterile lens paper which lay across a sterile, stainless
steel grid in a vented petri dish. The dish contained 4 ml Medium 199
(plus Earles salts) and glutamine (1%), amphotericin B (2.5 ng/ml),
kanamycin (50 jag/ml) and 10 |jCi ^H-AA (as the sodium salt). This
arrangement enabled the tissue to remain above the culture medium, but
still allowed the medium (containing ^H-AA) to be readily available to
the endometrial tissue by capillary action through the lens paper. Six
dishes containing endometrial tissue were prepared from the uterus of
each guinea-pig. The dishes were placed in modified Kilner jars and
were incubated at 37°C, in the presence of a 1:1 mixture of air/carbon
dioxide (95%:5%) and oxygen/carbon dioxide (95%:5%) at a pressure of
10 lb/in2 , for 3, 9 or 24 h. Two samples were cultured for each time
period. Following incubation, the tissue from each dish was washed in
fresh medium, blotted dry, weighed and homogenised in 15 ml chloroform
and methanol (2:1). Each extract was subjected to silicic acid column
chromatography followed by thin-layer chromatography (tic). Radioactivity
in each lipid extract before column chromatography, and in each lipid
class after both chromatographic procedures was measured by liquid
scintillation counting. Endometrial tissue from five guinea-pigs was
studied on both days.
O
b) Oleic acid (OA)■ Exp. la was repeated but using 10 yCi °H-0A
(as the sodium salt) instead of ^H-AA. Duplicate samples of endometrium
from six guinea-pigs on both Days 7 and 15 were cultured for 3, 9 or 24 h,
extracted and subjected to silicic acid column chromatography. One of
the duplicate samples from four guinea-pigs and both duplicate samples
from two guinea-pigs on each day were further analysed by tic.
Experiment 2 - Release studies.
All portions of endometrial tissue from a guinea-pig were placed
in a single petri dish, containing 4 ml Medium 199 (plus Earles salts
and supplements) and 62.5 pCi %-AA (as the sodium salt), and were
cultured for 24 h, under the same conditions as in Exp. la, in order to
"label" the different lipid classes. The endometrial tissue was then
equally distributed among 6 further petri dishes, containing 4 ml Medium
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199 (plus Earles salts, supplements and 0.1% bovine serum albumin), and
two glass bottles, each containing 5 ml chloroform and methanol (2:1).
The last two samples were stored at -20°C, while the remaining samples
were incubated as in Exp. la for 0.5, 3 or 24 h (two samples for each
period of time). The endometrial tissue samples were then analysed as
in Exp. la.
Details of silicic acid column chromatography.
Each chloroform and methanol extract of endometrial tissue was
taken to dryness on a rotary evaporator at 35°C, resuspended in 5 ml
diethyl ether, and applied to a glass column (1 cm x 10 cm) containing
4 g silicic acid. Each column was eluted in succession by 100 ml
diethyl ether (which elutes neutral lipids and free ^H-AA), 100 ml
diethyl ether and methanol (4:1) (which elutes cyclo-oxygenase and
lipoxygenase products), and 100 ml methanol (which elutes phospholipids).
A comparison of the results before and after column chromatography
indicated that 80% or more of the radioactivity was recovered. All
results were corrected for recovery.
Details of thin-layer chromatography (tic).
a) Neutral lipids were separated into individual lipid classes by
tic using a solvent system of petroleum spirit (b.p. 40° - 60°C), diethyl
ether and acetic acid (75:25:1). Triglyceride (TG), diglyceride (DG),
monoglyceride (MG), cholesterol ester (cho) and AA standards (25 yg of
each) were run simultaneously on each tic plate. Lipids were
visualized by exposure to iodine. Areas on the plate corresponding to
the Rf values of standard lipids were scraped off the tic plates and
were placed into scintillation vials. Diethyl ether (1 ml) was added to
each scintillation vial to extract the neutral lipids, followed by 10 ml
scintillation fluid. Results before and after this separation procedure
showed that between 50% and 90% of the radioactivity placed on the tic
plates was recovered. All results are corrected for recovery.
b) Phospholipids were separated by tic using a solvent system of
methyl acetate, propan-l-ol, chloroform, methanol and 0.25% aqueous
solution of KC1 (25:25:25:10:9). Standards (25 yg) of PC, PE,
phosphatidylserine (PS), phosphatidylinositol (PI) and sphingomyelin (Sph)
were run on each tic plate. Lipids were visualized by iodine vapour and
areas corresponding to the Rp values of the standard lipids were scraped
from the tic plates and placed into scintillation vials. PS and PI ran
very close together on the tic plate and were therefore not separated
for counting purposes. Methanol (1 ml) was added to extract the
phospholipids followed by 10 ml scintillation fluid. The recovery of
radioactivity from the tic plates ranged from 60% to 90%. All results
are corrected for recovery.
Statistical tests.
Appropriate data was analysed by the Student's "t" test.
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RESULTS
Experiment 1 - Uptake Studies.
3
a) Arachidonic acid (AA)■ The total amount of H-AA taken up into
Day 7 and Day 15 guinea-pig endometrial tissue increased with time, and
there was 2 to 3 times more radioactivity incorporated after 24 h than
after 3 h (Fig. 1). Day 15 tissue incorporated more ^H-AA than Day 7
tissue (significantly different (P < 0.05) at 3 h).
More %-AA was incorporated into neutral lipids than into
phospholipids at 3 h on both Days 7 and 15 (Fig. 1). By 24 h, however,
there was no difference in the incorporation of H-AA between the two
lipid pools on Day 7, and more ~%-AA was incorporated into phospholipids
than into neutral lipids on Day 15. The uptake of 3H-AA into neutral
lipids and phospholipids was greater on Day 15 than on Day 7
(significantly different (P < 0.05 and < 0.01, respectively) for
phospholipids at 9 h and 24 h). There were relatively low levels of
free ^H-AA in endometrial tissue at 3, 9 and 24 h on both Days 7 and 15
(Fig. 1).
Incorporation of ^H-AA into the different neutral lipid classes was
in the order of MG > DG > TG » cho at 3 h and TG > MG = DG » cho at 24 h,
on both Days 7 and 15 (Fig. 2). The incorporation of ^H-AA into MG and
DG at 3 h and 9 h was significantly greater (P < 0.05) on Day 15 than on
Day 7. At 24 h, more "%-AA was apparently incorporated into TG, MG and
DG on Day 15 than on Day 7, but none of the differences between the two
days reached statistical significance. Incorporation of ^H-AA into
phospholipids was in the order of PC > PE > PS/PI > Sph on both Days 7
and 15 (Fig. 2). More ^H-AA was incorporated into all phospholipid
classes on Day 15 than on Day 7 (significantly different (P < 0.05) for
PC, PE and PS/PI at 24 h).
b) Oleic acid (OA)■ The total amount of ^H-0A taken up into Day 7
and Day 15 guinea-pig endometrial tissue increased with time, and there
was twice as much radioactivity incorporated after 24 h than after 3 h
(Fig. 3). However, Day 15 tissue incorporated significantly less
(P < 0.05) "%-OA than Day 7 tissue at 3 h and 24 h. Generally more
^H-0A was incorporated into neutral lipids than into phospholipids,
the difference being least marked for the two lipid classes in Day 7
tissue at 24 h. There was a relatively high level of free ^H-OA in
both Day 7 and Day 15 tissue at the three times studied. Incorporation
of ^h—OA into neutral lipids at 3 h and into phospholipids at 24 h was
significantly lower (P < 0.05) on Day 15 than on Day 7 (Fig. 3).
Of the -OA incorporated into neutral lipids, generally more
"%-OA was incorporated into either TG or DG than in MG at 3, 9 and 24 h
on both days (Fig. 4). However, incorporation of ^H-0A into TG and DG
at 3 h was lower on Day 15 than on Day 7 (statistically significant
(P < 0.05) for TG). Also significantly less (P < 0.05) ^H-OA was
incorporated into MG on Day 15 than on Day 7 at 24 h. Uptake of ^H-0A
into cho was low at all times studied, although uptake on Day 7 was
generally higher than on Day 15 (significantly different (P < 0.05)













Figure 1. Mean ( ± s.e.m., n = 10) total uptake of %-arachidonic acid
into Day 7 and Day 15 guinea-pig endometrium during a 24 h culture period,
and its distribution among phospholipids (PL), neutral lipids (NL) and
free ^H-arachidonic acid (AA) (Standard errors for AA are too small to
include).
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Figure 2. Mean ( ± s.e.m., n = 10) uptake of H-arachidonic acid into
triglyceride (TG), monoglyceride (MG), diglyceride (DG), cholesterol
ester (cho), phosphatidylcholine (PC), phosphatidylethanolamine (PE),
phosphatidylserine + phosphatidylinositol (PS + PI) and sphingomyelin
(Sph) in Day 7 and Day 15 guinea-pig endometrium during a 24 h culture
period (Standard errors for cho, and for Sph on Day 7 are too small to
include).
t Significantly higher (P < 0.05) than corresponding Day 7 value.
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Figure 3. Mean ( ± s.e.m., n = 12) total uptake of 3H-oleic acid into
Day 7 and Day 15 guinea-pig endometrium during a 24 h culture period,
and its distribution among phospholipids (PL), neutral lipids (NL) and
free 3H-oleic acid (OA).
t (P < 0.05) ft (P < 0.01) Significantly lower than corresponding
Day 7 value.
* 103DPM/mg tissue xJ03DPM/mg tissue
Day 15
Uptake period(hours) Uptake period(hours)
Figure 4. Mean ( ± s.e.m., n = 8) uptake of ^H-oleic acid into
triglyceride (TG) monoglyceride (MG), diglyceride (DG), cholesterol
ester (cho), phosphatidylcholine (PC), phosphatidylethanolamine (PE)
and phosphatidylserine + phosphatidylinositol (PS + PI) in Day 7 and
Day 15 guinea-pig endometrium during a 24 h culture period.
+ (P < 0.05) ft (P < 0.01) Significantly lower than corresponding
Day 7 value.
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PC > PE > PS/PI (Sph was not studied). Significantly less (P < 0.05)
^H-OA was incorporated into PE and PS/PI, but not into PC, on Day 15
than on Day 7 at 24 h (Fig. 4).
Experiment 2 - Release Studies.
O
There was no apparent release of H-AA from any lipid class in
Day 7 endometrial tissue over the time period studied, except for a
significant decrease (P < 0.05) in the amount of 3H-AA bound to DG and
MG at 24 h compared to 0 h (Figs. 5 and 6). On Day 15, there was a
general 50 to 80% decrease in the 3H-AA content of all lipid classes
over the release period, particularly at 3 h (Figs. 5 and 6). However,
none of the values at 0.5, 3 and 24 h were significantly different from
the corresponding value at 0 h, due to the wide scatter of results.
DISCUSSION
Phospholipids and neutral lipids of guinea-pig endometrium
incorporated 3H-AA and 3H-0A in increasing amounts with time on both
Days 7 and 15 of the oestrous cycle. Of the neutral lipids, 3H-AA and
^H-OA were incorporated predominantly into MG, DG and TG. Only small
quantities of both fatty acids were esterified to cholesterol. 3H-AA
and ^h-OA were incorporated into phospholipids in the order of
PC > PE > PS/PI. It is not possible to compare the amounts of 3H-AA
O
and H-0A incorporated into the different lipids classes because the
quantity of 3H-0A used was much greater than the quantity of 3H-AA
used (10 uCi of both tritiated compounds was used but the specific
activity of 3H-AA was 14 times higher than that of 3H-0A). However,
at 24 h, particularly on Day 15, more of the 3H-0A was incorporated
into neutral lipids while more of the 3H-AA was incorporated into
phospholipids. In vivo, there is a 10- to 15-fold higher incorporation
of endogenous oleic acid than of endogenous arachidonic acid into TG,
while the incorporation of both acids into phospholipids is similar (5).
These observations indicate that there are differences in the
incorporation and relative distribution of arachidonic acid and oleic
acid among the different lipid classes in guinea-pig endometrium.
More "^H-AA was taken up into endometrial tissue on Day 15 than on
Day 7. Although more 3H-AA went into both neutral lipids and
phospholipids, a higher proportion of the increased amount of 3H-AA
taken up was incorporated into phospholipids than into neutral lipids.
In contrast, the uptake of 3H-0A into guinea-pig endometrium did not
increase between Days 7 and 15. In fact, uptake of 3H-0A was lower on
Day 15 than on Day 7 at 3 h (due to a lower incorporation into neutral
lipids) and at 24 H (due to a lower incorporation into phospholipids,
particularly PE and PS/PI).
Levels of free 3H-0A in guinea-pig endometrium were much higher than
the levels of free ^H-AA presumably due, at least in part, to the
conversion of 3H-AA into cyclo-oxygenase and lipoxygenase products.
Approximately 10% of the 3H-AA taken up into endometrial tissue was
metabolized in this way. 12-L-Hydroxy-5,8,10,14-eicosatetranoic acid
(12-HETE) is incorporated into TG in much greater quantities than into
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Figure 5. Mean ( ± s.e.m., n = 10) total content of 3H-arachidonic acid
in Day 7 and Day 15 guinea-pig endometrium, and its distribution among
phospholipids (PL), neutral lipids (NL) and free 3H-arachidonic acid
(AA) during a 24 h release period following a 24 h uptake period
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Figure 6. Mean ( ± s.e.m., n = 10) total content of 3H-arachidonic acid
in triglyceride (TG), monoglyceride (MG), diglyceride (DG), cholesterol
ester (cho), phosphatidylcholine (PC), phosphatidylethanolamine (PE),
phosphatidylethanolamine (PE), phosphatidylserine + phosphatidylinositol
(PS + PI) and sphingomyelin (Sph) in Day 7 and Day 15 guinea-pig
endometrium during a 24 h release period following a 24 uptake period
(Standard errors for cho are too small to include),
t Significantly lower (P < 0.05) than corresponding Day 7 value.
N U „




not known whether the radioactivity in neutral lipids is solely H-AA,
or whether a small proportion of the radioactivity consists also of
3H-12-HETE which has been synthesized from 3H-AA by lipoxygenase
enzymes in the guinea-pig endometrium.
Incorporation of the tritiated fatty acids into phospholipids
could have occurred in two ways, namely by the de novo synthesis of
fresh phospholipid or by acylation of lysophospholipids by the enzyme,
acyl-CoA:lysophosphatide acyltransferase. The latter process is the
most probable since Trotter and Ferber (9) state that "the rapid
incorporation of fatty acids into membrane phospholipids appears to be
due to a turnover of fatty acyl chains rather than the de novo synthesis
of phospholipids". In addition, arachidonic acid appears to be
incorporated into phospholipids exclusively by this mechanism (10, 11).
3
Increased uptake of H-AA into phospholipids on Day 15 could be due
to at least three reasons, namely (i) an increase in acyl-CoA:lyso¬
phosphatide acyltransferase activity, (ii) changes in the amount of
lysophospholipid present, (iii) an increase in the amount of arachidonyl-
CoA present due to an increase in acyl-CoA synthetase activity. However,
if one or more of these mechanisms were operative, the uptake of H-OA
would be expected to increase also. This was found not to be the case.
Consequently, further reasons must be sought to explain the specific
increase in uptake of 3H-AA.
The acyl-CoA:lysophosphatide acyltransferase in rat liver is fairly
specific for arachidonyl-CoA, being eight times more active when
arachidonyl-CoA rather than oleyl-CoA is used as substrate (11).
Furthermore, a subsequent study suggests that different enzymes or
different sites on a single enzyme exist for the transfer of different
acyl-CoAs to lysophospholipids in rat liver (12). Consequently, if
different enzymes or different sites on the same enzyme similarly exist
in guinea-pig endometrium, an increase in activity of the enzyme or of
the sites on one enzyme specific for arachidonyl-CoA towards the end of
the oestrous cycle may explain the increased uptake of H-AA, but not
of ^H-OA, on Day 15. In addition, it has been found that the
concentration of lysophospholipid can affect the rates of incorporation
of different fatty acids into the lysophospholipid, with very low
concentrations favouring the incorporation of arachidonic acid (13).
Consequently, changes in lysophospholipid concentration may also lead to
an increase in the uptake of H-AA, but not of 3H-0A, on Day 15.
Until recently, it has been assumed that only one acyl-CoA
synthetase is present in tissues (see 14). However, platelets have been
found to contain an acyl-CoA synthetase specific for arachidonic acid,
and a more general acyl-CoA which reacts with a wide range of fatty acids,
including oleic acid (15). If two such enzymes exist in guinea-pig
endometrium, a specific increase in arachidonyl-CoA synthetase activity
towards the end of the oestrous cycle could also explain the increased
uptake of ^H-AA, but not of ^H-OA, observed on Day 15. Further study
is obviously required to establish the precise reasons for the increased
uptake of 3H-AA into guinea-pig endometrium on Day 15.
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The incorporation of H-AA was higher into PC than into PE,
although more endogenous arachidonic acid is found in PE than in PC (5).
Furthermore, in spite of the enhanced rate of incorporation of ^H-AA into
endometrial phospholipids on Day 15 than on Day 7, the amount of
endogenous arachidonic acid bound as PC and PE in guinea-pig uterus is
lower on Day 15 than on Day 7 (5). This suggests that the release of
arachidonic acid from PC and PE in guinea-pig endometrium is also higher
on Day 15 than on Day 7. To determine the viability of this hypothesis,
a series of experiments to determine the release of ^H-AA from the
different endometrial lipid classes was carried out. There was little
apparent release of H-AA from any lipid class within the endometrium on
Day 7, except possibly from DG and MG at 24 h. However, whether the
significant decrease in the amount of ^H-AA bound as DG and MG represents
release from these lipid classes or conversion of these intermediate
lipids into other lipid classes, remains uncertain. On Day 15, there was
an apparent release of 3H-AA from most lipid classes, particularly from
PC, PE and TG at 3 h. Due to the wide scatter of the results, no
statistically significant differences were obtained. The wide scatters
were probably due to several reasons, including (i) a large variation in
the initial uptake of 3H-AA, (ii) dilution of incorporated 3H-AA by
varying amounts of endogenous fatty acids, (iii) re-acylation of
released ^H-AA into other lipid classes. Nevertheless, the apparent
higher release of arachidonic acid on Day 15 than on Day 7 may be partly
responsible for the higher output of PGF2a from guinea-pig endometrium,
maintained in tissue culture, on Day 15 than on Day 7 (8).
In conclusion, the present studies indicate that there is enhanced
turnover of arachidonic acid in phospholipids and, to a lesser extent,
in neutral lipids in guinea-pig endometrium on Day 15 compared to Day 7
of the oestrous cycle. Our studies have not shown there to be any one
specific lipid pool in the guinea-pig endometrium which releases
arachidonic acid for conversion into PGF2a> "the uterine luteolytic hormone.
However, PC, PE and possibly TG may form the main pools of arachidonic
acid for PG synthesis. Further tissue culture experiments involving
O
pre-labelling with H-AA then applying an appropriate stimulus known to
increase endometrial PGF20 production (such as oestradiol or A23187) may
provide further information about the source(s) of arachidonic acid for
PGF2a synthesis by the guinea-pig endometrium.
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